KOL | Erika RM von MutiusComprehensive Pneumology Center Munich (CPC-M), German Center for Lung Research (DZL), Munich, Germany; Dr. v. Haunersches Kinderspital, University Hospital, LMU Munich, ... |
Currículum de kol para Erika RM von Mutius
| Year | |
|---|---|
| 2022 | Comprehensive Pneumology Center Munich (CPC-M), German Center for Lung Research (DZL), Munich, Germany; Dr. v. Haunersches Kinderspital, University Hospital, LMU Munich, Munich, Germany; Institute of Asthma and Allergy Prevention (IAP), Helmholtz Zentrum München, Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH). Institute for Asthma and Allergy Prevention, Helmholtz Centre Munich, 85764 Neuherberg, Germany |
| 2021 | Dr von Hauner Children's Hospital, Ludwig Maximilian University, Munich, Germany |
| 2020 | German Center for Lung Research, CPC-M From the Institute of Asthma and Allergy Prevention, Helmholtz Centre Munich, Munich, and the Asthma and Airway Disease Research Center, University of Arizona, Tucson. |
| 2019 | Dr. von Hauner Children's Hospital, Ludwig-Maximilians-Universität Munich, Munich, Germany. Institute for Asthma and Allergy Prevention, Helmholtz Center Munich, German Research Center for Environmental Health, Neuherberg, Germany Dr von Hauner Children's Hospital, Ludwig Maximilian University German Center for Lung Research (DZL) |
| 2018 | Member of the German Centre for Lung Research, Munich, Germany Direktorin, Institut für Asthma und Allergieprävention Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Ingolstädter Landstraße 1, 85764 Neuherberg |
| 2017 | Children Hospital and Children Polyclinic in the Dr. von Haunersches Children Hospital, Ludwig-Maximilians-University, Lindwurmstr. 4, 80337 Munich, Germany Comprehensive Pneumology Center Munich (CPC-M), Member of the German Center for Lung Research (DZL) |
Erika RM von Mutius: Estadísticas de influencia
Sacar un reporte
| Concept | World rank |
|---|---|
| infant contact animals | #1 |
| atopy allergen specificity | #1 |
| asthma genetic effects | #1 |
| 95 asthma | #1 |
| breastfeeding length | #1 |
| ige seasonal allergens | #1 |
| environmental differences finland | #1 |
| yogurt diversity | #1 |
| childhood protective | #1 |
| immune stimulation life | #1 |
| ilcs neonatal mice | #1 |
| phenotype health variables | #1 |
| overweight dresden | #1 |
| menarche hormonal | #1 |
| children acrossolar cohort | #1 |
| expression 17q21 | #1 |
| increased prevalence cough | #1 |
| lower prevalence asthma | #1 |
| atopic sensitization birth | #1 |
| pets crowding | #1 |
| asthma indoor exposure | #1 |
| consumption asthma | #1 |
| recurrent unremitting wheeze | #1 |
| childhood gondii seropositivity | #1 |
| jobs potential confounders | #1 |
| indoor bacterial microbiota | #1 |
| acrossolar | #1 |
| asthmatics asthma phenotypes | #1 |
| dairy products protective | #1 |
| package functionality | #1 |
| jobs asthma risk | #1 |
| childhood bronchial hyperreactivity | #1 |
| germany dresden | #1 |
| positive sensitization egg | #1 |
| lpastimulation | #1 |
| environmental allergens variety | #1 |
| atopy microbial influences | #1 |
| feeding cattle cowsheds | #1 |
| bacterial exposures associations | #1 |
| hrqol farm children | #1 |
| bactoscan | #1 |
| subsample predominant obstruction | #1 |
| associations maternal sensitization | #1 |
| fever farm | #1 |
| phenotypes atopic sensitization | #1 |
| phenotypes lca | #1 |
| lca clinical phenotypes | #1 |
| polymorphisms tbx21 | #1 |
| preschool children predictor | #1 |
| risk mite sensitization | #1 |
| sige association | #1 |
| infant inflammation crp | #1 |
| allergies protective pet | #1 |
| asthma asthma bacteria | #1 |
| allergies endotoxin | #1 |
| “hygiene hypothesis | #1 |
| censored immunological | #1 |
| hypopharynx moraxella | #1 |
| adolescent aging asthma | #1 |
| food diversity year | #1 |
| atopic sensitisation fever | #1 |
| prehireonset odds ratio | #1 |
| association haplotype studies | #1 |
| asthma puberty | #1 |
| increased food diversity | #1 |
| interquartile range asthma | #1 |
| rs2738751 | #1 |
| east germany leipzig | #1 |
| asthma risk class | #1 |
| life fungi humans | #1 |
| prenatal farm | #1 |
| immunity newborn mothers | #1 |
| work ilc2s | #1 |
| munich dresden | #1 |
| age dust microbiota | #1 |
| new onset wheeze | #1 |
| actinomycetes cowsheds | #1 |
| peak airborne moulds | #1 |
| supplementation milk cla | #1 |
| wheeze farm living | #1 |
| non‐farm children | #1 |
| 1314 newborn infants | #1 |
| atopic dermatitis jobs | #1 |
| pattern atopic sensitization | #1 |
| coexpression igg1 | #1 |
| mite exposure risk | #1 |
| actinomycetes alpine farms | #1 |
| followup farm living | #1 |
| 2nd followup challenges | #1 |
| isaac phase data | #1 |
| allergic rhinitis type | #1 |
| th2 th1 gsdma | #1 |
| grass arabinogalactan | #1 |
| chapter 16 epidemiology | #1 |
| rural children w12 | #1 |
| atopy rural subjects | #1 |
| preschool wheezing aor | #1 |
| 9 10yold children | #1 |
| prediction quality snps | #1 |
| adolescence bronchial hyperreactivity | #1 |
| menarche allergic | #1 |
| failure☆ | #1 |
| network construction netcomi | #1 |
| farming allergies | #1 |
| childrens bedrooms cowsheds | #1 |
| microbes epigenetic mechanisms | #1 |
| increased risk rhinoconjunctivitis | #1 |
| childhood asthma allergies | #1 |
| hrqol protective | #1 |
| study parsifal | #1 |
| personal cleanliness | #1 |
| epigenetic regulation mechanism | #1 |
| lpastimulation cord blood | #1 |
| tregs life | #1 |
| tbx21 hlx1 snps | #1 |
| allergies cohort | #1 |
| npsr1 messenger receptors | #1 |
| endotoxin levels samples | #1 |
| atopy farm | #1 |
| pierced ears association | #1 |
| allergoprotective | #1 |
| transcription factors hlx1 | #1 |
| exposure farm | #1 |
| atopic dermatitis increase | #1 |
| food allergy yogurt | #1 |
| farming environments | #1 |
| persistence allergic rhinitis | #1 |
| germany allergic | #1 |
| farming environment development | #1 |
| maternal farm | #1 |
| cowsheds farm animals | #1 |
| amish hutterite children | #1 |
| association ilt4 | #1 |
| quantitative confirmation associations | #1 |
| immune activation populations | #1 |
| kazal type spink5 | #1 |
| cde source | #1 |
| igg4 ige expression | #1 |
| allergic sensitization latex | #1 |
| rora neuropeptide receptor | #1 |
| associations airwayrelated symptoms | #1 |
| igg1 galactosylation levels | #1 |
| agriculture asthma | #1 |
| authors grass arabinogalactans | #1 |
| prenatal animal | #1 |
| farm environments asthma | #1 |
| aor farm exposures | #1 |
| heating children | #1 |
| cowsheds cattle | #1 |
| environments pasture | #1 |
| amish environment | #1 |
| childhood asthma fever | #1 |
| specific exposures cows | #1 |
| prenatal animal contact | #1 |
| allergies cohort studies | #1 |
| seasonal allergens | #1 |
| phenotypes atopic | #1 |
| soot benzene | #1 |
| environmental exposures asthma | #1 |
| stimulation 45yearold children | #1 |
| asthma dresden | #1 |
| oropharyngeal microbiota children | #1 |
| npsr1 tnc | #1 |
| farmingrelated exposures | #1 |
| score total quantity | #1 |
| edta tubes countries | #1 |
| pasture cohort | #1 |
| initial cohort pattern | #1 |
| asthma interactions | #1 |
| farm children microorganisms | #1 |
| otus bacterial diversity | #1 |
| lukas2 birth cohorts | #1 |
| farm fungi humans | #1 |
| strongest predictor atopy | #1 |
| nickel allergy asthma | #1 |
| harmful workplace exposure | #1 |
| farming asthma | #1 |
| menarche allergic rhinitis | #1 |
| protective farm environment | #1 |
| animal contact infancy | #1 |
| ahr acinetobacter lwoffii | #1 |
| living environment children | #1 |
| west germany munich | #1 |
| 3 mm spt | #1 |
| asthma wisc | #1 |
| farm wheeze phenotypes | #1 |
| late introduction egg | #1 |
| pet contact infancy | #1 |
| psychosocial characteristics children | #1 |
| arabinogalactan cde | #1 |
| sige cutoff | #1 |
| atopic smokers baseline | #1 |
| 17q21 risk | #1 |
| microbial exposure sum | #1 |
| damage systemic inflammation | #1 |
| netcomi network construction | #1 |
| farm allergic rhinitis | #1 |
| lower atopy asthma | #1 |
| asthmatic children result | #1 |
| exposure farming environment | #1 |
| phase stratified sample | #1 |
| lca feeding patterns | #1 |
| farming environment protective | #1 |
| doctor allergic rhinitis | #1 |
| airborne fungi actinomycetes | #1 |
| reduced risk allergy | #1 |
| children diabimmune study | #1 |
| farm farm children | #1 |
| asthma farm children | #1 |
| life protective | #1 |
| yogurt year | #1 |
| 95 puberty | #1 |
| 1133 children | #1 |
| alpine farms | #1 |
| mold immune responsiveness | #1 |
| atopic embryonic allergic | #1 |
| solar 2nd followup | #1 |
| 3785 adolescents | #1 |
| childhood design | #1 |
| associations indoor mould | #1 |
| role th2 immunity | #1 |
| igg1 galactosylation predictor | #1 |
| year environmental exposures | #1 |
| dampness bronchial hyperreactivity | #1 |
| traditional upbringing | #1 |
| wheezing fever | #1 |
| grass pollen 95 | #1 |
| analyses isaac phase | #1 |
| protection yogurt | #1 |
| protective factors strategies | #1 |
| persistence bronchial hyperreactivity | #1 |
| unbalanced meat consumption | #1 |
| life maternal atopy | #1 |
| maturation gut microbiome | #1 |
| children automobiles child | #1 |
| childhood asthma age | #1 |
| protection allergic diseases | #1 |
| netcomi functionality | #1 |
| neonatal immune mechanisms | #1 |
| solar iii | #1 |
| parental questionnaires | #1 |
| barns samples | #1 |
| genetic association tnc | #1 |
| marked differences prevalence | #1 |
| farm living symptoms | #1 |
| overweight munich | #1 |
| neonatal mice ahr | #1 |
| selection bias responders | #1 |
| asthma risk lca | #1 |
| stepwise procedure gene | #1 |
| mite sensitization aor | #1 |
| relation late introduction | #1 |
| fever milk consumption | #1 |
| asthma concomitant bhr | #1 |
| asthma aor | #1 |
| advanced surveys | #1 |
| germany prevalence differences | #1 |
| followup solar | #1 |
| 5 years predictor | #1 |
| increased diversity food | #1 |
| farming environment role | #1 |
| tnc npsr1 | #1 |
| farm fever | #1 |
| review hygiene hypothesis | #1 |
| bacterial signals atopy | #1 |
| development preschool wheezing | #1 |
| 95 atopic eczema | #1 |
| 15ans | #1 |
| immune receptors birth | #1 |
| 420lys | #1 |
| followup solar cohort | #1 |
| immune responses birth | #1 |
| rora susceptibility gene | #1 |
| 6 years subtypes | #1 |
| farm animals cats | #1 |
| study rural environment | #1 |
| spts specific ige | #1 |
| protective 6 years | #1 |
| 95 hormonal contraceptives | #1 |
| nct02496468 | #1 |
| food items year | #1 |
| microorganisms animal sheds | #1 |
| exposure mattress dust | #1 |
| phytohemagglutinin ormdl3 | #1 |
| new microscope | #1 |
| sod3 sod3 snps | #1 |
| farming exposure childhood | #1 |
| offspring atopic mothers | #1 |
| farm children bavaria | #1 |
| farm nonfarm children | #1 |
| lumbricoides crude measure | #1 |
| persistence adolescence | #1 |
| protection childhood asthma | #1 |
| tobit regression ranks | #1 |
| stepwise procedure risk | #1 |
| newborn leukocytes surveys | #1 |
| grass arabinogalactan mice | #1 |
| farm protects | #1 |
| pierced ears asthma | #1 |
| asthma diversity | #1 |
| str bhr | #1 |
| immune responsiveness life | #1 |
| south bavarian population | #1 |
| 1 ppg stimulation | #1 |
| common infections infants | #1 |
| farm dwellings children | #1 |
| atopic sensitization | #1 |
| methods solar cohort | #1 |
| farmers nonfarmers children | #1 |
| predominant hyperreactivity subsample | #1 |
| 95 atopic sensitization | #1 |
| 28 dust samples | #1 |
| concomitant bhr 95 | #1 |
| protective effects diversity | #1 |
| sensitised children wheeze | #1 |
| dzl | #1 |
| external microbial | #1 |
| diversity protective effects | #1 |
| asthma richness | #1 |
| loft farm milk | #1 |
| allergic diseases hrqol | #1 |
| tregs age | #1 |
| moisture damage kitchen | #1 |
| 624 children | #1 |
| functionality network differences | #1 |
| peptidoglycan ppg birth | #1 |
| 7 yrs determinants | #1 |
| introduction yogurt | #1 |
| farms farm homes | #1 |
| “atopic march | #1 |
| polysaccharides cde | #1 |
| igein | #1 |
| endotoxin exposure association | #1 |
| farm lifestyles | #1 |
| tnc risk gene | #1 |
| germany breast feeding | #1 |
| features anthroposophic lifestyle | #1 |
| mold subclinical inflammation | #1 |
| asthma atopic disease | #1 |
| tbx21 hlx1 | #1 |
| diseases farm | #1 |
| current asthma age | #1 |
| solar study | #1 |
| children farm children | #1 |
| aa increased atp2a3 | #1 |
| paediatric origins | #1 |
| farm exposure asthma | #1 |
| tnc asthma | #1 |
| crp early age | #1 |
| groups netcomi | #1 |
| predictor immune activation | #1 |
| genetic interaction npsr1 | #1 |
| solar cohort | #1 |
| comparison microbiome data | #1 |
| lca male phenotype | #1 |
| coding region il4ra | #1 |
| evidence allergy prevention | #1 |
| 115 iu | #1 |
| dairying environment pollen | #1 |
| asthma west germany | #1 |
| bronchial hyperreactivity wheezing | #1 |
| risk hutterite children | #1 |
| cutoff 3 mm | #1 |
| rhinoconjunctivitis participation | #1 |
| pasture lukas2 | #1 |
| farm milk exposure | #1 |
| phase international | #1 |
| foxp3 demethylation tregs | #1 |
| tbx21 | #1 |
| countries isaac phase | #1 |
| hlx1 snps cbmcs | #1 |
| exposures pieces | #1 |
| farm environments farms | #1 |
| cd4cd25hi tcells | #1 |
| order covariates | #1 |
| symptoms school age | #1 |
| muramic acid concentration | #1 |
| development asthma | #1 |
| microbial exposure endotoxin | #1 |
| dermatitis symptoms | #1 |
| health services exposure | #1 |
| interaction rora | #1 |
| tregs maternal atopy | #1 |
| solids relation | #1 |
| abundances 6 otus | #1 |
| allergy symptoms childhood | #1 |
| bamse npsr1 | #1 |
| children isaac asthma | #1 |
| barns farm dwellings | #1 |
| predictor igg1 galactosylation | #1 |
| endotoxin levels stables | #1 |
| indoor microbiota development | #1 |
| seasonal rural | #1 |
| clec4e aa | #1 |
| farming children | #1 |
| 95 agmr | #1 |
| children alliance asthma | #1 |
| lpa ppg stimulation | #1 |
| parents allergies | #1 |
| domestic asthma child | #1 |
| farmrelated exposures | #1 |
| dresden munich | #1 |
| selfreported nickel allergy | #1 |
| endotoxin level production | #1 |
| gabriel advanced study | #1 |
| egg aor | #1 |
| cowsheds childrens bedrooms | #1 |
| wheezerelated latent classes | #1 |
| exposure protective | #1 |
| influential factors health | #1 |
| farming environments asthma | #1 |
| higher specificity asthma | #1 |
| stepwise protocol bhr | #1 |
| parsifal‐study | #1 |
| dermatitis depending | #1 |
| maschildren | #1 |
| work overload work | #1 |
| associations dna fingerprinting | #1 |
| aa immunity receptors | #1 |
| children amish children | #1 |
| messenger surveys | #1 |
| asthma turkish | #1 |
| agents reduced risk | #1 |
| current wheeze benzene | #1 |
| cowsheds peak | #1 |
| gpra polymorphisms | #1 |
| incident wheezing women | #1 |
| children amish farms | #1 |
| east germany allergic | #1 |
| 457 iu | #1 |
| computing microbial associations | #1 |
| cohorte pasture | #1 |
| early life insight | #1 |
| allergy prevention studies | #1 |
| psychosocial characteristics asthma | #1 |
| feeding overweight | #1 |
| igg nglycosylation populations | #1 |
| atopic disease bias | #1 |
| farm dairy products | #1 |
| farm homes homes | #1 |
| cattle childrens bedrooms | #1 |
| insight environmental factors | #1 |
| questionnaires childhood | #1 |
| spts agreement | #1 |
| cd4creil13 | #1 |
| life inversely | #1 |
| mold problems children | #1 |
| asthma allergies | #1 |
| protective asthma | #1 |
| farm exposure asthmatics | #1 |
| early phenotypes age | #1 |
| farm exposure igg4 | #1 |
| milk asthma | #1 |
| wheeze asthma questions | #1 |
| environmental exposure age | #1 |
| anthropometric data overweight | #1 |
| microbiome data package | #1 |
| validity food questionnaire | #1 |
| ormdl3 gasdermin | #1 |
| 1120 children | #1 |
| determinants airway responsiveness | #1 |
| regulatory triggering receptor | #1 |
| cleanliness dust parameters | #1 |
| participation rates phase | #1 |
| ddhay fever 95 | #1 |
| latent classes populations | #1 |
| pollen concentration feeding | #1 |
| protective atopic sensitization | #1 |
| allergies | #1 |
| infant adolescent aging | #1 |
| wheezing invertedu shape | #1 |
| farm milk meat | #1 |
| dampness childhood | #1 |
| children rural allergy | #1 |
| 26 farms bavaria | #1 |
| cla allergoprotective capacity | #1 |
| repeated infections life | #1 |
| gpra polymorphisms asthma | #1 |
| protection asthma | #1 |
| allergic rhinitis predictor | #1 |
| wheezing 3rd year | #1 |
| changing gender ratio | #1 |
| rhinoconjunctivitis sex | #1 |
| epidemiologic phenotype | #1 |
| cord blood offspring | #1 |
| 95 late introduction | #1 |
| birth tbx21 | #1 |
| incidence indoor allergens | #1 |
| allergen exposure associations | #1 |
| farm animals childhood | #1 |
| increased atp2a3 fpr2 | #1 |
| allergies existing cohort | #1 |
| ascaris lumbricoides exposure | #1 |
| gabriel study | #1 |
| aa clec4e | #1 |
| microorganisms farms | #1 |
| lukas2 umc | #1 |
| west germany allergic | #1 |
| hyperreactivity expiratory volume | #1 |
| 12 months crowding | #1 |
| w12 ddhay fever | #1 |
| allergic rhinitis menarche | #1 |
| males pierced ears | #1 |
| interaction npsr1 polymorphisms | #1 |
| late introduction solids | #1 |
| otitis fever | #1 |
| asthma german | #1 |
| eczema regions | #1 |
| expiratory volume lca | #1 |
| increased risks rhinoconjunctivitis | #1 |
| gsdma expression | #1 |
| netcomi network | #1 |
| children severe atopy | #1 |
| children preschool conjunctivitis | #1 |
| gasdermin gsdma | #1 |
| school age early | #1 |
| hyperreactive children | #1 |
| tregs asthmatics | #1 |
| prediction farm children | #1 |
| sige spt | #1 |
| network differences groups | #1 |
| transient wheeze age | #1 |
| hyperreaktivität | #1 |
| tubes rnastabilizing solution | #1 |
| crowding dry cough | #1 |
| farm indoor | #1 |
| unifying computational tool | #1 |
| 048 95 95 | #1 |
| demethylation foxp3 demethylation | #1 |
| cd4cd25hi isolated cells | #1 |
| adolescent agriculture | #1 |
| hrqol rural farm | #1 |
| unremitting wheeze | #1 |
| bhr fall | #1 |
| lukas2 lca | #1 |
| bacterial groups prevalence | #1 |
| dgge health outcomes | #1 |
| hypersensitivity infections | #1 |
| kitchen moisture damage | #1 |
| asthma microbiome analysis | #1 |
| bacterial exposures | #1 |
| predominant obstruction | #1 |
| no2 allergic sensitisation | #1 |
| domestic cats child | #1 |
| protective effects asthma | #1 |
| predictive models incidence | #1 |
| development childhood asthma | #1 |
| endotoxin allergy | #1 |
| prehireonset | #1 |
| farm asthma | #1 |
| muramic acid wheezing | #1 |
| maternal atopy secretion | #1 |
| anthroposophic lifestyle features | #1 |
| il4ra association | #1 |
| persistence earlylife exposures | #1 |
| environmental microbial | #1 |
| traditional farms | #1 |
| rs7164773 | #1 |
| classical definitions lca | #1 |
| food sensitization egg | #1 |
| asthma concomitant asthma | #1 |
| preventive measures counselling | #1 |
| managing wheezing | #1 |
| tolllike receptor farmers | #1 |
| aetiology early years | #1 |
| derp1lpa | #1 |
| asthma risk pasture | #1 |
| egg positive sensitization | #1 |
| domestic child child | #1 |
| 035 iu specificity | #1 |
| development allergic illnesses | #1 |
| shop milk | #1 |
| logistic models npsr1 | #1 |
| humans hypopharynx moraxella | #1 |
| no2 traffic counts | #1 |
| ilcs administration | #1 |
| europe protection | #1 |
| 812 children | #1 |
| asthma turkish children | #1 |
| 5–13‐year | #1 |
| subtypes atopic dermatitis | #1 |
| protective allergic diseases | #1 |
| incident wheezing association | #1 |
| associations transient sensitization | #1 |
| agreement association | #1 |
| 5–13‐year school children | #1 |
| respiratory symptoms childhood | #1 |
| farmers children | #1 |
| parasitic infections predictor | #1 |
| contact farm | #1 |
| associations hscrp values | #1 |
| 6 types cheese | #1 |
| ddhay fever | #1 |
| participants solar | #1 |
| respiratory sounds immunity | #1 |
| 17q21 polymorphisms ormdl3 | #1 |
| male poland quality | #1 |
| sige sensitizations symptoms | #1 |
| bronchial obstruction hyperreactivity | #1 |
| farmers anthroposophic families | #1 |
| countries pasture study | #1 |
| farm specific exposures | #1 |
| allergies childhood phase | #1 |
| protective effects exposure | #1 |
| girls late onset | #1 |
| atopic sensitization aor | #1 |
| phase isaac programme | #1 |
| sum indicators | #1 |
| protective farm asthma | #1 |
| cε germline transcript | #1 |
| current asthma soot | #1 |
| fever spt cutoff | #1 |
| agreement spts | #1 |
| atopic diseases association | #1 |
| normal censored | #1 |
| leipzig munich | #1 |
| crobiome data | #1 |
| asthma arabinogalactan | #1 |
| life chronic asthma | #1 |
| allergic diseases cutoff | #1 |
| farm milk asthma | #1 |
| aa hcs | #1 |
| association incident rhinoconjunctivitis | #1 |
| atopic dermatitis adolescence | #1 |
| early age risk | #1 |
| bhr str | #1 |
| allergic rhinitis jia | #1 |
| association spink5 420lys | #1 |
| farm living | #1 |
| animal sheds 28 | #1 |
| 035 iu sige | #1 |
| farm lung function | #1 |
| asthma toll | #1 |
| heattreated milk samples | #1 |
| allergy protective | #1 |
| gpra gene | #1 |
| childhood allergy children | #1 |
| fever atopic sensitization | #1 |
| fpr2 aa | #1 |
| 95 allergen | #1 |
| covariates potential confounding | #1 |
| prevalence atopic sensitisation | #1 |
| ige levels exposure | #1 |
| foxp3 cd4cd25hi | #1 |
| male parents receptors | #1 |
| aa ifih1 expression | #1 |
| asthma tregs | #1 |
| unpasteurized cows milk | #1 |
| children predominant hyperreactivity | #1 |
| ddhay fever children | #1 |
| serum ige levels | #1 |
| asthma rora | #1 |
| pasture cohort lca | #1 |
| exposure farm children | #1 |
| cowshed dust cde | #1 |
| personal cleanliness risk | #1 |
| inhaled steroids dresden | #1 |
| farm dwellings homes | #1 |
| epidemiological evidence consumption | #1 |
| lower atopic sensitization | #1 |
| 585883 | #1 |
| asthmatics hc | #1 |
| protective cheese consumption | #1 |
| bmi allergic dermatitis | #1 |
| microbial exposure asthma | #1 |
| gene expression ilt3 | #1 |
| allergy‐protective effects | #1 |
| fpr2 clec4e | #1 |
| pasture study spt | #1 |
| farming protective farm | #1 |
| ppg lpa ppg | #1 |
| newonset allergic rhinitis | #1 |
| age increased diversity | #1 |
| asthma consumption | #1 |
| mrna expression year | #1 |
| patients neutrophil inflammation | #1 |
| immunity innate infant | #1 |
| asthma questionnaire responses | #1 |
| benzene current wheeze | #1 |
| living farm | #1 |
| asthma austria allergic | #1 |
| wheeze farmers children | #1 |
| wheeze farming exposure | #1 |
| environmental factors sensitization | #1 |
| swinesheds | #1 |
| paper online questionnaires | #1 |
| complementary food year | #1 |
| influential factors phenotype | #1 |
| 9 bronchodilators | #1 |
| atopic dermatitis farm | #1 |
| 20 fall volume | #1 |
| gabriel advanced surveys | #1 |
| wheezing male respiratory | #1 |
| usage preventive measures | #1 |
| wheezing w12 | #1 |
| infant design | #1 |
| farm animals asthma | #1 |
| german peers | #1 |
| npsr1 rora | #1 |
| tregs cd4cd25hi | #1 |
| regression approach order | #1 |
| samples farm dwellings | #1 |
| asthmatics innate leukocytes | #1 |
| provocation time | #1 |
| identification immune phenotypes | #1 |
| observing children | #1 |
| patients treg cells | #1 |
| farms wheeze | #1 |
| kitchen visible mold | #1 |
| wholeto | #1 |
| age asthma child | #1 |
| 1120 german schoolchildren | #1 |
| asthma rhinoconjunctivitis eczema | #1 |
| study questionnaire responses | #1 |
| fever atopic dermatitis | #1 |
| single microbial markers | #1 |
| pets farm animals | #1 |
| treg marker genes | #1 |
| transient wheezing age | #1 |
| data netcomi | #1 |
| occurrence generations | #1 |
| stepwise protocol phase | #1 |
| allergies viral infections | #1 |
| allergies early phenotypes | #1 |
| animal farms substances | #1 |
| association farm | #1 |
| 168fold | #1 |
| farm animal exposure | #1 |
| allergyrisk factors | #1 |
| rs11071559 | #1 |
| atopic embryonic | #1 |
| preschool dermatitis questionnaires | #1 |
| ilt4 cb | #1 |
| identified polymorphisms asthma | #1 |
| class pasture | #1 |
| children 7 yrs | #1 |
| male saline solution | #1 |
| wheeze sensitisation | #1 |
| living area risk | #1 |
| 911 yrs | #1 |
| infancy jia | #1 |
| consumption allergic | #1 |
| farm children hrqol | #1 |
| richness asthma | #1 |
| isolated cd4cd25hi tregs | #1 |
| homes farm dwellings | #1 |
| dgge asthma | #1 |
| ilcs inception | #1 |
| farm milk consumption | #1 |
| prevalence environmental factors | #1 |
| 13 microbial influences | #1 |
| airborne moulds actinomycetes | #1 |
| study prehireonset | #1 |
| solids development | #1 |
| amish hutterite | #1 |
| worldwide asthma epidemic | #1 |
| protective exposures | #1 |
| regular farm animal | #1 |
| igg4 coexpression | #1 |
| helminth parasites exposure | #1 |
| allergies atopic dermatitis | #1 |
| data fetal growth | #1 |
| childhood dampness | #1 |
| atopic eczema 95 | #1 |
| histamine challenges age | #1 |
| maternal farming activities | #1 |
| wheezing children wheezing | #1 |
| mrna expression tregs | #1 |
| t1432c | #1 |
| association farm milk | #1 |
| prevent allergic diseases | #1 |
| allergyprotective potential | #1 |
| asthma bacteria | #1 |
| farm studies | #1 |
| pcr sscp method | #1 |
| allergic allergic dermatitis | #1 |
| current contact asthma | #1 |
| bronchial hyperreactivity age | #1 |
| alliance asthma | #1 |
| wheeze environmental determinants | #1 |
| work overload school | #1 |
| children unification | #1 |
| regular farm | #1 |
| city air pollution | #1 |
| pasture study tubes | #1 |
| methods 2nd followup | #1 |
| skin tests spt | #1 |
| children indoor mould | #1 |
| infants karelia | #1 |
| rora asthma susceptibility | #1 |
| children atopic sensitization | #1 |
| employment new onset | #1 |
| bronchial response wheeze | #1 |
| recurrence atopic dermatitis | #1 |
| allergic diseases protective | #1 |
| helminths protective | #1 |
| allergen exposure age | #1 |
| child environmental pollutants | #1 |
| 95 asthmatic children | #1 |
| estonia environmental differences | #1 |
| rnastabilizing solution | #1 |
| health urbanrural differences | #1 |
| diversity consumed types | #1 |
| allergic germany | #1 |
| menarche hormonal contraceptives | #1 |
| hygiene hypothesis endotoxin | #1 |
| girls allergic rhinitis | #1 |
| th2related genes cytokines | #1 |
| turkish children asthma | #1 |
| visible mold homes | #1 |
| maternal atopy tregs | #1 |
| cough soot | #1 |
| tregs foxp3 demethylation | #1 |
| unprocessed cows milk | #1 |
| farm milk | #1 |
| occurrence allergy | #1 |
| acrossolar study | #1 |
| network construction comparison | #1 |
| mold problems kitchen | #1 |
| tenascin neuropeptide receptor | #1 |
| adolescents jobs | #1 |
| allergies personal cleanliness | #1 |
| obstruktive atemwegserkrankungen | #1 |
| asthma german children | #1 |
| anthroposophic families validity | #1 |
| linens child dust | #1 |
| 30 amish | #1 |
| vehicle traffic asthma | #1 |
| blood ormdl3 | #1 |
| asthma bacterial diversity | #1 |
| association atopic sensitization | #1 |
| allergies year | #1 |
| aa nonallergic asthma | #1 |
| coupled receptor polymorphisms | #1 |
| association occupational disinfectants | #1 |
| gene expression ilt4 | #1 |
| tcells foxp3 | #1 |
| wheeze bronchial | #1 |
| infancy case status | #1 |
| boys fever | #1 |
| aor interquartile range | #1 |
| single taxa groups | #1 |
| lca pasture | #1 |
| children early phenotypes | #1 |
| indicators total quantity | #1 |
| ranks performance | #1 |
| children farmers | #1 |
| wheeze active smoking | #1 |
| 17q21 locus method | #1 |
| factor school behavior | #1 |
| otus farming | #1 |
| health influential factors | #1 |
| factors th1 | #1 |
| repeated episodes fever | #1 |
| asthma symptoms community | #1 |
| occupational disinfectants asthma | #1 |
| yoghurt asthma risk | #1 |
| studies microbial exposures | #1 |
| dresden east germany | #1 |
| common inhalants | #1 |
| children beta 2agonists | #1 |
| maternal farm exposure | #1 |
| rhinitis predictor | #1 |
| gene expression ormdl3 | #1 |
| lps recognition development | #1 |
| followup solar iii | #1 |
| symptoms gender ratio | #1 |
| 95 endotoxin exposure | #1 |
| moderate‐to‐adequate | #1 |
| fever blood samples | #1 |
| pets associations | #1 |
| lps foxp3 demethylation | #1 |
| atopic sensitization development | #1 |
| treatment childhood asthma | #1 |
| accuracy regression approach | #1 |
| rora snps | #1 |
| cleanliness matter | #1 |
| overweight marked differences | #1 |
| 18 months protective | #1 |
| gsdma expression secretion | #1 |
| physiciandiagnosed asthma groups | #1 |
| source arabinogalactan | #1 |
| children road traffic | #1 |
| 18 95 incidence | #1 |
| kitchen living area | #1 |
| mice atopic sensitization | #1 |
| protective childhood | #1 |
| farming nasal samples | #1 |
| 45yearold children protection | #1 |
| allergic rhinitis childhood | #1 |
| risk tcell phenotypes | #1 |
| spink5 kazal type | #1 |
| asthma symptoms adulthood | #1 |
| girls mechanism | #1 |
| ema protective farm | #1 |
| analysis step package | #1 |
| asthma food sensitization | #1 |
| unprocessed farm milk | #1 |
| lpastimulation carriers | #1 |
| diversity microbial exposure | #1 |
| transmaternal asthma protection | #1 |
| higher hscrp values | #1 |
| ormdl3 gsdma expression | #1 |
| protective diversity | #1 |
| alpine farm environments | #1 |
| perinatal influences | #1 |
| dust parameters development | #1 |
| clinical examinations challenges | #1 |
| regulatory responses protection | #1 |
| annual concentrations benzene | #1 |
| allergic illnesses | #1 |
| allergies generations | #1 |
| snps wheeze | #1 |
| allergic diseases questionnaires | #1 |
| allergic rhinitis puberty | #1 |
| atopic sensitization early | #1 |
| farm cowsheds | #1 |
| microbial exposure patterns | #1 |
| 12 months doctor | #1 |
| association farm contact | #1 |
| 95 grass pollen | #1 |
| asthmaprotective farm | #1 |
| netcomi | #1 |
| cumulative incidence finland | #1 |
| secretion life | #1 |
| infections hygiene hypothesis | #1 |
| insight asthma | #1 |
| yogurt cows milk | #1 |
| early development wheeze | #1 |
| unhygienic contact | #1 |
| risk gene asthma | #1 |
| milkassociated cla | #1 |
| antiasthma drugs children | #1 |
| stable dust extract | #1 |
| polymorphisms lps recognition | #1 |
| hlx1 polymorphisms influence | #1 |
| gel variations gels | #1 |
| copd sod3 | #1 |
| puberty infant | #1 |
| allergies topic surveys | #1 |
| school university life | #1 |
| asthmatic farm children | #1 |
| work overload followup | #1 |
| maternal farming | #1 |
| allergic asthmatics asthmatics | #1 |
| ilt4 cord blood | #1 |
| south bavarian | #1 |
| auc spt | #1 |
| 5 years aor | #1 |
| interaction npsr1 protein | #1 |
| 105 years richness | #1 |
| animal sheds barns | #1 |
| crohns disease atopy | #1 |
| late onset menarche | #1 |
| bronchial hyperreactivity childhood | #1 |
| atopy interactions | #1 |
| model bronchial hyperreactivity | #1 |
| transient wheeze asthma | #1 |
| school children germany | #1 |
| farm childhood asthma | #1 |
| protective mechanisms asthma | #1 |
| 95 nonatopic asthma | #1 |
| potential confounders jobs | #1 |
| incident wheezing asthma | #1 |
| feeding patterns risk | #1 |
| asthma bronchial response | #1 |
| consumption farm milk | #1 |
| richness farming | #1 |
| allergy cohort methods | #1 |
| ml1 cohort studies | #1 |
| bhr asthma child | #1 |
| fever atopic | #1 |
| h4 acetylation offspring | #1 |
| hc aa | #1 |
| jia domestic arthritis | #1 |
| hlx1 polymorphisms | #1 |
| juvenile crohn disease | #1 |
| farm exposure exposure | #1 |
| treatment 9 bronchodilators | #1 |
| wheeze classes | #1 |
| prognosis early wheeze | #1 |
| diagnosed fever 95 | #1 |
| throat microbiota | #1 |
| bifidobacterium breastfed infants | #1 |
| antipyretics reduced risk | #1 |
| farm rural children | #1 |
| exposure muramic | #1 |
| asthma protective | #1 |
| provocation time bhr | #1 |
| actinomycetes peak | #1 |
| allergy exposures | #1 |
| npsr1 interaction | #1 |
| unprocessed cow | #1 |
| crude measure exposure | #1 |
| leur relation | #1 |
| antipyretics increased risk | #1 |
| il13cd4 cells ilcs | #1 |
| allergies respiratory infections | #1 |
| asthma 105 years | #1 |
| aetiology atopic disease | #1 |
| positive sensitization | #1 |
| excessive sige production | #1 |
| development allergies | #1 |
| antibiotics allergies | #1 |
| rural allergy endotoxin | #1 |
| sensitisation early | #1 |
| preschool children rhinitis | #1 |
| spt atopic dermatitis | #1 |
| followup work discontent | #1 |
| asthma symptoms adolescence | #1 |
| munich leipzig | #1 |
| environmental exposures protection | #1 |
| life antibiotic exposure | #1 |
| age bacterial endotoxin | #1 |
| topic puberty rhinitis | #1 |
| protection hygiene hypothesis | #1 |
| bronchial hyperreactivity adolescence | #1 |
| adolescent agriculture dust | #1 |
| moisture mold exposure | #1 |
| allergies addition | #1 |
| west germany overweight | #1 |
| analyses provocation time | #1 |
| infant genetic polymorphism | #1 |
| 17q21 polymorphisms | #1 |
| spink5 420lys | #1 |
| tempo method | #1 |
| multicenter cohort prevalence | #1 |
| associations pet contact | #1 |
| cbmcs ormdl3 | #1 |
| rs11079788 | #1 |
| mattress dust association | #1 |
| questionnaire responses asthma | #1 |
| cla content plasma | #1 |
| incident wheezing | #1 |
| model hyperreactivity | #1 |
| exposure gstm1 deficiency | #1 |
| farm reduced prevalence | #1 |
| atopic dermatitis onset | #1 |
| environments asthma | #1 |
| epidemiologic phenotypes | #1 |
| children leipzig | #1 |
| gsdma phytohemagglutinin | #1 |
| 57 911yearold children | #1 |
| th2related genes | #1 |
| development atopic sensitisation | #1 |
| carriers hlx1 | #1 |
| innate immunity receptors | #1 |
| 1 year occurrence | #1 |
| newborn interleukin17 leukocytes | #1 |
| wheezing atopic sensitization | #1 |
| allergoprotective capacity | #1 |
| allergen exposure life | #1 |
| increased expression ormdl3 | #1 |
| pollen dairy farms | #1 |
| lumbricoides farmers children | #1 |
| anti‐asthmatic drugs | #1 |
| generations birth cohort | #1 |
| groups rural areas | #1 |
| protective farming | #1 |
| collected dust indoor | #2 |
| alliance ages | #2 |
| breathomics asthma | #2 |
| immunoglobulin life | #2 |
| probability incidence | #2 |
| highrisk predictors | #2 |
| individual level bhr | #2 |
| asthma child dermatitis | #2 |
| cd14 genotypes asthma | #2 |
| causation environmental associations | #2 |
| exposure farming | #2 |
| cd4cd25hi foxp3 | #2 |
| allergies farming status | #2 |
| nonfarming mothers lipid | #2 |
| adult arm alliance | #2 |
| munich participants | #2 |
| card4 association | #2 |
| nocturnal symptoms spirometry | #2 |
| cd14 maternal exposures | #2 |
| 95 047 95 | #2 |
| il4 gene | #2 |
| farmers children children | #2 |
| milk cd14 | #2 |
| phase isaac | #2 |
| bronchitis east germany | #2 |
| opposite direction children | #2 |
| prenatal farm exposure | #2 |
| ors affluent countries | #2 |
| halle west germany | #2 |
| atopic eczema phenotypes | #2 |
| cd14 1721 children | #2 |
| higher foxp3 | #2 |
| followup university | #2 |
| values edna concentrations | #2 |
| fieldworkers house dust | #2 |
| indoor bacterial | #2 |
| nonfarm homes children | #2 |
| consumption farm | #2 |
| germany asthma | #2 |
| order sensitized patients | #2 |
| th2 cytokines ilc2s | #2 |
| increase parent | #2 |
| frequency nocturnal symptoms | #2 |
| tbx21 gene | #2 |
| atopic sensitization 14 | #2 |
| highdna | #2 |
| nocturnal asthma severity | #2 |
| exposures farm | #2 |
| fdr clinical response | #2 |
| allergen levels socks | #2 |
| maternal immunity gondii | #2 |
| antiidiotypic aspergillosis | #2 |
| eczema lessaffluent countries | #2 |
| th17 markers | #2 |
| life pvalues | #2 |
| asthma crp | #2 |
| developing allergies | #2 |
| t2inflammation | #2 |
| alk samples | #2 |
| amish hutterite homes | #2 |
| measles vaccination infection | #2 |
| asthma parsifal | #2 |
| protection allergy | #2 |
| farm milk pregnancy | #2 |
| bacteriological properties | #2 |
| lower atopy | #2 |
| participants dresden | #2 |
| healthcare precision medicine | #2 |
| bhr individual level | #2 |
| cd14 1721 | #2 |
| association allergic diseases | #2 |
| beta1 endotoxin | #2 |
| asthma observed | #2 |
| pattern missing values | #2 |
| exposure lifestyle factors | #2 |
| 95 protective factors | #2 |
| antibiotic asthma risk | #2 |
| polymorphisms card4 | #2 |
| atopic dermatitis childhood | #2 |
| 95 school level | #2 |
| allergic asthma degradation | #2 |
| current exposure cats | #2 |
| environmental microorganisms children | #2 |
| rna russia | #2 |
| snps inflammatory diseases | #2 |
| agmr 95 | #2 |
| siblings atopic children | #2 |
| il4 il13 pathway | #2 |
| c4ma3 asthma | #2 |
| studies farms | #2 |
| strachan | #2 |
| lessaffluent countries adolescents | #2 |
| cases objective measurements | #2 |
| foxp3 demethylation | #2 |
| rora asthma | #2 |
| childhood lca | #2 |
| fev1 fdr fdr | #2 |
| asthma hygiene hypothesis | #2 |
| demethylation foxp3 | #2 |
| tregs cord blood | #2 |
| premature respiratory | #2 |
| dust endotoxin allele | #2 |
| association opposite direction | #2 |
| atopic dermatitis wheeze | #2 |
| coaacetate | #2 |
| ifnγ levels snps | #2 |
| cd14 1721 association | #2 |
| wheeze bronchial hyperresponsiveness | #2 |
| current paracetamol 95 | #2 |
| tregs demethylation | #2 |
| socks alk samples | #2 |
| affluent countries | #2 |
| card4 protein rhinitis | #2 |
| children nonfarm homes | #2 |
| associations hscrp levels | #2 |
| affluent countries eczema | #2 |
| allergic disorders children | #2 |
| life current symptoms | #2 |
| newonset asthma symptoms | #2 |
| atopic diseases subjects | #2 |
| microbial influences | #2 |
| arg130gln polymorphism linkage | #2 |
| atopic eczema causation | #2 |
| wheeze 12 | #2 |
| hutterite farm children | #2 |
| protein rhinitis allergic | #2 |
| isaac prevalence rates | #2 |
| allergic rhinitis adolescence | #2 |
| bronchial hyperresponsiveness exposure | #2 |
| lifelong farm exposure | #2 |
| time breastfed children | #2 |
| living farms | #2 |
| farmers child cross | #2 |
| animal exposure levels | #2 |
| cd4 cells offspring | #2 |
| early life prevalence | #2 |
| nonfarming families | #2 |
| farmers asthma symptoms | #2 |
| eczema allergic dermatitis | #2 |
| symptom control bmi | #2 |
| severe exacerbations feno | #2 |
| alk samples fieldworkers | #2 |
| messenger receptors tenascin | #2 |
| ages strongest associations | #2 |
| inflammatory diseases allergy | #2 |
| relation dust endotoxin | #2 |
| farmlike indoor microbiota | #2 |
| grass pollen dander | #2 |
| microbial exposure risk | #2 |
| microbial agents association | #2 |
| peptidoglycan ppg | #2 |
| 14 260 | #2 |
| sputum extracellular | #2 |
| interactions asthma | #2 |
| eczema affluent | #2 |
| fev1 score associations | #2 |
| exposure farmers children | #2 |
| agriculture allergens | #2 |
| asthmaassociated aor | #2 |
| cats eczema | #2 |
| 19th century allergic | #2 |
| farming nonfarming families | #2 |
| dresden higher greenness | #2 |
| il13 gene linkage | #2 |
| levels alk samples | #2 |
| asthma symptoms eczema | #2 |
| pha farming mothers | #2 |
| consumption unprocessed | #2 |
| farming exposure | #2 |
| standardized procedure centres | #2 |
| eczema farm exposures | #2 |
| influences development | #2 |
| allele specific ige | #2 |
| pa interrelations | #2 |
| bronchial hyperresponsiveness children | #2 |
| data maternal weight | #2 |
| university baseline | #2 |
| lessaffluent countries | #2 |
| test inhalent | #2 |
| parent asthma | #2 |
| nocturnal asthma life | #2 |
| adult farmers role | #2 |
| microbial exposure study | #2 |
| sensitized patients order | #2 |
| dendritic cells dust | #2 |
| role maternal exposures | #2 |
| prediction asthma | #2 |
| patients childhood symptoms | #2 |
| processed cow | #2 |
| improvements fdr | #2 |
| atopic developing countries | #2 |
| childhood symptoms relapse | #2 |
| asthma symptoms children | #2 |
| current symptoms asthmaassociated | #2 |
| domestic child dust | #2 |
| socks dust | #2 |
| atopic sensitization upregulation | #2 |
| difference endotoxin levels | #2 |
| asthma adolescence | #2 |
| human microbiota asthma | #2 |
| south bavaria | #2 |
| bhr west germany | #2 |
| genetic variation card4 | #2 |
| alternaria animals animals | #2 |
| immune responses function | #2 |
| lipid ppg | #2 |
| asthma cohort | #2 |
| influence cord | #2 |
| affluent countries centers | #2 |
| traditional farm | #2 |
| ga²len harmonization | #2 |
| immunoglobulin nod1 | #2 |
| snps il4 gene | #2 |
| sensitization patterns inhalant | #2 |
| life increased risk | #2 |
| life rural children | #2 |
| study participants levels | #2 |
| study design participation | #2 |
| statistical analysis performance | #2 |
| immunoglobulin analyses children | #2 |
| asthma protection | #2 |
| th17 lineage markers | #2 |
| allergic tolllike receptor | #2 |
| farm animals symptoms | #2 |
| improvements fdr score | #2 |
| low sensitization rates | #2 |
| viable listeria spp | #2 |
| age allergic rhinitis | #2 |
| pha th17 lineage | #2 |
| artemisia olive pollen | #2 |
| asthma symptoms fever | #2 |
| eczema farmers children | #2 |
| associations atopy | #2 |
| dairying eczema | #2 |
| antiige therapy response | #2 |
| children bronchial hyperresponsiveness | #2 |
| tirana mumbai | #2 |
| specificity lca | #2 |
| allele cd14 1721 | #2 |
| antit2 biological therapy | #2 |
| exposure environmental microorganisms | #2 |
| asthmaassociated | #2 |
| childhood phase | #2 |
| hc ca2 | #2 |
| protect development | #2 |
| 17q21 | #2 |
| bhr tirana | #2 |
| new onset wheezing | #2 |
| school level 95 | #2 |
| symptom control pa | #2 |
| 645 children | #2 |
| consumption unpasteurized milk | #2 |
| doctors diagnosed asthma | #2 |
| 047 95 gg | #2 |
| fev1 fdr | #2 |
| increase worldwide | #2 |
| affluent countries associations | #2 |
| c4ma3 biomarker | #2 |
| farming environment mother | #2 |
| sod3 transcript | #2 |
| maternal contact protective | #2 |
| current interpretation | #2 |
| children affluent countries | #2 |
| dander artemisia | #2 |
| asthma phenotypes negative | #2 |
| asthma control pa | #2 |
| allergies cd14 expression | #2 |
| atopic smokers | #2 |
| farming families | #2 |
| farming environment allergies | #2 |
| children dresden | #2 |
| allergic diseases allergies | #2 |
| paracetamol fever | #2 |
| aa hc | #2 |
| gels bands | #2 |
| onset male recurrence | #2 |
| farm children | #2 |
| followup ndvi | #2 |
| ages current paracetamol | #2 |
| amish farms | #2 |
| parsifal study phenotypes | #2 |
| quartile work discontent | #2 |
| age asthma cohort | #2 |
| gmcsf ifnγ levels | #2 |
| fieldworkers absolute levels | #2 |
| pregnancy specific ige | #2 |
| bm190th | #2 |
| igg4 ige levels | #2 |
| exposure life | #2 |
| farms reference | #2 |
| pha maternal farming | #2 |
| fieldworkers dust collection | #2 |
| card4 21596 children | #2 |
| bronchial challenge children | #2 |
| development atopic diseases | #2 |
| children bronchial obstruction | #2 |
| neu5gc role | #2 |
| atopy early life | #2 |
| bronchial hyperresponsiveness allergic | #2 |
| card4 21596 | #2 |
| multivariate analyses haying | #2 |
| geneenvironment interactions asthma | #2 |
| endotoxin allergen exposure | #2 |
| farming families allergies | #2 |
| imposed social isolation | #2 |
| children farm | #2 |
| doctors diagnosis aor | #2 |
| dust samples levels | #2 |
| interval156 | #2 |
| farming anthroposophic | #2 |
| role helminths | #2 |
| phase prevalence rates | #2 |
| associations lessaffluent countries | #2 |
| allergies genetic variation | #2 |
| farming mothers ppg | #2 |
| neu5gc exposure | #2 |
| positive spt sige | #2 |
| positive maternal record | #2 |
| expression innate | #2 |
| association atopic children | #2 |
| relapse newonset | #2 |
| allele card4 21596 | #2 |
| polymorphisms il13 gene | #2 |
| severity spirometric measures | #2 |
| histamine challenges | #2 |
| work discontent | #2 |
| adaptor protein rhinitis | #2 |
| serum levels c4ma3 | #2 |
| nonfarm children | #2 |
| eczema conjunctivitis eczema | #2 |
| environmental exposures mother | #2 |
| childhood obesoty | #2 |
| negative volatile organic | #2 |
| ppg pha | #2 |
| excessive edna production | #2 |
| alk samples levels | #2 |
| wheeze bronchial responsiveness | #2 |
| increased risk employment | #2 |
| fever west germany | #2 |
| rhinitis adolescents | #2 |
| higher greenness quartile | #2 |
| early immune maturation | #2 |
| animal sheds pregnancy | #2 |
| frequency nocturnal asthma | #2 |
| subsample children | #2 |
| environmental microorganisms | #2 |
| asthma meeting | #2 |
| olive pollen dander | #2 |
| isaac atopic eczema | #2 |
| lipid lpa | #2 |
| eczema symptom prevalence | #2 |
| environmental microbial exposure | #2 |
| study participants fieldworkers | #2 |
| leipzig halle | #2 |
| microorganisms dust | #3 |
| eosinophil pathway genes | #3 |
| pcdh1 asthma | #3 |
| col29a1 polymorphisms | #3 |
| farming farm | #3 |
| today1 | #3 |
| animal sheds | #3 |
| rare tlr2 mutations | #3 |
| allergy a20 induction | #3 |
| g1258a | #3 |
| cx3cr1 polymorphisms atopy | #3 |
| sensitisation affluent countries | #3 |
| atopic dermatitis aor | #3 |
| endotoxin milk | #3 |
| sige asthma | #3 |
| 9 mmp9 mmp9 | #3 |
| occurrence rhinitis | #3 |
| 1q31 locus | #3 |
| dcs a20 induction | #3 |
| sod3 extracellular matrix | #3 |
| conjunctivitis paf | #3 |
| allergic asthmatics aa | #3 |
| gni rho | #3 |
| asthma major | #3 |
| polymorphisms gm csf | #3 |
| bhr pcdh1 polymorphisms | #3 |
| ferme | #3 |
| allergic inflammation polymorphisms | #3 |
| allergyprotective | #3 |
| adam33 polymorphisms asthma | #3 |
| 1431c | #3 |
| rhinitis increased risk | #3 |
| children negative spts | #3 |
| severity moisture damage | #3 |
| ppg expression | #3 |
| children bronchial hyperreactivity | #3 |
| domestic arthritis | #3 |
| col29a1 polymorphisms eczema | #3 |
| atopic asthma effects | #3 |
| children african ancestry | #3 |
| asthma identified | #3 |
| european science foundation | #3 |
| irf1 interferon expression | #3 |
| asthma farming environment | #3 |
| col29a1 genetic variants | #3 |
| locus dennd1b | #3 |
| pcr sscp analysis | #3 |
| mmp9 variants mmp9 | #3 |
| sod3 variants | #3 |
| breastfeeding overweight | #3 |
| atopic diseases mutations | #3 |
| t12888c | #3 |
| allergic phenotype polymorphism | #3 |
| allergic disequilibrium rhinitis | #3 |
| il15 il15 associations | #3 |
| affluent countries atopy | #3 |
| susceptibility col29a1 expression | #3 |
| asthma 1431c | #3 |
| 45yearold children | #3 |
| eczema strong association | #3 |
| il15 gene variants | #3 |
| dresden odds ratio | #3 |
| mmp9 influence development | #3 |
| asthma genetic severity | #3 |
| phase international study | #3 |
| individual level questionnaires | #3 |
| cytokine cluster bhr | #3 |
| parent prevalence | #3 |
| farm animals farm | #3 |
| rural areas europe | #3 |
| tlr2 polymorphisms | #3 |
| rhinoconjunctivitis atopic eczema | #3 |
| 280met | #3 |
| eczema farmers | #3 |
| exposure helminths | #3 |
| increased treg cells | #3 |
| asthma snp rs2786098 | #3 |
| throat microbiota asthma | #3 |
| dennd1b asthma | #3 |
| protection contre | #3 |
| populations illness surveys | #3 |
| paf sensitisation | #3 |
| microbiota farm | #3 |
| allergic diseases children | #3 |
| asthma tolllike receptors | #3 |
| dogs exposure | #3 |
| il15 associations | #3 |
| prenatal protection asthma | #3 |
| lwoffii f78 | #3 |
| genetic variation crth2 | #3 |
| doctors diagnosis | #3 |
| stat1 gene variations | #3 |
| children farming | #3 |
| role asthma prevalence | #3 |
| eczema international study | #3 |
| wheeze allergy | #3 |
| regular contact | #3 |
| atopic mothers | #3 |
| maternal tlr | #3 |
| bavaria obesity | #3 |
| 1431c specific ige | #3 |
| col29a1 polymorphisms susceptibility | #3 |
| stat6 gene regulation | #3 |
| experimental asthma progeny | #3 |
| substances protection | #3 |
| nonatopic asthma 95ci | #3 |
| f78 | #3 |
| growing farm | #3 |
| il5 c746t | #3 |
| albania antibody specificity | #3 |
| farm dust endotoxin | #3 |
| disequilibrium rhinitis allergic | #3 |
| nf kappa polymorphism | #3 |
| age 7–10 years | #3 |
| organic waste storage | #3 |
| asthma endotoxin levels | #3 |
| domestic asthma | #3 |
| female fetus immunity | #3 |
| risk nonatopic asthma | #3 |
| effects single snps | #3 |
| associations pcdh1 | #3 |
| c2892 | #3 |
| lukas2 birth | #3 |
| overweight germany | #3 |
| paracetamol risk | #3 |
| german children munich | #3 |
| hygiene hypothesis development | #3 |
| eosinophils matrix metalloproteinase | #3 |
| isaac polymorphisms | #3 |
| c39134a | #3 |
| tlr2 amino acid | #3 |
| perennial allergens paf | #3 |
| il5 il5 c746 | #3 |
| food correction | #3 |
| atopic sensitisation | #3 |
| eczema col29a1 | #3 |
| cd14 association | #3 |
| 1q31 locus dennd1b | #3 |
| hlx1 gene variants | #3 |
| t3085 | #3 |
| farm dwellings | #3 |
| hlx1 gene | #3 |
| protection development | #3 |
| asthma pcdh1 | #3 |
| paf seasonal allergens | #3 |
| eosinophil pathway | #3 |
| countries endotoxin levels | #3 |
| 3099 children | #3 |
| farm contact | #3 |
| young adult europe | #3 |
| col29a1 variants eczema | #3 |
| farming status | #3 |
| questionnaires physical examination | #3 |
| stat6 haplotype | #3 |
| —study | #3 |
| treatment asthma phenotypes | #3 |
| gni measurements | #3 |
| c746t | #3 |
| crosssectional population | #3 |
| auc asthma | #3 |
| rural dwellings | #3 |
| role neu5gc | #3 |
| tlr2 receptor function | #3 |
| protein rhinitis | #3 |
| allergy protection | #3 |
| munich polymorphism | #3 |
| united kingdom albania | #3 |
| children isaac phase | #3 |
| food year | #3 |
| anthroposophic children | #3 |
| vivo expression irf1 | #3 |
| asthma cattle | #3 |
| monocytes lps stimulation | #3 |
| prevalence asthma | #3 |
| mmp9 variants risk | #3 |
| c1407t | #3 |
| crth2 influences development | #3 |
| asthma amino acid | #3 |
| asthma genetic association | #3 |
| population german | #3 |
| cowshed dust | #3 |
| protective farm | #3 |
| ile117thr | #3 |
| hygiene hypothesis | #3 |
| atopy dresden | #3 |
| bias asthma bias | #3 |
| amino acid cx3cr1 | #3 |
| life allergic diseases | #3 |
| culture techniques study | #3 |
| persistent flexural eczema | #3 |
| germany west german | #3 |
| crude measure | #3 |
| work work overload | #3 |
| farms asthma | #3 |
| role adam33 polymorphisms | #3 |
| network construction | #3 |
| jobrelated chronic stress | #3 |
| moraxella colonization | #3 |
| polymorphisms hlx1 gene | #3 |
| puberty risk factors | #3 |
| protocadherin‐1 | #3 |
| current asthma rhinoconjunctivitis | #3 |
| environmental dusts | #3 |
| allergic phenotypes correction | #3 |
| asthma subphenotypes | #3 |
| fever aor | #3 |
| cowshed dust extract | #3 |
| adam33 snps | #3 |
| markers fetal growth | #3 |
| cohort alliance | #3 |
| duration prevalence | #3 |
| asthma protection progeny | #3 |
| pcdh1 polymorphisms associations | #3 |
| wheezing neutrophils | #3 |
| il5 c746 allergic | #3 |
| childhood asthma community | #3 |
| arabinogalactan isolated | #3 |
| forward initiative | #3 |
| dennd1b chromosome | #3 |
| rhinoconjunctivitis paf | #3 |
| paf allergic | #3 |
| hlx1 gene development | #3 |
| putative functional role | #3 |
| atopic female germany | #3 |
| responses innate | #3 |
| european ancestry asthma | #3 |
| samples 1q31 locus | #3 |
| bdnf polymorphisms asthma | #3 |
| 1000 enfants | #3 |
| eczema isaac phase | #3 |
| asthma bordetella | #3 |
| characteristics respiratory | #3 |
| progeny asthma | #3 |
| onset asthma child | #3 |
| bacterial diversity asthma | #3 |
| il15 gene asthma | #3 |
| 53152 | #3 |
| individual level centers | #3 |
| rhinoconjunctivitis conjunctivitis | #3 |
| role atopic sensitization | #3 |
| prenatal protection | #3 |
| asthma atopic sensitization | #3 |
| endotoxin dust samples | #3 |
| endotoxin levels asthma | #3 |
| 95ci nonatopic asthma | #3 |
| prenatal asthma protection | #3 |
| biomaterial collection | #3 |
| col29a1 eczema | #3 |
| life development | #3 |
| prevalence allergies | #3 |
| blatella | #3 |
| blood allergen | #3 |
| col29a1 expression eczema | #3 |
| seasonal allergens atopy | #3 |
| cx3cr1 polymorphisms polymorphism | #3 |
| bhr haplotypes humans | #3 |
| wheezing onset | #4 |
| wheeze ige levels | #4 |
| sas genetics | #4 |
| childhood asthma | #4 |
| nonfarming | #4 |
| lower risk allergy | #4 |
| fever 17 | #4 |
| ige levels associations | #4 |
| 5 13 years | #4 |
| immunity receptors | #4 |
| parental allergic rhinitis | #4 |
| childhood protect | #4 |
| stables farm milk | #4 |
| questionnaires populations | #4 |
| questionnaires adolescent eczema | #4 |
| asthma induction | #4 |
| prevalence random | #4 |
| endotoxin relation | #4 |
| phase 2 allergies | #4 |
| c746 | #4 |
| gene expression receptors | #4 |
| adolescents duration | #4 |
| lrti asthma | #4 |
| inhalant patients | #4 |
| anthroposophic families | #4 |
| particle boluses | #4 |
| current symptoms asthma | #4 |
| tlr2 mutations | #4 |
| stable dust | #4 |
| h20like homeobox | #4 |
| development atopic | #4 |
| neonatal window | #4 |
| children mattresses | #4 |
| minimum battery | #4 |
| bacillus licheniformis spores | #4 |
| agreement spt | #4 |
| increase eczema prevalence | #4 |
| incident sensitization | #4 |
| doctors diagnosis asthma | #4 |
| risk factor symptoms | #4 |
| genotypes cd14 | #4 |
| early identification atopy | #4 |
| secretory receptors allergic | #4 |
| eczema flg mutations | #4 |
| a20 induction | #4 |
| development atopic sensitization | #4 |
| cord blood lipid | #4 |
| allergic diseases humans | #4 |
| benzene no2 | #4 |
| lukas2 | #4 |
| col29a1 gene | #4 |
| allergies children | #4 |
| cromolyns | #4 |
| microbes asthma | #4 |
| birthcohort study | #4 |
| rare tlr2 | #4 |
| exposure cats | #4 |
| predictor wheezing | #4 |
| fatty acids allergic | #4 |
| asthma hygiene | #4 |
| fetal growth asthma | #4 |
| asthma current symptoms | #4 |
| allergic dermatitis allergic | #4 |
| common sensitizations | #4 |
| promoter region arg130gln | #4 |
| parent odds ratio | #4 |
| birth atopic dermatitis | #4 |
| allergy international study | #4 |
| asthma medication exposure | #4 |
| lifetime prevalence asthma | #4 |
| asthma symptoms association | #4 |
| asthma symptoms adults | #4 |
| feeding prevalence | #4 |
| permanovas | #4 |
| 95 gene expression | #4 |
| early life basis | #4 |
| cd4cd25hi tregs | #4 |
| eczema questionnaires adolescent | #4 |
| indoor pollen | #4 |
| risk atopic dermatitis | #4 |
| exposure microbial | #4 |
| human genetic nod1 | #4 |
| microbial compounds | #4 |
| predictors visits | #4 |
| 99th dahlem conference | #4 |
| allergic il5 | #4 |
| tolllike receptors receptor | #4 |
| wheeze bhr | #4 |
| asthma atopic diseases | #4 |
| infections early | #4 |
| cowsheds | #4 |
| dietary habits children | #4 |
| n2267 | #4 |
| atopic dermatitis birth | #4 |
| genes il4r | #4 |
| late phenotype | #4 |
| life childhood | #4 |
| alliance cohort | #4 |
| cx3cr1 polymorphisms | #4 |
| il4r tlr4 | #4 |
| occurrence atopic dermatitis | #4 |
| heating prevalence | #4 |
| glu420lys | #4 |
| asthma phenotype children | #4 |
| questionnaires eczema | #4 |
| environmental dust samples | #4 |
| cough bronchitis | #4 |
| candidate genes wheeze | #4 |
| col29a1 expression | #4 |
| east germany bhr | #4 |
| leisure time activity | #4 |
| genetic rhinitis allergic | #4 |
| farm environment development | #4 |
| ilc2s human asthma | #4 |
| participants fieldworkers | #4 |
| gabriel advanced | #4 |
| children maternal overweight | #4 |
| asthma snps | #4 |
| flexural eczema | #4 |
| t2high asthma | #4 |
| rs2786098 | #4 |
| aetiology asthma | #4 |
| prenatal asthma | #4 |
| cheese consumption | #4 |
| genetic nod1 | #4 |
| high‐sensitivity c‐reactive protein | #4 |
| dust personal | #4 |
| factors wheeze | #4 |
| fever year | #4 |
| adult lung disease | #4 |
| occupational allergy risks | #4 |
| environmental factors development | #4 |
| antibiotics antipyretics | #4 |
| crp blood leukocytes | #4 |
| pro27ser | #4 |
| children farms | #4 |
| groups taxa | #4 |
| german children bavaria | #4 |
| asthma auc | #4 |
| licheniformis spores | #4 |
| sounds rhinitis | #4 |
| children munich | #4 |
| current asthma bhr | #4 |
| allergic ecuador eczema | #4 |
| fever eczema | #4 |
| cats pregnancy | #4 |
| mother role | #4 |
| asthma 3 | #4 |
| spt sige | #4 |
| initial data analysis | #4 |
| study centers phase | #4 |
| severe atopy | #5 |
| phänotypen | #5 |
| rs3771300 | #5 |
| cowshed | #5 |
| childhood isaac phase | #5 |
| linkage development | #5 |
| atopy airway hyperresponsiveness | #5 |
| duration jobs | #5 |
| farming mothers | #5 |
| endotoxin protection | #5 |
| 2nd followup | #5 |
| hlx1 polymorphisms development | #5 |
| ors atopy | #5 |
| receptors innate immunity | #5 |
| ormdl3 gsdma | #5 |
| allergic rhinitis wheeze | #5 |
| 95 reverse causation | #5 |
| agriculture animals | #5 |
| ige regulation | #5 |
| hlx1 variants | #5 |
| pregnancy year | #5 |
| participation behaviour | #5 |
| 2q14 | #5 |
| jf1 msf | #5 |
| c2892t | #5 |
| cats risk factor | #5 |
| asthma endotoxins | #5 |
| incident wheeze | #5 |
| milk exposure | #5 |
| il13cd4 cells | #5 |
| communitybased random sample | #5 |
| cd4cd25hi | #5 |
| disinfectants asthma | #5 |
| pattern sensitization | #5 |
| west german children | #5 |
| dogs symptoms | #5 |
| allergic diseases exposure | #5 |
| trigger factors asthma | #5 |
| asthma child dust | #5 |
| children validity | #5 |
| tnc nps | #5 |
| parental reports asthma | #5 |
| atopy flexural eczema | #5 |
| thr280met | #5 |
| atopic dermatitis age | #5 |
| allergystudy | #5 |
| tbx21 promoter activity | #5 |
| tbx21 combination | #5 |
| cd14 gene expression | #5 |
| 26 farms | #5 |
| ornonaffluent | #5 |
| mmp9 influence | #5 |
| combination hlx1 variants | #5 |
| ors positive association | #5 |
| nonfarmers children | #5 |
| cow milk samples | #5 |
| young adults methods | #5 |
| genetic asthma | #5 |
| mechanism environmental factors | #5 |
| rhinitis increase | #5 |
| 95 populationattributable risk | #5 |
| nod1 variation | #5 |
| current symptoms rhinoconjunctivitis | #5 |
| visits predictors | #5 |
| milk odds | #5 |
| sensitization atopic | #5 |
| environmental dust | #5 |
| tbx21 gene variants | #5 |
| neu5gc mice | #5 |
| processing intensity | #5 |
| risk atopic | #5 |
| exposure rhinitis | #5 |
| lung health disease | #5 |
| asthma girls | #5 |
| atopic eczema allergic | #5 |
| subtypes risk | #5 |
| 14452 | #5 |
| tbx21 polymorphisms development | #5 |
| life questionnaires switzerland | #5 |
| hyperreactivity child | #5 |
| puberty menarche | #5 |
| milk consumption age | #5 |
| moisture mold problems | #5 |
| wisconsin infant | #5 |
| female germany allergic | #5 |
| consumption 4 years | #5 |
| popular terms | #5 |
| verlaufsformen | #5 |
| rural subjects | #5 |
| combination hlx1 polymorphisms | #5 |
| flexural eczema strength | #5 |
| helsinki alert | #5 |
| delayed manifestation | #5 |
| influence ige | #5 |
| allergen 95 | #5 |
| inverse association overweight | #5 |
| taxa groups | #5 |
| associations wheeze | #5 |
| atopic sensitization asthma | #5 |
| airway responsiveness age | #5 |
| timing exposures | #5 |
| n1046 | #5 |
| il13cd4 | #5 |
| dresden | #5 |
| moulds actinomycetes | #5 |
| children current wheeze | #5 |
| eczema relation | #5 |
| tests bronchitis | #5 |
| adulthood asthma | #5 |
| genetic variants tbx21 | #5 |
| asthma medication 95 | #5 |
| allergens needed | #6 |
| parsifal | #6 |
| allergic epistasis | #6 |
| allergic markers | #6 |
| lifestyle factors symptoms | #6 |
| german nationality | #6 |
| 939 children | #6 |
| 11094 | #6 |
| oropharyngeal microbiota | #6 |
| inversely asthma | #6 |
| rhinoconjunctivitis eczema | #6 |
| longitudinal populations | #6 |
| polymorphisms stat6 gene | #6 |
| bolus dispersion | #6 |
| sensitisation exposure | #6 |
| 14 genes tripeptidylpeptidases | #6 |
| cold air challenge | #6 |
| dipeptidyl peptidases tripeptidylpeptidases | #6 |
| dogs environmental exposure | #6 |
| sounds surveys | #6 |
| complete screening | #6 |
| tests asthma | #6 |
| 17q12q21 earlier onset | #6 |
| farm nonfarm | #6 |
| steiner schools | #6 |
| children east germany | #6 |
| children positive spt | #6 |
| pair deubiquitinating enzyme | #6 |
| lung barrier | #6 |
| lowgrade inflammation hscrp | #6 |
| il33 17q12q21 | #6 |
| asthma transition | #6 |
| pierced ears | #6 |
| susceptibility gene asthma | #6 |
| children farming environment | #6 |
| new locus time | #6 |
| hypertonic skin tests | #6 |
| natural atopic dermatitis | #6 |
| countries albania | #6 |
| allergic immunologic receptors | #6 |
| pair male nod2 | #6 |
| fever wheezing | #6 |
| rora npsr1 | #6 |
| progression asthma | #6 |
| data 7 years | #6 |
| fever atopy | #6 |
| genetic variants 17q12q21 | #6 |
| overweight data | #6 |
| allergoprotective properties | #6 |
| 7 years association | #6 |
| childhood asthma phenotypes | #6 |
| prevent allergic | #6 |
| current contact | #6 |
| atemwegserkrankungen | #6 |
| interactions farm exposures | #6 |
| tlr1 tlr10 | #6 |
| deubiquitinating enzyme tao | #6 |
| childhood aa | #6 |
| allergic diseases | #6 |
| central europe asthma | #6 |
| sscp method | #6 |
| devenues | #6 |
| european dairy farms | #6 |
| protection allergies | #6 |
| isaac programme | #6 |
| asthma allergic sensitisation | #6 |
| childhood asthma genes | #6 |
| abschnitten | #6 |
| study rarer snps | #6 |
| genetic variants time | #6 |
| yearly interviews | #6 |
| nonaffluent | #6 |
| bavarian preschool children | #6 |
| dust collection | #6 |
| tripeptidylpeptidases subunit p40 | #6 |
| asthma authors | #6 |
| eating environmental | #6 |
| distinct underlying mechanisms | #6 |
| 5 regions tao | #6 |
| responders frequency | #6 |
| comprehensive questionnaires | #6 |
| primary preventive strategies | #6 |
| no2 current asthma | #6 |
| allergy tests children | #6 |
| asthma context | #6 |
| rhinoconjunctivitis atopic | #6 |
| asthma austria | #6 |
| 16q12 region | #6 |
| central europe interactions | #6 |
| strategies disease | #6 |
| onset disease germany | #6 |
| food allergy 95 | #6 |
| systemic inflammation age | #6 |
| nd132656 | #6 |
| microorganisms samples | #6 |
| asthma genotypes | #6 |
| infectious diseases phenotype | #7 |
| childhoodonset disease | #7 |
| invading microorganism | #7 |
| child dust | #7 |
| farm exposure | #7 |
| 95 endotoxin | #7 |
| genetic predisposition role | #7 |
| farm life | #7 |
| highrisk occupations | #7 |
| chemokine cx3cl1 cx3cr1 | #7 |
| large centres | #7 |
| isaac eczema | #7 |
| allergy antibiotics | #7 |
| 5 harmonization | #7 |
| children international study | #7 |
| hypersensitivity male | #7 |
| questionnaires phase | #7 |
| asthma school age | #7 |
| perennial allergen | #7 |
| infantis populations | #7 |
| pbmcs asthmatics | #7 |
| children breast | #7 |
| fetal development allergic | #7 |
| association cord blood | #7 |
| strategies asthma | #7 |
| inverse association consumption | #7 |
| questionnaires allergic | #7 |
| pregnancy atopic dermatitis | #7 |
| wheeze atopy | #7 |
| juvenile inflammatory | #7 |
| interleukin4 sequence analysis | #7 |
| stat1 gene | #7 |
| aerosol bolus dispersion | #7 |
| centers increase | #7 |
| environmental factors children | #7 |
| bhr current asthma | #7 |
| functional phenotypes | #7 |
| secretory receptors | #7 |
| inhalant age | #7 |
| grass rphl | #7 |
| lower risk asthma | #7 |
| wheeze 12 months | #7 |
| hypertonic sensitivity | #7 |
| log2fold | #7 |
| foxp3 blood | #7 |
| exposure farms | #7 |
| birth cohorts report | #7 |
| cells dust | #7 |
| fieldworkers | #7 |
| immunologic receptors allergic | #7 |
| reference exposure | #7 |
| preanalytix | #7 |
| indoor moisture | #7 |
| influence neonatal | #7 |
| exposure neu5gc | #7 |
| steiner school children | #7 |
| lung sod3 | #7 |
| hutterite children | #7 |
| asthma fever | #7 |
| school age asthma | #7 |
| paracetamol year | #7 |
| symptoms adulthood | #7 |
| biomarker immune activation | #7 |
| level variety | #7 |
| seasonal sensitivity allergic | #7 |
| pasture study | #7 |
| rhinitis early childhood | #7 |
| childrens bedrooms | #7 |
| breastfeeding prevalence | #7 |
| diversity introduction | #7 |
| children prognosis | #7 |
| asthma environmental factors | #7 |
| european science | #7 |
| birth function | #7 |
| nonfarm homes | #7 |
| murine offspring | #7 |
| pasture birth | #7 |
| fever atopic asthma | #7 |
| environmental exposure endotoxin | #7 |
| allergic atopic embryonic | #7 |
| polymorphisms il4 gene | #7 |
| 15245 | #7 |
| steiner school | #7 |
| lymphoid cells asthma | #7 |
| children regular contact | #7 |
| levels farm | #7 |
| amish children | #7 |
| atopic dermatitis association | #7 |
| viral infections development | #7 |
| endotoxin allergen | #7 |
| adult farmers | #7 |
| atopic europe | #7 |
| farm homes | #7 |
| indoor microbiota | #8 |
| influence cytokine | #8 |
| children reference | #8 |
| proteins dendritic cells | #8 |
| finlande | #8 |
| p7×10−14 | #8 |
| age positive spts | #8 |
| asthma bias | #8 |
| asthma physiciandiagnosed asthma | #8 |
| repeats sequence homology | #8 |
| association food diversity | #8 |
| surveyed children | #8 |
| allergies childhood | #8 |
| childhoodonset disease elevation | #8 |
| th2 cells ilc2s | #8 |
| fever atopic sensitisation | #8 |
| c4ma3 | #8 |
| il13 variants | #8 |
| association wheeze | #8 |
| eczema asthma child | #8 |
| immunity gene expression | #8 |
| agmr | #8 |
| children anthroposophic | #8 |
| p11×10−8 | #8 |
| sensitization mite | #8 |
| amish child | #8 |
| ppg stimulation | #8 |
| p3×10−9 | #8 |
| lipid peptidoglycan | #8 |
| cows milk age | #8 |
| rs8076131 | #8 |
| 17q12q21 | #8 |
| igg1 galactosylation | #8 |
| bronchial histamine challenge | #8 |
| hlx1 | #8 |
| inhalant europe | #8 |
| current asthma data | #8 |
| university work | #8 |
| genetic risk asthma | #8 |
| chromosome 2q14 | #8 |
| children anthroposophic families | #8 |
| atopic sensitization prevalence | #8 |
| asthma analyses | #8 |
| exposure dogs | #8 |
| gabriela study | #8 |
| mice children | #8 |
| allergy study | #8 |
| il15 snps | #8 |
| asthmaprotective | #8 |
| asthma child conjunctivitis | #8 |
| highthroughput sequencing data | #8 |
| asthma 08 | #8 |
| diet year | #8 |
| international variations | #8 |
| amino acid asthma | #8 |
| chromosome childhoodonset disease | #8 |
| invertedu shape | #8 |
| study rural | #8 |
| age 911 years | #8 |
| sensitization patterns | #8 |
| dogs risk factor | #8 |
| 3113 children | #8 |
| antibiotics year | #8 |
| airwayrelated symptoms | #8 |
| asthma birth weight | #8 |
| gabriela | #8 |
| p4×10−9 | #8 |
| 824 children | #8 |
| asthma maternal smoking | #8 |
| asthma atopic sensitisation | #8 |
| early age exposure | #8 |
| austrian schoolchildren | #8 |
| diversity year | #8 |
| hrqol questions | #8 |
| allergy epidemiology | #8 |
| factor analysis factor | #8 |
| crohns disease polymorphisms | #8 |
| childhood asthma atopy | #8 |
| 95 food allergy | #8 |
| chromosome ige levels | #9 |
| factors sensitization | #9 |
| eczema weight | #9 |
| allergic inflammation patients | #9 |
| polymorphisms development | #9 |
| asthma child | #9 |
| ige levels gwas | #9 |
| tbx21 promoter | #9 |
| rural farm | #9 |
| asthma symptoms baseline | #9 |
| germany munich | #9 |
| cytokines environmental | #9 |
| farming environment | #9 |
| asthma early life | #9 |
| asthma respiratory conditions | #9 |
| clinical response score | #9 |
| teenagers asthma | #9 |
| low levels hscrp | #9 |
| levels allergens | #9 |
| skinprick | #9 |
| fcer1a susceptibility locus | #9 |
| subspecies bifidobacterium | #9 |
| microbial substances | #9 |
| igg4 ige | #9 |
| autriche | #9 |
| conjunctivitis cross | #9 |
| study asthma | #9 |
| ecuador eczema | #9 |
| dennd1b | #9 |
| 1314 children | #9 |
| gwas approaches | #9 |
| regular exposure | #9 |
| cord blood cytokines | #9 |
| allergic phenotypes | #9 |
| asthma allergy symptoms | #9 |
| life ahr | #9 |
| life prenatal exposure | #9 |
| bronchial hyper‐responsiveness | #9 |
| animals supplementation | #9 |
| symptoms 12 months | #9 |
| col29a1 variants | #9 |
| positive spts | #9 |
| prevalence atopic | #9 |
| young german | #9 |
| association stat6 variation | #9 |
| exposure farming environments | #9 |
| relation environment | #9 |
| asthma antibiotics | #9 |
| atopic sensitization children | #9 |
| random subsample | #9 |
| 1314yrolds | #9 |
| allergic seasonal risk | #9 |
| allergic preschool conjunctivitis | #9 |
| association wheezing | #9 |
| ausprägungen | #9 |
| 1 npsr1 | #9 |
| 5 european | #9 |
| relation asthma | #9 |
| partial nonresponders | #9 |
| asthma child child | #9 |
| n7498 | #9 |
| regulatory th17 cells | #9 |
| 105 years age | #9 |
| longitudinal follow‐up | #9 |
| kazal type | #9 |
| unprocessed milk | #9 |
| asthma risk | #9 |
| microbial exposure | #9 |
| npsr1 snps | #9 |
| rad50 gene chromosome | #9 |
| role human asthma | #9 |
| asthma infant | #9 |
| ribosomal 16s risk | #9 |
| life female germany | #9 |
| drug development strategies | #9 |
| mattress dust | #10 |
| early life immunity | #10 |
| countries centres | #10 |
| rural school children | #10 |
| endotoxin muramic acid | #10 |
| association new onset | #10 |
| ratio asthma | #10 |
| international study asthma | #10 |
| farm exposures asthma | #10 |
| new onset rhinitis | #10 |
| centers prevalence rates | #10 |
| latex children | #10 |
| blood samples tubes | #10 |
| house dust endotoxin | #10 |
| association atopic | #10 |
| substances development | #10 |
| young german adults | #10 |
| adult cases controls | #10 |
| mothers contact | #10 |
| leipzig east germany | #10 |
| gabriel advanced studies | #10 |
| bdnf gene variants | #10 |
| infection allergic | #10 |
| hormonal factors role | #10 |
| missing values paper | #10 |
| life allergen | #10 |
| study occupational | #10 |
| atopic dermatitis 95 | #10 |
| bias exposure | #10 |
| predictors health utilization | #10 |
| interrelations risk factors | #10 |
| prevalence differences | #10 |
| receptors immunity | #10 |
| bhr prevalence | #10 |
| humans hypersensitivity | #10 |
| asthma chromosome | #10 |
| airway hyperresponsiveness children | #10 |
| farm children children | #10 |
| genetic probability receptors | #10 |
| ilt3 ilt4 | #10 |
| 1992–2001 | #10 |
| reservoir method | #10 |
| production cord blood | #10 |
| indoor heating | #10 |
| mechanisms oral tolerance | #10 |
| 45 saline | #10 |
| new zealand bhr | #10 |
| n1138 | #10 |
| ige levels asthma | #10 |
| phase protocol | #10 |
| consumption raw | #10 |
| context eczema | #10 |
| urban rural area | #10 |
| asthma nocturnal | #10 |
| symptoms allergic rhinoconjunctivitis | #11 |
| asthma bacterial | #11 |
| allergy risks | #11 |
| health outcomes countries | #11 |
| subsequent development asthma | #11 |
| genotyped polymorphisms | #11 |
| farm buildings | #11 |
| early life development | #11 |
| cytokines allergic inflammation | #11 |
| asthma risk participants | #11 |
| parsifal study | #11 |
| microbiome lung | #11 |
| persistent uncontrolled asthma | #11 |
| transient wheezing | #11 |
| atopic dust | #11 |
| occupational disinfectants | #11 |
| atopy | #11 |
| asthma lower | #11 |
| protective development | #11 |
| association respiratory health | #11 |
| blood foxp3 | #11 |
| school beginners | #11 |
| tuberculosis notification rates | #11 |
| ige measurements | #11 |
| factors agriculture | #11 |
| reduced risk asthma | #11 |
| npsr1 polymorphisms | #11 |
| samples persons | #11 |
| german schoolchildren | #11 |
| pregnancy early life | #11 |
| farm exposures | #11 |
| lebensbedingungen | #11 |
| tbx21 polymorphisms | #11 |
| newborn male polymorphism | #11 |
| wheeze aor | #11 |
| active smoking association | #11 |
| overweight body mass | #11 |
| allergic disease children | #11 |
| wheeze year | #11 |
| allergic asthma conjunctivitis | #11 |
| children school entry | #11 |
| children rural | #11 |
| fetal ige | #11 |
| munich west germany | #12 |
| asthma epidemic | #12 |
| bhr wheeze | #12 |
| dermatitis phenotypes | #12 |
| exposure asthma symptoms | #12 |
| incident asthma 95 | #12 |
| early priming | #12 |
| hypersensitivity immunity | #12 |
| current paracetamol | #12 |
| 7 years data | #12 |
| ige grass | #12 |
| participants allergic rhinitis | #12 |
| multicentre allergy | #12 |
| pet contact | #12 |
| farm | #12 |
| asthma disease humans | #12 |
| cattle child | #12 |
| east germany munich | #12 |
| polymorphism asthma | #12 |
| management childhood asthma | #12 |
| german multicentre | #12 |
| fever exposure | #12 |
| asthmatic cohort | #12 |
| standard deviation skewness | #12 |
| children background | #12 |
| increase prevalence | #12 |
| healthy children asthma | #12 |
| mattress dust samples | #12 |
| damage mold | #12 |
| infection analyses | #12 |
| transient wheeze | #12 |
| doctor asthma | #12 |
| overweight breast | #12 |
| symptoms atopic | #12 |
| children low levels | #12 |
| polymorphisms bdnf gene | #12 |
| children exposed children | #12 |
| validated questions | #12 |
| male respiratory | #12 |
| backgroundasthma | #12 |
| young adults school | #12 |
| association moisture | #12 |
| age 105 years | #12 |
| female humans hypersensitivity | #12 |
| asthma candidate gene | #12 |
| sensitization birth | #12 |
| child environmental | #12 |
| 95 nox | #12 |
| skin prick testing | #12 |
| birth cohorts asthma | #12 |
| asthma parent | #12 |
| rural environments | #12 |
| stepwise protocol | #12 |
| asthma bronchial | #13 |
| nod1 gene | #13 |
| asthma rhinoconjunctivitis | #13 |
| farm animal contact | #13 |
| local immunity | #13 |
| polymorphisms influence | #13 |
| ibd sle | #13 |
| asthma mental health | #13 |
| children polymorphisms | #13 |
| eastern western germany | #13 |
| spt specific ige | #13 |
| sx1 | #13 |
| rural schoolchildren | #13 |
| cord adult blood | #13 |
| groups phenotype | #13 |
| northern indiana | #13 |
| children raised | #13 |
| developing microbiota | #13 |
| subjects jobs | #13 |
| expression ormdl3 | #13 |
| childhood allergy | #13 |
| farming exposures | #13 |
| hygiene hypersensitivity | #13 |
| childhood isaac | #13 |
| asthma community | #13 |
| occupational exposure disinfectants | #13 |
| asthma nocturnal symptoms | #13 |
| allergic sensitisation children | #13 |
| n349 | #13 |
| asthma snp | #13 |
| wheezing ages | #13 |
| children inhaled steroids | #13 |
| antibiotic exposure pregnancy | #13 |
| npsr1 | #13 |
| rhinitis allergens | #13 |
| dresden germany | #13 |
| asthma outcomes patients | #13 |
| switzerland children | #13 |
| atopic eczema symptoms | #13 |
| th1cells | #13 |
| farm dust | #13 |
| cross environmental exposure | #14 |
| burden prevalence | #14 |
| mrna expression vivo | #14 |
| polymorphisms ormdl3 | #14 |
| positive spts age | #14 |
| increased risk age | #14 |
| diabimmune study | #14 |
| asthma step | #14 |
| delayed introduction solids | #14 |
| respiratory atopic | #14 |
| symptoms rhinoconjunctivitis | #14 |
| changing gender | #14 |
| farming lifestyle | #14 |
| air challenge | #14 |
| asthma1 | #14 |
| late introduction | #14 |
| 10‐year‐old children | #14 |
| detailed questionnaires | #14 |
| diseases atopic | #14 |
| standardised questionnaires | #14 |
| th2 commitment | #14 |
| farm rural | #14 |
| untypical | #14 |
| fx5 | #14 |
| nonaffluent countries | #14 |
| role lung microbiome | #14 |
| exacerbations fev1 | #14 |
| introduction complementary food | #14 |
| breast feeding children | #14 |
| incidence rhinitis | #14 |
| il15 gene | #14 |
| 7 polymorphisms | #14 |
| innate infant | #14 |
| german children | #14 |
| 3099 | #14 |
| asthma bronchial hyperresponsiveness | #14 |
| atopic environmental | #14 |
| maternal sensitization | #14 |
| upper respiratory symptoms | #14 |
| rhinitis conjunctivitis | #14 |
| preventive development | #14 |
| allergic sensitization age | #14 |
| bronchial hyperreactivity | #15 |
| sensitization indoor allergens | #15 |
| rhinitis puberty | #15 |
| unpasteurized | #15 |
| contact farm animals | #15 |
| ahr male mice | #15 |
| asthma allergy | #15 |
| dogs children | #15 |
| ω3 polyunsaturated | #15 |
| bronchial responsiveness children | #15 |
| mold problems | #15 |
| skin prick tests | #15 |
| allergy risk | #15 |
| children early | #15 |
| immunity asthma | #15 |
| children allele | #15 |
| respective tlrs | #15 |
| pregnancy protective | #15 |
| association asthma symptoms | #15 |
| epidemiological studies exposure | #15 |
| allele2 | #15 |
| street residence | #15 |
| allele evidence | #15 |
| nocturnal symptoms | #15 |
| factors bronchial | #15 |
| 17q21 locus | #15 |
| puberty rhinitis | #15 |
| diabimmune | #15 |
| asthma asthma risk | #16 |
| newborn phenotype | #16 |
| wheeze trajectories | #16 |
| polymorphisms atopy | #16 |
| lung microbiome health | #16 |
| diseases allergy | #16 |
| association atopy | #16 |
| protocadherin1 | #16 |
| n1133 | #16 |
| chronic asthma children | #16 |
| 80 chromosomes | #16 |
| allergic diseases childhood | #16 |
| 7 year | #16 |
| bacteria respiratory tract | #16 |
| nonatopic asthma children | #16 |
| microbial exposures | #16 |
| hutterite | #16 |
| asthma farm | #16 |
| endotoxin house | #16 |
| 9 11 | #16 |
| sas institute | #16 |
| microbial environment | #16 |
| burden childhood asthma | #16 |
| multi‐centre study | #16 |
| childhood asthma asthma | #16 |
| increased food | #16 |
| clinical response measures | #16 |
| exposure atopic | #16 |
| seasonal surveys questionnaires | #16 |
| child allergic | #17 |
| epidemiologic dermatitis | #17 |
| eczema exposure | #17 |
| allergic asthma aa | #17 |
| persistent sensitization | #17 |
| age 7 years | #17 |
| single microbial | #17 |
| animals domestic | #17 |
| variants increase | #17 |
| atopy childhood | #17 |
| asthma biomarkers humans | #17 |
| dust extract | #17 |
| respiratory health children | #17 |
| humans preschool haemophilus | #17 |
| aerosol bolus | #17 |
| munich germany | #17 |
| rhinoconjunctivitis | #17 |
| bavarian | #17 |
| neuropeptide receptor npsr1 | #17 |
| asthma 95 | #17 |
| asthma environment | #17 |
| ga2len skin | #17 |
| munich | #17 |
| function school | #17 |
| factors atopic | #17 |
| levels microbial | #17 |
| pregnancy gene expression | #17 |
| asthma immune responses | #17 |
| asthma associations | #17 |
| asthma 6 years | #18 |
| protective microbiota | #18 |
| 7 yrs | #18 |
| cbmcs | #18 |
| childrens mattresses | #18 |
| ormdl3 gene | #18 |
| asthma exposure | #18 |
| female humans asthma | #18 |
| trajectories asthma | #18 |
| eczema 95 | #18 |
| meat children | #18 |
| pregnancy 6 years | #18 |
| german populations | #18 |
| immune adaptation | #18 |
| maternallyacquired mice mice | #18 |
| increase childhood | #18 |
| mef75 | #18 |
| preschool dna ribosomal | #18 |
| type employment | #18 |
| phenotypes children | #18 |
| children german | #18 |
| current wheezers | #18 |
| edna concentrations | #18 |
| col29a1 | #18 |
| measles infection | #18 |
| underlying responses | #18 |
| wheeze | #18 |
| polymorphism genetic receptors | #18 |
| anthroposophic lifestyle | #18 |
| cb production | #18 |
| atopy rhinitis | #18 |
| asthma phenotyping | #18 |
| maternal contact | #18 |
| asthma allergy development | #19 |
| atopic dermatitis studies | #19 |
| developing asthma | #19 |
| poor symptom control | #19 |
| farming activities | #19 |
| hscrp age | #19 |
| life asthma risk | #19 |
| sounds risk | #19 |
| disease atopic | #19 |
| arg130gln | #19 |
| birth 13 years | #19 |
| asthma report | #19 |
| seasonal risk | #19 |
| 3 years life | #19 |
| receptors innate | #19 |
| susceptibility human | #19 |
| german center | #19 |
| symptoms asthma | #19 |
| children current | #19 |
| microbial association networks | #19 |
| innate mice models | #19 |
| ilt4 | #19 |
| regulatory tolllike receptor | #19 |
| receptors innate immune | #19 |
| atopy phenotypes | #19 |
| linkage disequilibrium polymorphisms | #19 |
| cary | #19 |
| rural children | #19 |
| life diversity | #19 |
| crp levels age | #19 |
| tcell phenotypes | #19 |
| higher levels endotoxin | #19 |
| asthma bronchiale | #19 |
| newonset symptoms | #19 |
| child crosssectional studies | #19 |
| viable bacterial counts | #19 |
| life exposures | #19 |
| asthma | #19 |
| expression treg | #19 |
| school university | #20 |
| pvalues patients | #20 |
| asthma nonatopic asthma | #20 |
| breast feeding risk | #20 |
| infant colonization | #20 |
| npsr1 nps | #20 |
| farm environments | #20 |
| adults childhood | #20 |
| 6 haplotype | #20 |
| persistent uncontrolled | #20 |
| children living | #20 |
| symptoms wheeze | #20 |
| westernized countries | #20 |
| inbred balb spores | #20 |
| gender ratio | #20 |
| animal exposure | #20 |
| disease germany | #20 |
| isaac | #20 |
| specific ige food | #20 |
| allergic disease prevalence | #20 |
| asthma trajectories | #20 |
| life farm | #20 |
| dermatitis early | #20 |
| unboiled | #20 |
| atopy snps | #20 |
| gene expression measurements | #20 |
| unhygienic | #20 |
| stables | #20 |
| haplotype studies | #20 |
| mice sod3 | #20 |
| dust female humans | #20 |
| n1062 | #21 |
| markers early | #21 |
| bifidobacterium colonization | #21 |
| environmental microbiome | #21 |
| current asthma wheeze | #21 |
| studies eczema | #21 |
| plasma erythrocyte membranes | #21 |
| childhood background | #21 |
| hypersensitivity infant | #21 |
| farm environment | #21 |
| turkish children | #21 |
| rora | #21 |
| atopic asthma children | #21 |
| patients degradation | #21 |
| bhr 95 | #21 |
| asthma review | #21 |
| children inhaled | #21 |
| germany humans germany | #21 |
| c589t | #21 |
| network differences | #21 |
| tripeptidylpeptidases | #21 |
| tlr2 receptor | #21 |
| development allergic diseases | #21 |
| pseudocroup | #21 |
| unremitting | #21 |
| environment lifestyle | #21 |
| children east | #21 |
| prevalence rates symptoms | #21 |
| eczema atopy | #21 |
| ige igg4 | #21 |
| pregnancy production | #21 |
| gstm1 deficiency | #21 |
| highschool | #22 |
| muramic acid | #22 |
| 95 prenatal exposure | #22 |
| seasonal risk factors | #22 |
| samples dust | #22 |
| alleles asthma | #22 |
| feeding obesity | #22 |
| immune maturation | #22 |
| living germany | #22 |
| objective sought | #22 |
| npsr1 gene | #22 |
| isaac childhood | #22 |
| gabriel | #22 |
| r753q | #22 |
| respiratory diseases children | #22 |
| lower prevalences | #22 |
| exposure germany | #22 |
| asthmatic phenotypes | #22 |
| endotoxin house dust | #22 |
| crth2 th2 cells | #22 |
| food diversity | #22 |
| lps risk | #22 |
| chromosome asthma | #22 |
| effective airway | #22 |
| childhood atopy | #22 |
| β1→3glucans | #22 |
| allergic rhinitis 95 | #22 |
| 17q21 asthma | #22 |
| neonatal immune responses | #22 |
| farm childhood | #23 |
| microbiota respiratory | #23 |
| traffic counts | #23 |
| asthma cats | #23 |
| gross national | #23 |
| childhood allergies | #23 |
| nonfarm | #23 |
| isaac phase | #23 |
| child cross | #23 |
| nonlinear relations | #23 |
| bronchial challenge tests | #23 |
| hillerød | #23 |
| association atopic asthma | #23 |
| symptoms atopic eczema | #23 |
| asthma 12 months | #23 |
| breast feeding asthma | #23 |
| new onset | #23 |
| southern bavaria | #23 |
| fecal microbiota children | #23 |
| asthma agents | #23 |
| rapid alternative | #23 |
| children adulthood | #23 |
| 7 prevalence | #23 |
| single taxa | #23 |
| asthma prevention | #24 |
| doctor diagnosed | #24 |
| tobit regression | #24 |
| dust endotoxin | #24 |
| contact livestock | #24 |
| allergic respiratory symptoms | #24 |
| asthma early | #24 |
| exposure road traffic | #24 |
| eczema susceptibility | #24 |
| asthma aa | #24 |
| differences asthma prevalence | #24 |
| 4 phenotypes | #24 |
| children indoor | #24 |
| asthma 5 years | #24 |
| asthma age | #24 |
| asthma cross | #24 |
| countrys | #24 |
| phenotypes childhood | #24 |
| 2fold risk | #24 |
| west german | #24 |
| wheeze symptoms | #24 |
| current symptoms | #24 |
| allergic dermatitis | #24 |
| gene expression immunity | #24 |
| haying | #24 |
| asthma bhr | #24 |
| bronchitis child | #24 |
| cytokines children | #25 |
| prevention asthma | #25 |
| methods association | #25 |
| expression ige | #25 |
| il13 pathway | #25 |
| risk atopic diseases | #25 |
| 5030 | #25 |
| 2 12 months | #25 |
| antibiotic year | #25 |
| exposure paracetamol | #25 |
| farm animals | #25 |
| sensitization early | #25 |
| car traffic | #25 |
| environmental determinants | #25 |
| igg1 ige | #25 |
| sputum eosinophils feno | #26 |
| early atopic | #26 |
| wheezing childhood | #26 |
| farms humans | #26 |
| allergen sensitisation | #26 |
| 5 european countries | #26 |
| written questionnaire | #26 |
| fev1 bhr | #26 |
| microbiota asthma | #26 |
| card4 | #26 |
| child conjunctivitis | #26 |
| 3rd year | #26 |
| early phenotypes | #26 |
| risk allergic sensitization | #26 |
| blood samples children | #26 |
| levels mite | #26 |
| clinical phenotypes children | #26 |
| trendwise | #26 |
| increased treg | #26 |
| asthma syndrome | #26 |
| environmental asthma | #26 |
| risk factors probability | #26 |
| respiratory infections year | #27 |
| visible mould | #27 |
| prevalence atopic eczema | #27 |
| asthma childhood | #27 |
| muramic | #27 |
| specific ige levels | #27 |
| single snps | #27 |
| association childhood asthma | #27 |
| 035 iu | #27 |
| childhood origins | #27 |
| asthma child cross | #27 |
| asthma environmental | #27 |
| children asthma symptoms | #27 |
| 9 11 years | #27 |
| prevention allergic diseases | #27 |
| npsr1 asthma | #27 |
| allergens europe | #27 |
| wheeze childhood | #27 |
| asthmatic participants | #27 |
| ilt3 | #27 |
| factors year | #27 |
| prevalence fever | #27 |
| children parental asthma | #27 |
| consumption raw milk | #27 |
| ige therapy | #28 |
| gene asthma | #28 |
| host factors infection | #28 |
| dust children | #28 |
| weekly diaries | #28 |
| early identification children | #28 |
| atopic phenotypes | #28 |
| analysis lca | #28 |
| levels sensitization | #28 |
| 10 years data | #28 |
| il13 polymorphisms | #28 |
| recurrence persistence | #28 |
| east germany | #28 |
| pregnancy increase | #28 |
| feno fev1 | #28 |
| higher hrqol | #28 |
| childhood asthma risk | #28 |
| immune phenotypes | #28 |
| adult agriculture | #29 |
| pediatric asthma patients | #29 |
| rad50 gene | #29 |
| anthroposophy | #29 |
| pblc | #29 |
| primary prevention asthma | #29 |
| questionnaires urban | #29 |
| enhanced expression genes | #29 |
| farming | #29 |
| polymorphisms il13 | #29 |
| early years life | #29 |
| dust indoor | #29 |
| centers prevalence | #29 |
| acinetobacter lwoffii | #29 |
| preschool environmental | #29 |
| polymorphisms identified | #29 |
| mite sensitization | #29 |
| women males | #29 |
| bioair | #29 |
| vivo age | #29 |
| viral infections asthma | #30 |
| asthma childhood asthma | #30 |
| biodiversity child | #30 |
| il10 snps | #30 |
| boys asthma | #30 |
| affluent | #30 |
| dismutase 3 | #30 |
| incidence recurrence | #30 |
| effective ways | #30 |
| centres countries | #31 |
| children diagnosed asthma | #31 |
| atopic food | #31 |
| moisture damage | #31 |
| questionnaires asthma | #31 |
| enhancer marks | #31 |
| atopy children | #31 |
| ribosomal preschool dna | #31 |
| il10 polymorphisms | #31 |
| traditional farming | #31 |
| childhood infectious | #31 |
| probability persistence | #31 |
| bronchial obstruction | #31 |
| persons european ancestry | #31 |
| card4 nod1 | #31 |
| asthma atopic | #31 |
| huge burden | #32 |
| african ancestry asthma | #32 |
| disease childhood | #32 |
| preschool day | #32 |
| allergic diseases age | #32 |
| européens | #32 |
| r2447x | #32 |
| infants countries | #32 |
| symptoms childhood | #32 |
| association paracetamol | #32 |
| asthma odds ratio | #32 |
| obese children age | #32 |
| microbial environments | #32 |
| cohorts asthma | #32 |
| prick tests | #32 |
| transferase deficiency | #32 |
| germany leipzig | #32 |
| rural regions | #32 |
| linked polymorphisms | #32 |
| gata3 gene | #32 |
| atopic diseases | #32 |
| susceptibility asthma | #32 |
| studies dermatitis | #32 |
| doctordiagnosed | #32 |
| living environments | #32 |
| microbial components | #32 |
| epidemiology asthma | #32 |
| multiancestry association | #33 |
| multiancestry association study | #33 |
| imputation data | #33 |
| genetic epigenesis allergic | #33 |
| eczema prevalence | #33 |
| asthma associations loci | #33 |
| bhr fev1 | #33 |
| allergic genetic epigenesis | #33 |
| immune cell enhancer | #33 |
| specificity skin tests | #33 |
| participants questionnaire | #34 |
| new onset symptoms | #34 |
| curve asthma | #34 |
| year life | #34 |
| indoor mould | #34 |
| asthma risk children | #34 |
| endotoxins environmental | #34 |
| pattern frequency | #34 |
| development atopy | #34 |
| asthma atopic eczema | #34 |
| participants childhood | #34 |
| mite allergen exposure | #34 |
| bradykinin receptor gene | #34 |
| pregnancy maternal health | #34 |
| health utilization children | #34 |
| clec4e | #34 |
| dust microbiota | #34 |
| tests surveys | #34 |
| studies dust | #34 |
| infant contact | #34 |
| bacterial farms | #34 |
| fascinating | #34 |
| feno lung function | #35 |
| nonatopic mothers | #35 |
| 95 atopic dermatitis | #35 |
| prick testing | #35 |
| western lifestyle | #35 |
| raw cows milk | #35 |
| anthroposophic | #35 |
| diseases rhinitis | #35 |
| children cross | #35 |
| urbanrural differences | #35 |
| risk asthma | #35 |
| western germany | #35 |
| wingedhelix | #35 |
| farms female | #35 |
| germany haplotypes | #35 |
| endotoxin levels | #35 |
| preschool fatty acids | #35 |
| asthma conjunctivitis | #35 |
| asthma asthma phenotypes | #35 |
| analysis steps | #35 |
| tagging polymorphisms | #35 |
| 1 stimulation | #36 |
| skin test reactivity | #36 |
| maternal vitamin intake | #36 |
| chapter 1 epidemiology | #36 |
| prevalence childhood asthma | #36 |
| asthma dendritic cells | #36 |
| maternal exposures | #36 |
| exposure genetic | #36 |
| tolerance biomarkers | #36 |
| leipzig | #36 |
| 16s rrna data | #36 |
| nasal samples | #37 |
| allemagne | #37 |
| lifestyle environment | #37 |
| incidence persistence | #37 |
| earlylife exposures | #37 |
| case status | #37 |
| native milk | #37 |
| 8263 | #37 |
| asthma candidate | #37 |
| ril33 | #37 |
| asthma allergens | #38 |
| foxp3 levels | #38 |
| endotoxin asthma | #38 |
| association ndvi | #38 |
| dust asthma | #38 |
| maximum expiratory flow | #38 |
| wisc | #38 |
| life increased | #38 |
| eczema environmental | #38 |
| nps npsr1 | #38 |
| development allergic | #38 |
| amish | #38 |
| allergy birth | #38 |
| atopy prevalence | #38 |
| reverse causation | #38 |
| innate immunity genes | #38 |
| mouse model asthma | #38 |
| asthma cough | #38 |
| recurrence risk factors | #38 |
| itchy | #38 |
| ormdl3 expression | #38 |
| degradation patients | #39 |
| ige switching | #39 |
| adulthood risk factors | #39 |
| genetic rhinitis | #39 |
| maternal health pregnancy | #39 |
| levels house | #39 |
| seasonal perennial | #39 |
| haploview | #39 |
| wheezing phenotypes | #39 |
| allergic symptoms children | #39 |
| traffic asthma | #39 |
| c589 | #39 |
| protect children | #39 |
| igg nglycosylation | #39 |
| polymorphisms asthma | #39 |
| diversity environmental | #39 |
| antibiotics development | #40 |
| eczema | #40 |
| children bronchial | #40 |
| animal farms | #40 |
| crosssectional studies | #40 |
| preschool conjunctivitis | #40 |
| isolated polysaccharides | #40 |
| 4606 | #40 |
| mite exposure | #40 |
| transcription 6 | #40 |
| symptoms allergic | #40 |
| biodiversity health | #40 |
| german cities | #41 |
| allergic child | #41 |
| farm residence | #41 |
| discotheques | #41 |
| asthma wheeze | #41 |
| eczema phenotypes | #41 |
| effects asthma | #41 |
| risk factors health | #41 |
| stress young | #41 |
| allergens age | #41 |
| treg cells patients | #41 |
| small airway dysfunction | #41 |
| pcdh1 | #42 |
| polymorphism single nucleotide | #42 |
| microbiome data | #42 |
| dust female | #42 |
| food questionnaire | #42 |
| bronchiale | #42 |
| onset year | #42 |
| 95 antibiotics | #42 |
| international patterns | #42 |
| sensitized subjects | #43 |
| dermatitis food | #43 |
| subspecies infantis | #43 |
| treg th17 cells | #43 |
| time asthma | #43 |
| asthma onset | #43 |
| increased regulatory | #43 |
| asthma food | #43 |
| worldwide variations | #43 |
| early childhood infections | #44 |
| increased risk symptoms | #44 |
| diseases childhood | #44 |
| atp2a3 | #44 |
| national institute allergy | #44 |
| 97th | #44 |
| developing countries children | #44 |
| asthma cystic fibrosis | #44 |
| wide variations | #44 |
| facklamia | #44 |
| asthma food allergy | #44 |
| gsdma | #44 |
| work overload | #44 |
| followup physical activity | #44 |
| sequential switching | #44 |
| prevalence symptoms | #44 |
| atopic diseases asthma | #44 |
| microbiome asthma | #44 |
| cells cord | #44 |
| sensitization inhalant | #45 |
| exposure early life | #45 |
| fever 95 | #45 |
| questionnaire responses | #45 |
| bamse | #45 |
| biodiversity hypothesis | #45 |
| 7445 | #45 |
| phenotype respiratory | #45 |
| birth 12 months | #45 |
| traffic exposure | #45 |
| dust endotoxins | #45 |
| severe atopic eczema | #45 |
| antiasthma drugs | #45 |
| animals pregnancy | #45 |
| asthma cluster | #46 |
| prevalence current wheeze | #46 |
| farm animal | #46 |
| spt reactivity | #46 |
| humans hygiene | #46 |
| prevalence bhr | #46 |
| atopic diseases children | #46 |
| improvement reduction | #46 |
| prevalence diseases | #46 |
| control physical | #46 |
| adolescence differences | #46 |
| receptor tolllike receptors | #46 |
| evidence gene | #46 |
| asthma gwas | #46 |
| analysis step | #47 |
| children atopic disease | #47 |
| factors asthma | #47 |
| 95 eczema | #47 |
| germany east | #47 |
| franche | #47 |
| international study | #47 |
| prevalence rhinoconjunctivitis | #47 |
| wheeze phenotypes | #47 |
| efraim | #47 |
| tirana | #47 |
| asthma risk loci | #48 |
| doctordiagnosed asthma | #48 |
| frequent wheeze | #48 |
| halle | #48 |
| breath volatile | #48 |
| parental interviews | #48 |
| airways diseases | #48 |
| perennial allergens | #48 |
| lung function spirometry | #48 |
| asthma adjusted | #48 |
| asthma biological | #48 |
| fungal flora | #48 |
| cluster children | #48 |
| prevalences asthma | #48 |
| polymorphisms il4 | #48 |
| wheeze age | #48 |
| risk factors incidence | #49 |
| n228 | #49 |
| chromosome susceptibility | #49 |
| children female humans | #49 |
| children paracetamol | #49 |
| milk farm | #49 |
| fcer1a | #49 |
| beta13glucans | #50 |
| background atopic | #50 |
| bacterial markers | #50 |
| pcrsscp | #50 |
| diversity food | #50 |
| physiciandiagnosed | #50 |
| exposures asthma | #50 |
| longum subsp infantis | #50 |
| unpasteurized milk | #50 |
| asthma dust | #51 |
| allergy symptoms | #51 |
| maintenant | #51 |
| igg1 igg4 | #51 |
| populationattributable risk | #51 |
| conjugated mice mice | #51 |
| asthma maternal | #51 |
| association atopic dermatitis | #51 |
| microbial burden | #51 |
| country prevalence | #51 |
| association allergic | #51 |
| lwoffii | #51 |
| identified polymorphisms | #51 |
| common chronic disease | #51 |
| children cities | #51 |
| milk consumption | #52 |
| doctor diagnosis | #52 |
| prevalence wheeze | #52 |
| infant study | #52 |
| epidemiologischen | #52 |
| age wheezing | #52 |
| specific protective | #52 |
| itchy rash | #52 |
| eczema childhood | #52 |
| geneenvironment interactions | #52 |
| sensitization children | #52 |
| 9357 | #52 |
| ige sige | #52 |
| wheeze cough | #52 |
| bmi asthma | #52 |
| indoor endotoxin | #52 |
| gpra | #52 |
| outdoor pollution | #53 |
| adam33 asthma | #53 |
| ige children | #53 |
| il13 gene | #53 |
| atopic eczema children | #53 |
| early life exposure | #53 |
| 2q32 | #53 |
| life exposure | #53 |
| children current asthma | #53 |
| animals asthma | #54 |
| asthma odds | #54 |
| prevalence wheezing | #54 |
| estonian children | #54 |
| male prevalence | #54 |
| female germany life | #54 |
| nonmicrobial | #54 |
| cross sectional studies | #54 |
| cough wheeze | #55 |
| samples farm | #55 |
| prevalence association | #55 |
| year asthma | #55 |
| bacterial microbiota | #55 |
| stepwise procedure | #55 |
| random samples | #56 |
| immunoglobulin interleukin13 | #56 |
| alex study | #56 |
| atopy development | #56 |
| cd14 tolllike receptor | #56 |
| visible mold | #56 |
| adult asthma patients | #56 |
| strong protective | #56 |
| asthma atopy | #56 |
| maternal ige | #56 |
| tuberculosis notification | #56 |
| eczema flg | #57 |
| asthma allergic rhinoconjunctivitis | #57 |
| atopy wheeze | #57 |
| life atopic dermatitis | #57 |
| mononuclear lipid | #57 |
| mef50 | #57 |
| prevention allergic | #57 |
| derp1 | #57 |
| member 1 polymorphism | #57 |
| diseases methods | #57 |
| pollutant exposure | #57 |
| 3785 | #57 |
| adam33 polymorphisms | #57 |
| diseases children | #58 |
| total serum | #58 |
| hypersensitivity immunoglobulin | #58 |
| early asthma | #58 |
| reported parents | #58 |
| stat6 gene | #58 |
| eczema female | #58 |
| specificity asthma | #58 |
| th17 lineage | #59 |
| finland estonia | #59 |
| german participants | #59 |
| farm families | #59 |
| 6 years age | #59 |
| asthma morbidity children | #59 |
| 1q31 | #59 |
| milk cla | #59 |
| preschool wheezing | #60 |
| iedap | #60 |
| development childhood | #60 |
| birth school age | #60 |
| rna yield | #60 |
| allergic surveys | #60 |
| predictors incidence | #60 |
| beta 2agonists | #60 |
| species colonization | #61 |
| breastfed children | #61 |
| exposure asthma | #61 |
| implicated genes | #61 |
| seasonal skin tests | #61 |
| atopy eczema | #61 |
| immunoglobulin infant | #62 |
| estonia finland | #62 |
| respiratory sounds | #62 |
| large german | #62 |
| development airway hyperresponsiveness | #62 |
| asthma birth | #62 |
| childhoodonset asthma | #62 |
| life immune | #62 |
| persistence asthma | #62 |
| cystic fibrosis abpa | #63 |
| children regions | #63 |
| children role | #63 |
| exposure assessed | #63 |
| dermatitis risk | #63 |
| asthma breast | #63 |
| total quantity | #63 |
| atopic | #63 |
| indoor allergen exposure | #63 |
| endotoxin level | #63 |
| hyperreactivity bronchial | #63 |
| helminth ascariasis ascaris | #64 |
| dust parameters | #64 |
| children centers | #64 |
| differential networks | #64 |
| no2 benzene | #64 |
| newborn lymphocyte | #64 |
| allergenspecific ige | #64 |
| healthy controls children | #65 |
| animal contact | #65 |
| risk wheezing | #65 |
| childhood allergic diseases | #65 |
| atopic symptoms | #66 |
| ga²len | #66 |
| preschool haemophilus humans | #66 |
| dust extracts | #66 |
| umc | #66 |
| living area | #66 |
| prevalence current asthma | #66 |
| sensitization allergic | #66 |
| immunological data | #66 |
| allergic rhinitis age | #66 |
| maternal atopy | #67 |
| ige expression | #67 |
| biomarkers predictors | #67 |
| respiratory allergies | #67 |
| pa obesity | #67 |
| 2 questionnaires | #67 |
| weight boys | #68 |
| early wheeze | #68 |
| antibiotic sales | #68 |
| mère | #68 |
| ige allergens | #69 |
| atopic disease children | #70 |
| suisse | #70 |
| asthma complex | #70 |
| sod3 | #70 |
| gene gene interaction | #70 |
| allergic disorders | #70 |
| hypersensitivity immunization | #70 |
| unprocessed | #71 |
| barns | #71 |
| atopic rhinitis | #71 |
| small airway function | #71 |
| occurrence progression | #71 |
| breathomics | #71 |
| prenatal vitamin | #71 |
| tlr2 tlr1 | #71 |
| allergic sensitization children | #71 |
| factor asthma | #72 |
| molecular fingerprinting | #72 |
| infantis | #72 |
| children wheeze | #72 |
| 158 95 | #72 |
| persistent asthma children | #72 |
| association occupational exposure | #72 |
| onset allergic | #73 |
| european ancestry association | #73 |
| sounds respiratory | #73 |
| ormdl3 | #73 |
| gni | #73 |
| exposure europe | #74 |
| west humans | #74 |
| food allergy asthma | #74 |
| risk wheeze | #74 |
| health services children | #74 |
| severe eczema | #74 |
| asthmatic mothers | #75 |
| chromosome 17q21 | #75 |
| total serum ige | #75 |
| rfel | #75 |
| children hrqol | #75 |
| maternal immunity | #75 |
| asthma genome | #75 |
| standardized procedure | #75 |
| wheezing | #76 |
| asthma case | #76 |
| rural differences | #76 |
| microbial molecules | #76 |
| symptoms eczema | #76 |
| eczema children | #76 |
| food inhalant | #76 |
| allergy childhood | #76 |
| hyperresponsiveness bhr | #77 |
| diversity microbial | #77 |
| 9 mmp9 | #77 |
| asthma healthy | #77 |
| sexspecific association | #77 |
| 6399 | #78 |
| edta tubes | #78 |
| turkish origin | #78 |
| childhood | #78 |
| sensitisation children | #78 |
| years odds | #78 |
| findings prevalence | #78 |
| rhinitis atopic | #78 |
| wheezing illnesses | #78 |
| blood cytokines | #78 |
| mothers asthma | #78 |
| neuropeptide receptor | #79 |
| milk yoghurt | #79 |
| 95 protection | #79 |
| interactions snps | #79 |
| seasonal asthma | #79 |
| genes innate immunity | #79 |
| dander | #80 |
| ige skin | #80 |
| cats child | #80 |
| development atopic dermatitis | #81 |
| childhood wheeze | #81 |
| lower prevalence | #81 |
| microbial agents | #81 |
| prevalence respiratory | #81 |
| symptoms 12 | #81 |
| forkhead box protein | #81 |
| ribosomal pcr | #82 |
| children european | #82 |
| bacterial viral infections | #82 |
| age 45 | #82 |
| concentrations so2 | #82 |
| 13 14 | #82 |
| introduction solids | #82 |
| laryngitis | #82 |
| age prevalence | #82 |
| gut commensals | #83 |
| study pcr | #83 |
| reporter genetic predisposition | #83 |
| current wheezing | #83 |
| children siblings | #83 |
| hypersensitivity risk | #83 |
| study population patients | #83 |
| total fat content | #83 |
| microbial stimulation | #83 |
| cleanliness | #83 |
| new asthma | #84 |
| oligoarticular juvenile | #84 |
| 4732 | #84 |
| specific exposures | #84 |
| control pa | #84 |
| tests child | #84 |
| n134 | #85 |
| bronchial responsiveness | #85 |
| européenne | #85 |
| atopy risk | #85 |
| α1 antitrypsin | #85 |
| single nucleotide rna | #85 |
| truck traffic | #86 |
| ige levels | #86 |
| infant inflammation | #86 |
| wheeze prevalence | #86 |
| comté | #86 |
| children feeding | #86 |
| arabinogalactan | #86 |
| bifidobacterium species | #86 |
| hyper responsiveness | #86 |
| age asthma | #87 |
| exposure associations | #87 |
| visits asthma | #87 |
| influential factors | #87 |
| genes asthma | #87 |
| analysis respiratory | #87 |
| 95 fever | #87 |
| asthma polymorphisms | #88 |
| rhinitis risk | #88 |
| allergy tests | #88 |
| tolllike receptors tlrs | #88 |
| pollution allergens | #88 |
| exposure tobacco smoke | #88 |
| asthma children | #89 |
| asthma phenotypes | #89 |
| rphl | #89 |
| aged 6 | #89 |
| bronchial hyper | #89 |
| allergic seasonal surveys | #90 |
| children area | #90 |
| current exposure | #90 |
| critical time window | #90 |
| newborn leukocytes | #91 |
| joint workshop | #91 |
| asthma school | #91 |
| filaggrin mutations | #91 |
| newborn limit | #91 |
| development eczema | #91 |
| mononuclear polymorphism | #92 |
| sensitisation | #92 |
| rs2305480 | #93 |
| south germany | #93 |
| geführt | #93 |
| preschool haemophilus | #93 |
| previous studies association | #93 |
| experimental asthma | #93 |
| low levels exposure | #93 |
| allergic rhinitis symptoms | #93 |
| east west germany | #93 |
| tregulatory cells | #94 |
| pertussis infection | #94 |
| zpbp2 | #94 |
| international variation | #95 |
| nickel allergy | #95 |
| 16q12 | #95 |
| expression toll | #95 |
| greater consumption | #95 |
| asthma common | #95 |
| university life | #95 |
| eczema symptoms | #95 |
| fed children | #95 |
| asthma loci | #95 |
| allergic sensitisation | #96 |
| trigger factors | #96 |
| expression th1 | #96 |
| dysbalance | #96 |
| airway dysfunction | #96 |
| dust environmental | #96 |
| nonfarmers | #96 |
| anaphylaxie | #96 |
| onset wheeze | #96 |
| cumulative prevalence | #96 |
| lps recognition | #96 |
| schoolchildren aged | #97 |
| regulatory treg | #97 |
| indoor factors | #97 |
| city air | #97 |
| 95 overweight | #97 |
| inhalant allergens | #97 |
| factors school | #98 |
| age 3 years | #98 |
| background asthma | #98 |
| children germany | #98 |
| seasonal sensitivity | #98 |
| childhood adulthood | #98 |
| tlr1 tlr2 | #98 |
| rural school | #99 |
| comprehensive questionnaire | #99 |
| seasonal surveys | #99 |
| eastern germany | #99 |
| children atopic | #99 |
| years aor | #99 |
| asthma inflammation | #99 |
| current wheeze | #99 |
| earlyonset asthma | #99 |
| isaac questionnaire | #100 |
| preschool crosssectional studies | #100 |
| childhood atopic dermatitis | #100 |
| weight girls | #101 |
| mef25 | #101 |
| genetic factors susceptibility | #101 |
| raw cow | #101 |
| expression measurements | #101 |
| summarised | #101 |
| ige concentrations | #102 |
| effects respiratory | #102 |
| tenascin tnc | #102 |
| retinoid acid | #102 |
| risk factors persistence | #102 |
| factors wheezing | #102 |
| hdm exposure | #103 |
| 4264 | #103 |
| children increased risk | #103 |
| years early | #103 |
| sensitization eczema | #103 |
| irf1 gene | #103 |
| children relation | #104 |
| sensitization childhood | #104 |
| exposure milk | #104 |
| hutterites | #105 |
| high‐sensitivity | #105 |
| hyperreactivity | #105 |
| arabinogalactans | #105 |
| pollen concentration | #105 |
| physiciandiagnosed asthma | #106 |
| questionnaires switzerland | #106 |
| blood ige | #106 |
| prevalence atopy | #106 |
| children contact | #106 |
| animal dander | #106 |
| wheezing disorders | #106 |
| underlying factor | #107 |
| socs4 | #107 |
| detailed questionnaire | #107 |
| puberty age | #107 |
| fever episodes | #108 |
| inverse associations | #108 |
| overweight 95 | #108 |
| breast feeding | #108 |
| moulds | #109 |
| air pollution children | #109 |
| complex syndrome | #109 |
| asthma wheezing | #109 |
| healthy children children | #109 |
| allergic perennial rhinitis | #109 |
| publication air pollution | #109 |
| p≤003 | #110 |
| folgenden | #110 |
| genotype germany | #110 |
| atopic eczema humans | #110 |
| rs7216389 | #110 |
| female germany | #110 |
| il4ra | #111 |
| parental questionnaire | #111 |
| tbox transcription factor | #112 |
| milk samples | #112 |
| female histones | #112 |
| environmental study | #112 |
| olive pollen | #112 |
| 1314 | #112 |
| allergic | #113 |
| experimental allergic asthma | #113 |
| indoor asthma | #113 |
| phenotypes asthma | #113 |
| flg variants | #113 |
| risk allergic | #113 |
| occupational allergy | #114 |
| allergic disease | #114 |
| parent reported | #114 |
| mould exposure | #114 |
| challenge data | #114 |
| tests bronchial | #114 |
| asthma sensitization | #114 |
| notification rates | #115 |
| cord blood ige | #115 |
| cough children | #115 |
| increased diversity | #115 |
| foxp3 locus | #115 |
| igg4 responses | #115 |
| aged 9 | #116 |
| exclusive breast feeding | #116 |
| regulatory th17 | #116 |
| immune responsiveness | #116 |
| glutathione transferase gst | #117 |
| psychosocial characteristics | #117 |
| children underwent | #117 |
| living rural | #118 |
| reference children | #118 |
| indoor microbial | #118 |
| allergic sensitization | #118 |
| germany humans | #118 |
| skinprick tests | #118 |
| west germany | #118 |
| ratio prevalence | #118 |
| switching immunoglobulin | #119 |
| ancestry asthma | #119 |
| children wheezing | #119 |
| skin prick | #119 |
| delayed introduction | #119 |
| environment children | #120 |
| association chromosome | #120 |
| levels endotoxin | #120 |
| childhood risk factors | #120 |
| fibrolysis | #120 |
| aliments | #121 |
| dampness | #121 |
| symptom control | #121 |
| vitamin supplementation pregnancy | #121 |
| factors rural | #121 |
| allergens asthma | #121 |
| common aeroallergens | #121 |
| lung function measurements | #121 |
| life early | #122 |
| tlr10 | #122 |
| 300 people | #122 |
| preventive potential | #122 |
| hayfever | #123 |
| frequency pattern | #123 |
| urban traffic | #123 |
| atopic manifestations | #124 |
| germany prevalence | #124 |
| severe eosinophilic asthma | #124 |
| active asthma | #124 |
| passive smoke exposure | #124 |
| immunologic tolllike receptor | #125 |
| potted plants | #125 |
| common inhalant | #125 |
| il18r1 | #125 |
| exposure pets | #126 |
| sensitization development | #126 |
| paediatric studies | #126 |
| effects prevalence | #126 |
| prevalence allergic diseases | #126 |
| eczema patients | #126 |
| asthma background | #126 |
| await | #126 |
| 3 infections | #126 |
| adaptive cells | #127 |
| exposure endotoxin | #127 |
| parent questionnaire | #127 |
| test reactivity | #127 |
| prävalenz | #127 |
| caspase recruitment domain | #127 |
| allergens child | #127 |
| environmental allergens | #127 |
| 95 ors | #127 |
| bdnf polymorphisms | #128 |
| microbial markers | #129 |
| bdnf gene | #129 |
| receptors male | #129 |
| medall | #130 |
| protein allergy | #131 |
| severe eosinophilic | #131 |
| asthma objective | #131 |
| sensitization allergens | #131 |
| test study | #131 |
| common allergens | #131 |
| respiratory symptoms children | #131 |
| hypersensitivity respiratory | #131 |
| factors allergens | #131 |
| expression receptors | #132 |
| male occupational | #132 |
| effects development | #132 |
| diseases asthma | #132 |
| immunoglobulin inflammation | #132 |
| asthma adolescent | #132 |
| bavaria | #133 |
| age 7 | #133 |
| understanding natural | #133 |
| early age | #133 |
| pollen prevalence | #133 |
| dpp10 | #134 |
| 7 years age | #134 |
| allergy | #134 |
| 95 ages | #135 |
| crth2 | #135 |
| prevalence rhinitis | #135 |
| childhood risk | #135 |
| body composition bmi | #135 |
| allergic phenotype | #136 |
| 60 iu | #136 |
| eczema risk | #136 |
| bronchial response | #136 |
| asthma young | #136 |
| mechanisms asthma | #137 |
| ms4a2 | #137 |
| 6 7 | #137 |
| ga2len | #137 |
| exposure children | #137 |
| actinomycetes | #137 |
| snps asthma | #137 |
| pollutants allergens | #138 |
| snps interactions | #138 |
| sensitized children | #138 |
| mattress | #138 |
| asthma atopic dermatitis | #138 |
| reduced prevalence | #138 |
| asthma development | #138 |
| régions | #138 |
| 3 14 | #139 |
| milk animals | #139 |
| pollution asthma | #139 |
| allergen levels | #139 |
| serum ige | #139 |
| sebacate | #139 |
| listeria spp | #139 |
| microbiota children | #140 |
| duration type | #140 |
| pasture | #140 |
| exposure symptoms | #140 |
| tregs foxp3 | #140 |
| largest reduction | #140 |
| asthma genes | #141 |
| age 6 years | #141 |
| exposure indoor | #141 |
| indoor allergens | #142 |
| factors difference | #142 |
| cla content | #142 |
| asthma bronchitis | #142 |
| susceptibility children | #142 |
| n183 | #142 |
| questionnaires illness surveys | #142 |
| unifrac | #143 |
| pregnancy early | #143 |
| replication association | #144 |
| pet exposure | #144 |
| inconclusive | #144 |
| exposure year | #144 |
| asthma defined | #144 |
| incident asthma | #144 |
| snps chromosome | #144 |
| dermatitis asthma | #145 |
| onset menarche | #145 |
| expositions | #145 |
| children allergy | #145 |
| lower airways | #146 |
| interleukin13 interleukin4 | #146 |
| prevalence skin | #146 |
| prematurely born children | #146 |
| allergy testing | #146 |
| airway mechanics | #146 |
| health outcomes children | #146 |
| original article | #147 |
| study centers | #147 |
| biomarkers child | #147 |
| germany west | #148 |
| association early | #148 |
| children 6 | #148 |
| feno patients | #148 |
| atopic outcomes | #149 |
| indoor allergen | #149 |
| early immune | #149 |
| perennial rhinitis allergic | #150 |
| fall fev1 | #150 |
| pregnancy respiratory | #150 |
| 105 years | #151 |
| wheezing children | #151 |
| wheeze children | #151 |
| confer protection | #151 |
| profound differences | #151 |
| prevalence childhood | #151 |
| established asthma | #152 |
| distribution asthma | #152 |
| bhr | #152 |
| immunomodulatory molecules | #152 |
| children review | #152 |
| exposure increased | #152 |
| environmental exposure | #152 |
| consumption dairy products | #152 |
| asthma dermatitis | #153 |
| wheeze asthma | #153 |
| function measurements | #153 |
| tagging single | #153 |
| common respiratory | #153 |
| hens egg | #153 |
| cd28null | #154 |
| hormonal factors | #154 |
| bronchial challenge | #155 |
| onset association | #155 |
| tests sex factors | #155 |
| neighboring countries | #155 |
| atopic children | #156 |
| association asthma | #156 |
| positive spt | #157 |
| gene 3 | #157 |
| absolute levels | #157 |
| neu5gc | #157 |
| severity frequency | #157 |
| development allergy | #157 |
| lower diversity | #158 |
| asthma females | #158 |
| paediatric asthma | #158 |
| early environmental | #158 |
| bacterial lysates | #158 |
| children asthma | #159 |
| developing immune | #159 |
| patients controlled asthma | #159 |
| prevention allergy | #159 |
| children rhinitis | #160 |
| german adults | #160 |
| children homes | #160 |
| allergic seasonal | #160 |
| microbiome diversity | #160 |
| spts | #160 |
| reported prevalence | #160 |
| asthma presence | #161 |
| wheeze rhinitis | #161 |
| newborn longitudinal | #161 |
| preventive measure | #161 |
| atopy asthma | #161 |
| children lower | #162 |
| female humans allergic | #162 |
| parental asthma | #162 |
| immune pathways | #162 |
| environmental associations | #163 |
| perennial rhinitis | #163 |
| exposure prevalence | #163 |
| specific ige | #163 |
| kindl | #164 |
| sscp | #164 |
| sensitised | #164 |
| children sensitized | #165 |
| atopic dermatitis | #165 |
| atopic eczema | #165 |
| asthma ige | #165 |
| 5q31 | #166 |
| ige asthma | #166 |
| infant respiratory | #166 |
| epidemiologie | #166 |
| illness surveys questionnaires | #166 |
| feeding child | #166 |
| preadolescent children | #167 |
| studies exposure | #167 |
| adolescent allergens | #167 |
| preschool cross | #167 |
| air pollutant concentrations | #167 |
| disease life | #167 |
| year children | #168 |
| years lung | #168 |
| current asthma | #168 |
| 2688 | #169 |
| airway size | #169 |
| workplace young | #169 |
| regulatory treg cells | #169 |
| stratification patients | #169 |
| chronic inflammatory disease | #170 |
| aged 13 | #171 |
| nucleotide rna | #171 |
| inhalant | #171 |
| adolescent analysis | #171 |
| sensitization pollen | #171 |
| prevalence current | #172 |
| studien | #172 |
| nucleotide pregnancy | #172 |
| ifnγ levels | #172 |
| endotoxins female | #172 |
| sheds | #172 |
| skin prick test | #172 |
| unifying concept | #173 |
| risk score model | #173 |
| antipyretics | #174 |
| risk atopy | #174 |
| patients nocturnal | #175 |
| mice asthma | #175 |
| female humans questionnaires | #175 |
| small airway | #175 |
| asthma attack | #176 |
| school level | #176 |
| repeated infections | #176 |
| sensitization common | #176 |
| serine protease inhibitor | #176 |
| sensitization pattern | #177 |
| wheezers | #177 |
| life respiratory function | #177 |
| situ hybridization infant | #177 |
| 9p24 | #178 |
| genetic severity | #178 |
| aa patients | #178 |
| childhood infections | #178 |
| sensitization asthma | #178 |
| nocturnal asthma | #179 |
| objective measurements | #179 |
| sputum neutrophils | #179 |
| childhood adolescence | #179 |
| w12 | #179 |
| standardized methodology | #179 |
| traffic characteristics | #179 |
| studies environmental | #179 |
| socks | #180 |
| asthma genetic | #180 |
| breastfed infant | #180 |
| lung function testing | #181 |
| bacterial count | #181 |
| environmental predictors | #181 |
| children environmental | #181 |
| mattresses | #181 |
| differences hrqol | #182 |
| dermatitis children | #182 |
| vitamin asthma | #182 |
| dust levels | #182 |
| immunemediated diseases | #182 |
| children levels | #183 |
| german population | #183 |
| tlr signaling | #183 |
| exposure humans | #183 |
| environmental microbiology | #183 |
| vocational training | #183 |
| mögliche | #183 |
| life prevalence | #185 |
| incidence allergic | #185 |
| school district | #185 |
| work asthma | #186 |
| protein child | #187 |
| selfselection | #188 |
| asthma body | #188 |
| development allergic disease | #188 |
| tests children | #188 |
| childhood early adulthood | #188 |
| environmental exposures | #188 |
| qpcrs | #188 |
| tlr genes | #189 |
| jf1 | #189 |
| bacterial groups | #190 |
| muscle mass patients | #190 |
| association antibiotic | #190 |
| wheezing age | #190 |
| early wheezing | #190 |
| mother pregnancy | #190 |
| inversely | #190 |
| type duration | #190 |
| cd14 gene | #191 |
| atopic dermatitis children | #191 |
| dry cough | #191 |
| blood gene | #191 |
| pyroglyphidae | #192 |
| adjusted irr | #192 |
| longum subsp | #192 |
| milk serum | #193 |
| adam33 | #193 |
| cε | #193 |
| model allergic | #193 |
| prevalence severity | #195 |
| eosinophilic asthma | #195 |
| estonian | #195 |
| caspase recruitment | #196 |
| review asthma | #197 |
| enthusiasm | #197 |
| germany switzerland | #197 |
| questionnaire data | #198 |
| earlylife | #198 |
| decreased prevalence | #199 |
| rhinitis eczema | #199 |
| representative population | #199 |
| upper lower airways | #200 |
| allergy infectious diseases | #202 |
| bacteria role | #202 |
| complex interplay | #202 |
| paediatrician | #203 |
| bronchial hyperresponsiveness bhr | #203 |
| patients europe | #203 |
| patients aa | #204 |
| phenotyped | #204 |
| difference prevalence | #204 |
| amebocyte | #205 |
| 13 years age | #205 |
| dermatitis atopic | #205 |
| new locus | #205 |
| allergen specific | #206 |
| 3034 | #206 |
| asthma methods | #207 |
| factors atopy | #207 |
| asthma respiratory symptoms | #207 |
| karelia | #208 |
| male phenotype | #208 |
| allergic asthmatics | #208 |
| diagnosed asthma | #208 |
| studies germany | #208 |
| newborn logistic | #209 |
| higher diversity | #209 |
| sensitization age | #209 |
| col4a3 | #209 |
| glycolylneuraminic acid | #209 |
| prevalence obesity | #209 |
| innate adaptive immunity | #209 |
| studies cytokines | #209 |
| bhr asthma | #210 |
| symptoms children | #210 |
| core microbiome | #210 |
| bronchial provocation | #210 |
| epithelial barrier function | #210 |
| low prevalence | #211 |
| cats dogs | #211 |
| influence development | #211 |
| exposure sensitization | #211 |
| tlr4 cd14 | #212 |
| birth 6 | #212 |
| atopic dermatitis asthma | #212 |
| methodssubjects | #212 |
| asthma allergic | #212 |
| asthma animals | #212 |
| exposure allergens | #213 |
| 1872 | #213 |
| cohort methods | #213 |
| patients uncontrolled asthma | #213 |
| distinct clusters | #213 |
| 00035 | #214 |
| reverse causality | #214 |
| rural environment | #214 |
| workplace exposure | #214 |
| prevalence allergic | #214 |
| expression cd14 | #214 |
| asthma allergic diseases | #214 |
| life allergic | #215 |
| regulatory responses | #216 |
| mast cell chymase | #216 |
| obesity overweight | #216 |
| atopic female | #218 |
| il2rb | #218 |
| causation | #219 |
| microbial products | #219 |
| geneticist | #219 |
| disinfectants | #219 |
| child dna | #219 |
| steiner | #220 |
| pierced | #220 |
| variants asthma | #220 |
| allergy development | #220 |
| schistosoma schistosomiasis | #221 |
| method participants | #221 |
| homogenised | #221 |
| sensitization rates | #222 |
| increased asthma | #222 |
| 90 children | #222 |
| environmental epidemiology | #223 |
| symptoms baseline | #223 |
| groups asthma | #224 |
| german study | #225 |
| sibship size | #225 |
| alpha1 antitrypsin | #226 |
| conjunctivitis allergic | #226 |
| sensitization allergen | #226 |
| german | #226 |
| provocative concentration | #227 |
| school age | #227 |
| test spt | #228 |
| allergic diseases asthma | #228 |
| specific stimulation | #228 |
| lung health | #228 |
| 95 obesity | #228 |
| data asthma | #228 |
| healthy worker | #229 |
| tuberculosis prevalence | #229 |
| wheezing asthma | #229 |
| road traffic | #229 |
| understanding asthma | #229 |
| cord blood cells | #230 |
| umwelt | #230 |
| asthma allergic rhinitis | #230 |
| butyryl | #230 |
| asthma phenotype | #230 |
| cord blood cb | #231 |
| allergy prevention | #231 |
| 20 fall | #232 |
| discontent | #232 |
| health variables | #232 |
| living conditions | #232 |
| subgroup children | #232 |
| nonallergic asthma | #232 |
| innate leukocytes | #233 |
| lively | #233 |
| prevalence overweight | #233 |
| dermatophagoides pteronyssinus | #234 |
| complementary food | #234 |
| hyperreactive | #234 |
| fourth grade | #235 |
| n144 | #235 |
| levels asthma | #236 |
| exposure pregnancy | #236 |
| resequenced | #236 |
| specific allergen | #236 |
| finland france | #238 |
| puberty girls | #238 |
| incidence asthma | #239 |
| strategies prevention | #239 |
| neutrophilic asthma | #240 |
| preschool cytokines | #241 |
| regulatory th1 | #242 |
| age exposure | #243 |
| immune development | #243 |
| th2 immunity | #243 |
| receptor 1 | #245 |
| adaptor protein polymorphism | #245 |
| adjusted odds ratio | #245 |
| fungal dna ribosomal | #246 |
| muropeptides | #246 |
| prick test | #247 |
| role development | #247 |
| nasal microbiota | #247 |
| fever asthma | #247 |
| children analysis | #248 |
| patients healthcare | #248 |
| baseline incidence | #249 |
| factors allergic | #249 |
| class analysis | #249 |
| clinical science | #250 |
| therapy severe | #250 |
| biological therapy | #251 |
| tlr2 gene | #251 |
| communism | #252 |
| contact animals | #253 |
| china factors | #253 |
| asthma symptoms | #253 |
| cold air | #253 |
| hormonal influences | #254 |
| atopic disease | #255 |
| lowgrade inflammation | #255 |
| h4 acetylation | #256 |
| low pa | #256 |
| preschool dermatitis | #256 |
| body mass children | #257 |
| 454pyrosequencing | #257 |
| adolescent asthma | #257 |
| human asthma | #257 |
| niaid | #258 |
| association expression | #258 |
| epidemiological studies | #259 |
| airborne fungi | #259 |
| prediction quality | #259 |
| 2051 | #260 |
| life asthma | #260 |
| life symptoms | #260 |
| age 6 | #260 |
| rhinitis allergic | #260 |
| exposure early | #260 |
| westernization | #261 |
| early life | #261 |
| discriminate | #261 |
| eczema atopic | #261 |
| spink5 | #262 |
| utilization health services | #262 |
| interferon expression | #262 |
| alpha1antitrypsin | #263 |
| protein 15 | #263 |
| physician diagnosed | #263 |
| milk pregnancy | #263 |
| development immune | #263 |
| children associations | #264 |
| latex sensitization | #265 |
| indoor exposures | #265 |
| exposure traffic | #265 |
| tightly linked | #265 |
| increase asthma | #266 |
| nox concentrations | #266 |
| age 13 years | #267 |
| early work | #267 |
| settled dust | #267 |
| pollen sensitization | #268 |
| rhinitis | #269 |
| fever children | #269 |
| prick | #269 |
| symptom prevalence | #270 |
| allergen extracts | #270 |
| hypersensitivity immune | #270 |
| conditions asthma | #271 |
| relation body mass | #272 |
| child chromosomes | #272 |
| dipeptidyl peptidases | #273 |
| study centres | #273 |
| asthma control patients | #274 |
| objective markers | #274 |
| inflammatory properties | #275 |
| host microbiome | #276 |
| exposure female | #276 |
| future asthma | #277 |
| dust samples | #277 |
| extracellular polysaccharides | #277 |
| male microbiota | #277 |
| increased exposure | #278 |
| study birth | #279 |
| tests allergens | #280 |
| hire | #280 |
| remedy | #280 |
| questionnaires adolescent | #281 |
| 6 years | #282 |
| allergies asthma | #282 |
| adolescent animals | #282 |
| child dermatitis | #282 |
| randomeffects | #284 |
| impulse oscillometry | #284 |
| collection methods | #284 |
| population burden | #285 |
| 17 children | #285 |
| allergic symptoms | #286 |
| tests respiratory | #287 |
| differences asthma | #287 |
| cells ilc2s | #287 |
| gg 95 | #288 |
| geometric ratio | #288 |
| epidemiological surveys | #289 |
| hdms | #289 |
| pollution air | #289 |
| role asthma | #290 |
| data normalization | #290 |
| risk factors children | #290 |
| asthma increased | #291 |
| allergic manifestations | #291 |
| eczema food | #292 |
| asthma factors | #292 |
| answered | #293 |
| longitudinal cohort study | #293 |
| indoor exposure | #293 |
| cohort participants | #293 |
| exposure environmental | #293 |
| allergic perennial | #293 |
| environnement | #293 |
| recruitment domain | #293 |
| cbmc | #294 |
| asthma data | #294 |
| mucosal surfaces | #296 |
| smoke pollution | #297 |
| pollution respiratory | #297 |
| global synthesis | #298 |
| bifidobacterium | #298 |
| unification | #299 |
| exposure benzene | #299 |
| nonatopic | #299 |
| obesity asthma | #299 |
| paxgene | #299 |
| exposure allergic | #299 |
| infancy development | #300 |
| risk allergy | #303 |
| asthma drugs | #306 |
| analysis phase | #307 |
| lumbricoides | #307 |
| reported association | #307 |
| antigens dermatophagoides | #308 |
| severe exacerbations | #308 |
| ige sensitization | #309 |
| messenger tlymphocytes | #309 |
| exposure childhood | #309 |
| 2623 | #309 |
| mucosal microbiota | #309 |
| neonatal immune | #309 |
| factors early | #311 |
| controlled asthma | #311 |
| midexpiratory | #312 |
| birth cohort studies | #312 |
| atopic march | #312 |
| asthma inflammatory | #313 |
| allergy age | #313 |
| skin examination | #314 |
| signal transducer activator | #314 |
| jusqu | #315 |
| bacillus spores | #315 |
| variance animals antigens | #315 |
| genotyping data | #315 |
| independent study | #316 |
| 2 toll | #316 |
| older siblings | #317 |
| child comorbidity | #318 |
| adjustment covariates | #318 |
| pregnancy expression | #318 |
| compared children | #319 |
| bmi united states | #320 |
| il5 il13 | #320 |
| fpr2 | #320 |
| chronic airway inflammation | #321 |
| mfi20 | #321 |
| moisturizer | #323 |
| children birth | #324 |
| ige responses | #325 |
| maximal expiratory | #325 |
| airway hyperresponsiveness ahr | #326 |
| 2 yrs | #326 |
| stratified sample | #326 |
| ichthyosis vulgaris | #327 |
| flg mutations | #327 |
| selfadministered questionnaire | #328 |
| active smoking | #328 |
| bedrooms | #328 |
| recurrent wheeze | #328 |
| extracellular dna | #329 |
| glycolylneuraminic | #330 |
| male milk | #330 |
| floor dust | #331 |
| accuracy analysis | #331 |
| reference equations | #331 |
| pollutant levels | #331 |
| dermatophagoides asthma | #331 |
| demethylation | #331 |
| onset asthma | #333 |
| streptococcaceae | #333 |
| asthma biomarkers | #333 |
| upper respiratory | #334 |
| development sensitization | #334 |
| reduced lung function | #334 |
| children controls | #335 |
| asthma china | #336 |
| boluses | #336 |
| 1st year | #337 |
| prevalence surveys | #337 |
| predictive risk factors | #337 |
| risk current | #337 |
| childhood atopic | #338 |
| 3113 | #338 |
| respiratory outcomes | #339 |
| risk eczema | #339 |
| medical advice | #340 |
| asthma parents | #340 |
| exposure development | #341 |
| adultonset asthma | #341 |
| humans prevalence | #341 |
| persistent wheeze | #342 |
| filaggrin gene | #342 |
| kitchen | #342 |
| nonatopic asthma | #343 |
| age introduction | #343 |
| age 9 | #344 |
| breast fed | #345 |
| stat6 transcription | #346 |
| hypersensitivity | #346 |
| 90th | #348 |
| childhood onset | #349 |
| increasing prevalence | #350 |
| rates asthma | #350 |
| prevalence | #350 |
| exposed children | #350 |
| factors surveys | #351 |
| th1 th2 cells | #353 |
| activator transcription | #354 |
| repeated episodes | #356 |
| freeways | #358 |
| purposepatients | #359 |
| genetic interaction | #359 |
| kazal | #360 |
| subsequent asthma | #360 |
| regression approach | #360 |
| eurotium | #361 |
| asthma disease | #361 |
| strength association | #361 |
| children cohort | #361 |
| expression asthma | #363 |
| cord blood | #363 |
| age 3 | #363 |
| food sensitization | #364 |
| farming practices | #364 |
| allergic outcomes | #364 |
| austria germany | #365 |
| annual concentrations | #365 |
| children reported | #366 |
| chronic inflammatory disorders | #366 |
| lactadherin | #368 |
| atopic status | #369 |
| expression tlr2 | #370 |
| adolescent air | #370 |
| earlylife exposure | #370 |
| single snp | #370 |
| austria switzerland | #371 |
| testing procedures | #371 |
| conclusionwe | #371 |
| 1159 | #371 |
| east west | #373 |
| obesity prevalence | #373 |
| time activity | #373 |
| performance accuracy | #374 |
| asthma current | #374 |
| 22 countries | #374 |
| asthmatic symptoms | #374 |
| paragraphs | #374 |
| foxp3 tregs | #375 |
| smoking asthma | #375 |
| upper respiratory tract | #376 |
| asthma cases | #376 |
| positional cloning | #377 |
| cows milk | #377 |
| statistical approaches | #377 |
| associations exposure | #377 |
| parental reports | #379 |
| mite allergens | #379 |
| population studies | #379 |
| dietary strategies | #381 |
| pieces | #382 |
| inverse association | #383 |
| unifying | #384 |
| measles vaccination | #384 |
| preschool cohort studies | #384 |
| normal lung function | #385 |
| latex | #386 |
| bronchial | #386 |
| impaired lung function | #386 |
| chronic asthma | #386 |
| alliance | #388 |
| gene environment | #389 |
| allergie | #390 |
| potential association | #391 |
| immunological analysis | #391 |
| critical window | #391 |
| haplotype analyses | #391 |
| 11 year | #392 |
| cde | #393 |
| early feeding | #394 |
| 14 year | #394 |
| risk sensitization | #394 |
| mmp9 gene | #394 |
| polymorphism gene | #395 |
| linear regressions | #395 |
| increased risk asthma | #395 |
| immunological mechanisms | #396 |
| th2 th1 | #398 |
| salmeterol xinafoate | #399 |
| study polymorphisms | #399 |
| respiratory health | #399 |
| receptor cx3cr1 | #400 |
| antiviral responses | #401 |
| receptor polymorphisms | #402 |
| 2033 | #402 |
| regions countries | #402 |
| length time | #403 |
| analysis asthma | #403 |
| exposure animals | #403 |
| plea | #404 |
| study agreement | #405 |
| allergens | #405 |
| timothy grass | #405 |
| production ifngamma | #406 |
| allergen exposure | #406 |
| cells asthma | #406 |
| 071 | #407 |
| childhood allergic | #407 |
| mugwort | #407 |
| data cohort | #409 |
| geneenvironment interaction | #409 |
| mold exposure | #410 |
| living room | #411 |
| endotoxin exposure | #411 |
| common occurrence | #411 |
| blood cb | #413 |
| blood rna | #413 |
| gene variations | #413 |
| ige synthesis | #414 |
| germany | #415 |
| childhood exposure | #416 |
| facemasks | #416 |
| mite allergen | #416 |
| house dust | #417 |
| 7 years | #418 |
| bronchial hyperresponsiveness | #418 |
| illness asthma | #418 |
| extended haplotypes | #419 |
| alimentary | #420 |
| population sample | #420 |
| age 2 years | #420 |
| prenatal factors | #421 |
| halfwidth | #421 |
| confers protection | #424 |
| tnc | #424 |
| cytokine secretion | #426 |
| asthma eczema | #427 |
| parasitic infections | #427 |
| asthma treatment | #428 |
| childhood eczema | #429 |
| duration breastfeeding | #429 |
| childrens hospitals | #430 |
| tlr1 | #430 |
| allergic conditions | #431 |
| clinical examinations | #432 |
| risk overweight | #433 |
| 441 | #433 |
| specific sensitization | #434 |
| respiratory allergic | #434 |
| age odds ratio | #438 |
| decrements | #438 |
| allergy diagnosis | #438 |
| tobit | #438 |
| conundrum | #440 |
| annual prevalence | #441 |
| asthma gene | #441 |
| population asthma | #442 |
| chronic inflammatory diseases | #443 |
| fecal microbiota | #443 |
| inception | #443 |
| male odds | #443 |
| cell phenotypes | #444 |
| asthma effects | #444 |
| persisting | #444 |
| increase bmi | #445 |
| observed differences | #445 |
| specific serum | #446 |
| asthma respiratory | #446 |
| exposure respiratory | #448 |
| ethnic origin | #449 |
| allergic rhinoconjunctivitis | #449 |
| 033 | #450 |
| allergy food | #450 |
| adult asthmatics | #451 |
| associations asthma | #452 |
| n149 | #452 |
| including asthma | #455 |
| school entry | #456 |
| dermatophagoides farinae | #457 |
| pregnancy increased risk | #457 |
| germany health | #458 |
| mice role | #460 |
| provocation tests | #460 |
| allergic risk | #460 |
| external environment | #460 |
| airway hyper | #462 |
| westernized | #463 |
| asthma higher | #464 |
| rural health | #464 |
| asthma control test | #465 |
| environmental factors | #466 |
| cells innate | #467 |
| opposite effects | #467 |
| postal questionnaire | #467 |
| severity asthma | #468 |
| immunocap | #468 |
| alex | #468 |
| so2 concentrations | #469 |
| early identification | #470 |
| clinical asthma | #470 |
| nod1 signaling | #470 |
| emphasised | #471 |
| exposure | #471 |
| asthma rhinitis | #471 |
| microbial counts | #471 |
| fodder | #473 |
| antibiotics children | #473 |
| birth cohorts | #473 |
| yrs | #474 |
| 1133 | #474 |
| cross sectional survey | #476 |
| champ | #476 |
| exposure antibiotics | #477 |
| early exposure | #481 |
| risk severity | #482 |
| childhood environment | #483 |
| asthma association | #484 |
| total immunoglobulin | #484 |
| subphenotypes | #485 |
| immunity genes | #486 |
| atopic disorders | #486 |
| children | #486 |
| prospective birth cohort | #487 |
| phenotypes | #487 |
| potential confounding | #489 |
| exposure data | #489 |
| studies rhinitis | #490 |
| genes environment | #490 |
| multicenter cohort | #491 |
| snp association | #494 |
| polymorphisms association | #495 |
| uncontrolled asthma | #495 |
| age 10 | #496 |
| lifestyles | #496 |
| housing animal | #497 |
| southern germany | #497 |
| children jia | #497 |
| phenotype polymorphism | #498 |
| asthma severe | #498 |
| individual level | #498 |
| respiratory hypersensitivity | #500 |
| omega6 fatty acids | #500 |
| birth age | #501 |
| asthma susceptibility | #503 |
| lung function children | #503 |
| sensitizations | #504 |
| white children | #505 |
| diet diversity | #505 |
| methods studies | #505 |
| tests specific | #505 |
| ranks | #508 |
| allergy children | #508 |
| prevalence rates | #509 |
| rna samples | #509 |
| childhood respiratory | #509 |
| housing humans | #510 |
| perennial | #511 |
| stimulation lps | #511 |
| il15 | #513 |
| age 10 years | #514 |
| europe female | #514 |
| asthma prevalence | #515 |
| children exposed | #515 |
| cities china | #516 |
| receptor tlr | #516 |
| infections asthma | #516 |
| levels children | #516 |
| asthma bronchiolitis | #516 |
| cd4cd25high | #517 |
| dpps | #518 |
| atopic conditions | #519 |
| th2 immune | #519 |
| haplotype association | #520 |
| neutrophils eosinophils | #522 |
| eczema asthma | #522 |
| children maternal | #523 |
| risk factors asthma | #523 |
| age 1 year | #523 |
| polymorphisms snps | #523 |
| p0041 | #523 |
| time window | #524 |
| rural areas | #524 |
| maternal vitamin | #525 |
| adolescence age | #525 |
| trans fatty acids | #526 |
| bmi increased risk | #528 |
| obesity body mass | #528 |
| baseline participants | #528 |
| c‐reactive protein | #529 |
| allergens animals | #529 |
| blood humans | #529 |
| 117 95 | #529 |
| edifice | #530 |
| persistent asthma | #530 |
| obesity smoking | #531 |
| environmental bacteria | #531 |
| protect | #532 |
| samples children | #532 |
| oral tolerance | #533 |
| allergic airway inflammation | #534 |
| children methods | #535 |
| immune stimulation | #536 |
| topic rhinitis | #537 |
| il4r | #538 |
| blood eosinophil counts | #539 |
| industrialised | #540 |
| human microbiota | #541 |
| adolescence early adulthood | #541 |
| airway symptoms | #542 |
| rubella virus | #543 |
| pregnancy asthma | #543 |
| lipopolysaccharide receptors | #543 |
| immunological markers | #543 |
| cypress | #544 |
| pathomechanisms | #545 |
| regulatory cell | #546 |
| antitrypsin alpha | #547 |
| 17q12 | #547 |
| greenness | #548 |
| floorcoverings | #549 |
| oligoarticular | #549 |
| hypersensitivity humans | #550 |
| epidemic proportions | #553 |
| isotype switching | #553 |
| association children | #553 |
| multidisciplinary study | #554 |
| lung microbiome | #554 |
| children parental | #555 |
| mental health patients | #555 |
| asthma status | #556 |
| overweight prevalence | #556 |
| aqlq | #558 |
| allergic rhinitis asthma | #558 |
| 1129 | #559 |
| blood eosinophils | #560 |
| letzten | #560 |
| activity body | #561 |
| reduced exposure | #564 |
| inhaled steroids | #566 |
| 2 immunity | #566 |
| hormonal contraceptives | #566 |
| 077 | #567 |
| immune regulatory | #569 |
| tripeptidyl | #570 |
| exposure matrix | #570 |
| initial observations | #570 |
| health urban | #571 |
| asthma symptom | #571 |
| diseases prevalence | #575 |
| affluence | #575 |
| levels total | #575 |
| hcs patients | #575 |
| atopic asthma | #579 |
| creactive protein levels | #579 |
| oro | #580 |
| followups | #580 |
| association obesity | #581 |
| age controls | #581 |
| fdr | #582 |
| asthma population | #582 |
| flanking regions | #582 |
| tlr6 | #584 |
| uht | #584 |
| asthma severity | #584 |
| function asthma | #585 |
| bacterial microbiome | #588 |
| gsdmb | #589 |
| longum | #590 |
| n63 | #590 |
| skin test | #591 |
| 1 antitrypsin | #592 |
| holiday | #593 |
| endotoxin concentrations | #593 |
| gasdermin | #596 |
| factors respiratory | #596 |
| il1rl1 | #596 |
| model asthma | #597 |
| advising | #598 |
| zeigen | #598 |
| total specific | #598 |
| pathogenesis asthma | #598 |
| galactosylation | #600 |
| genetic environmental | #600 |
| active immunity | #601 |
| factors humans | #602 |
| pregnancy maternal | #603 |
| 048 | #603 |
| humans human | #604 |
| statistical analyses | #604 |
| hladqa1 | #604 |
| sensitization | #606 |
| microbes | #606 |
| agents asthma | #606 |
| microbiome studies | #607 |
| ige production | #608 |
| allergic rhinitis | #610 |
| 2 inflammation | #610 |
| infant feeding practices | #611 |
| 11–13 | #612 |
| regulatory molecules | #612 |
| work life | #612 |
| bolus | #612 |
| pollen allergens | #616 |
| aged allergens | #619 |
| chronic stress | #619 |
| albania | #619 |
| urban populations | #620 |
| life age | #621 |
| body plethysmography | #621 |
| arthropod proteins | #621 |
| deep phenotyping | #622 |
| unstimulated | #623 |
| radioallergosorbent | #623 |
| functional features | #625 |
| data prevalence | #627 |
| 779 | #627 |
| endotoxin | #627 |
| protective properties | #629 |
| crosssectional | #629 |
| smoking surveys | #632 |
| school children | #632 |
| models asthma | #633 |
| feeding patterns | #635 |
| settled | #635 |
| exacerbating | #635 |
| child asthma | #636 |
| children atopic dermatitis | #637 |
| standardized questionnaire | #637 |
| lifetime prevalence | #638 |
| european children | #639 |
| igg glycosylation | #639 |
| factors urban | #639 |
| clustering approach | #641 |
| grass pollen | #642 |
| innate immunity | #642 |
| humans microbiota | #643 |
| years increased | #645 |
| symptoms | #646 |
| innate lung | #647 |
| pollen concentrations | #648 |
| participation rates | #650 |
| health rural | #650 |
| kindern | #650 |
| pets | #650 |
| life children | #650 |
| glucocorticoid induced | #652 |
| helsinki | #653 |
| comprehensive analysis | #654 |
| dermatitis allergic | #654 |
| prospective studies association | #656 |
| 16 countries | #658 |
| common chronic | #659 |
| age 1 | #662 |
| latent classes | #662 |
| conclusion data | #663 |
| cd14 expression | #664 |
| abpa | #665 |
| hygiene | #665 |
| di2ethylhexyl | #665 |
| pvalues | #666 |
| hypertonic saline | #667 |
| chemokine cx3cl1 | #668 |
| adult lung | #669 |
| standardized questionnaires | #670 |
| birth cohort | #671 |
| central european | #672 |
| susceptibility locus | #672 |
| cellules | #673 |
| études | #674 |
| jobs | #676 |
| ilc2s | #677 |
| age 45 years | #679 |
| common infections | #680 |
| protective | #681 |
| random sample | #681 |
| dairy farm | #681 |
| female forced | #681 |
| egg allergy | #682 |
| cohorte | #683 |
| dietary habits | #685 |
| recurrent wheezing | #685 |
| childhood experiences | #686 |
| factors air | #688 |
| european community | #692 |
| major gene | #693 |
| doctor | #693 |
| turkish | #694 |
| factors skin | #695 |
| physical examination | #699 |
| rhinitis symptoms | #702 |
| sensitization food | #703 |
| risk obesity | #703 |
| hypersensitivity inflammation | #703 |
| microbial flora | #703 |
| tao | #707 |
| dramatic increase | #708 |
| microbial interactions | #708 |
| 459 | #708 |
| perpetuation | #709 |
| immune activation | #709 |
| immunologic tlymphocytes | #712 |
| population surveys | #712 |
| children time | #713 |
| pregnancy children | #718 |
| bacterial spores | #720 |
| mediated diseases | #721 |
| allergy asthma | #722 |
| ratio aor | #724 |
| function children | #727 |
| sensitized patients | #727 |
| 95 males | #734 |
| alias | #734 |
| il4 il13 | #738 |
| population adolescent | #741 |
| linkage chromosome | #741 |
| nonasthmatic | #742 |
| fractional exhaled | #742 |
| farms | #743 |
| treg cell | #745 |
| type 5 | #748 |
| traffic air | #748 |
| ifih1 | #749 |
| children low | #753 |
| earlier study | #754 |
| total lung | #755 |
| h20 | #758 |
| environment interactions | #758 |
| aeroallergens | #759 |
| moderate levels | #764 |
| indoor dust | #766 |
| air trapping | #768 |
| edn1 | #768 |
| allergists | #769 |
| pulmonary function tests | #769 |
| hscrp levels | #769 |
| pattern recognition receptors | #770 |
| blood leukocytes | #770 |
| hyperresponsiveness | #770 |
| asthma adults | #771 |
| strabismus surgery | #772 |
| nucleotide receptors | #773 |
| term impact | #773 |
| incidence longitudinal | #773 |
| volume humans | #777 |
| rhinitis children | #781 |
| new associations | #784 |
| studies asthma | #784 |
| factors incidence | #785 |
| children allergic | #785 |
| factors tobacco | #788 |
| nonallergic | #788 |
| shortness breath | #789 |
| asthma therapy | #791 |
| male metaanalysis | #793 |
| gis | #793 |
| children health | #794 |
| airway hyperresponsiveness | #795 |
| βdiversity | #795 |
| natural habitat | #796 |
| distinct trajectories | #796 |
| personalization | #798 |
| pc20 | #798 |
| protective effects | #799 |
| card15 | #799 |
| 45 years | #800 |
| pair 1 chromosomes | #801 |
| confer | #802 |
| allergen | #805 |
| age 4 years | #806 |
| infant food | #807 |
| dairy farms | #808 |
| bifidobacterium longum | #810 |
| tenascin | #810 |
| exposure age | #810 |
| subclinical inflammation | #811 |
| pteronyssinus | #811 |
| peak flow | #813 |
| bacillus licheniformis | #813 |
| initial data | #814 |
| boiled | #814 |
| onset age | #815 |
| foe | #816 |
| foxp3 | #817 |
| brevibacterium | #818 |
| positive skin | #819 |
| 0053 | #820 |
| food infant | #821 |
| breastfeeding duration | #822 |
| skin tests | #822 |
| spt | #827 |
| studies respiratory | #830 |
| trier | #830 |
| prevention strategies | #831 |
| asthma health | #832 |
| current analysis | #833 |
| rad50 | #833 |
| promoter polymorphisms | #834 |
| farinae | #835 |
| snps haplotypes | #835 |
| regularly | #835 |
| igg4 | #835 |
| adolescent age | #837 |
| cx3cr1 | #838 |
| exhaled breath | #838 |
| parental smoking | #839 |
| public health problem | #839 |
| asthma bronchi | #839 |
| toll receptors | #839 |
| subsequent development | #840 |
| cladosporium | #841 |
| chronification | #844 |
| modifies | #845 |
| fetal blood | #845 |
| innate | #849 |
| potted | #849 |
| maternal exposure | #850 |
| bacterial endotoxin | #850 |
| allergen sensitization | #852 |
| inspections | #854 |
| 17q | #855 |
| provocation | #856 |
| infant health | #856 |
| infant infant | #858 |
| age 5 | #861 |
| repeatedly | #861 |
| paracetamol | #862 |
| asthma lung | #864 |
| receptors tlrs | #864 |
| questionnaires young adult | #864 |
| volatile organic | #865 |
| airway eosinophilia | #866 |
| birth cohort study | #866 |
| ige | #866 |
| outdoor air pollution | #874 |
| cumulative incidence | #874 |
| latent class analysis | #875 |
| hmos | #878 |
| dermatitis | #878 |
| microbiome humans | #879 |
| 057 | #880 |
| 1940 | #880 |
| 12q | #884 |
| ifngamma tnfalpha | #886 |
| 856 | #888 |
| brink | #888 |
| oscillometry | #890 |
| european populations | #891 |
| bacterial counts | #892 |
| subsample | #895 |
| exposure study | #895 |
| esl | #896 |
| asthma incidence | #896 |
| impact asthma | #900 |
| immunoglobulin ige | #902 |
| inflammation airway | #902 |
| breastfed | #904 |
| respiration disorders | #905 |
| allergen induced | #907 |
| shortness | #908 |
| adult asthma | #908 |
| children overweight | #910 |
| microbiome composition | #910 |
| microbiota development | #912 |
| cow milk | #917 |
| complex disease | #917 |
| immunity innate | #919 |
| peripheral blood samples | #920 |
| methods cross | #920 |
| 710 | #920 |
| estonia | #923 |
| prospective birth | #927 |
| sectional population | #928 |
| sounds | #928 |
| ilcs | #929 |
| biomérieux | #929 |
| participants baseline | #932 |
| lactococcus lactis | #939 |
| 026 | #939 |
| dermatophagoides | #940 |
| potential confounders | #940 |
| 13 years | #940 |
| floors | #942 |
| life style | #944 |
| microbiome host | #949 |
| 055 | #950 |
| environmental effects | #952 |
| identification genes | #952 |
| 454 pyrosequencing | #953 |
| 1120 | #954 |
| solids | #954 |
| polymorphisms | #954 |
| asthma exercise | #954 |
| genotyped | #954 |
| human life | #955 |
| infections child | #957 |
| fever | #959 |
| children countries | #959 |
| rhinitis asthma | #961 |
| domestic | #961 |
| exposures | #961 |
| nasal secretions | #964 |
| disease asthma | #964 |
| immunoglobulin male | #965 |
| cytokines female | #965 |
| obesity children | #966 |
| innsbruck | #970 |
| readings | #971 |
| fev | #973 |
| immunization immunoglobulin | #973 |
| onset child child | #974 |
| teenagers | #975 |
| orphan receptor | #976 |
| gondii infection | #976 |
| bmi physical activity | #977 |
| nucleotide promoter | #978 |
| respiratory conditions | #979 |
| 682 | #981 |
| receptor gene | #981 |
| xinafoate | #981 |
| yearly | #982 |
| 1333 | #983 |
| small effects | #984 |
| child cohort | #986 |
| adolescents asthma | #987 |
| 12 months age | #990 |
| 068 | #991 |
| c3h hej | #991 |
| pasteurization | #991 |
| hercules | #992 |
| asthma humans | #992 |
| function development | #992 |
| sectional | #994 |
| design methods | #994 |
| immunoglobulin class | #995 |
| diagnosis asthma | #998 |
| respiratory symptoms | #1001 |
| bradykinin receptors | #1003 |
| yoghurt | #1005 |
| ppg | #1006 |
| maternally | #1006 |
| rural population | #1006 |
| linens | #1009 |
| preventive measures | #1010 |
| pt15 | #1012 |
| asthma outcomes | #1014 |
| timeframe | #1016 |
| phytohemagglutinin | #1017 |
| 039 | #1017 |
| association physical activity | #1018 |
| median levels | #1019 |
| strongest associations | #1020 |
| asthma medication | #1021 |
| western countries | #1022 |
| sought | #1024 |
| raw milk | #1027 |
| asthma adult | #1029 |
| outcome variables | #1030 |
| upper airways | #1031 |
| 096 | #1033 |
| genomewide association | #1033 |
| asthmatic children | #1035 |
| veillonella | #1037 |
| cell child | #1038 |
| dairying | #1039 |
| breastmilk | #1039 |
| nod1 | #1042 |
| milieu | #1046 |
| disease children | #1046 |
| missing values | #1047 |
| exposure conditions | #1048 |
| controls age | #1051 |
| severe allergic | #1057 |
| il5 | #1058 |
| hobbies | #1059 |
| infant gut | #1059 |
| metalloprotease | #1060 |
| pregnancy prospective | #1062 |
| class switching | #1064 |
| signaling adaptor | #1065 |
| rural | #1066 |
| predictor | #1066 |
| 8 12 | #1068 |
| skin sensitization | #1068 |
| gnp | #1069 |
| margarine | #1070 |
| moraxella | #1070 |
| central europe | #1070 |
| prevalence prospective | #1071 |
| expression humans | #1072 |
| interrelation | #1075 |
| cross sectional study | #1077 |
| large population | #1077 |
| west east | #1079 |
| box transcription | #1079 |
| trflp | #1080 |
| risk development | #1081 |
| factors child | #1081 |
| life respiratory | #1082 |
| allergic airway | #1083 |
| cells tregs | #1083 |
| study areas | #1083 |
| sufferers | #1086 |
| children prevalence | #1086 |
| maternal asthma | #1089 |
| lca | #1090 |
| gene expression data | #1090 |
| exposure delayed | #1091 |
| longduration | #1094 |
| disintegrin | #1095 |
| nationality | #1096 |
| proteins polymorphism | #1096 |
| 930 | #1097 |
| supplementary data | #1098 |
| overweight bmi | #1101 |
| enfants | #1103 |
| forkhead | #1103 |
| studies evidence | #1104 |
| conjunctivitis | #1104 |
| adolescence adulthood | #1105 |
| cd14 | #1106 |
| weight risk | #1116 |
| 248 | #1116 |
| characteristically | #1117 |
| risk gene | #1117 |
| associations observed | #1118 |
| meat consumption | #1119 |
| prevalences | #1122 |
| association exposure | #1123 |
| intermediate phenotypes | #1125 |
| newonset | #1126 |
| lung function decline | #1127 |
| il12b | #1127 |
| sscp analysis | #1127 |
| based clustering | #1128 |
| taxonomies | #1130 |
| endotoxins | #1130 |
| age birth | #1132 |
| expiratory flow | #1132 |
| 859 | #1134 |
| based birth | #1136 |
| pet ownership | #1144 |
| log2 | #1144 |
| allergic asthma | #1145 |
| gondii | #1145 |
| patients severe asthma | #1146 |
| pediatric asthma | #1146 |
| skewness | #1152 |
| 837 | #1152 |
| humans respiratory | #1153 |
| environmental tobacco | #1154 |
| regions china | #1154 |
| disease cohort | #1156 |
| dust mite | #1156 |
| 862 | #1158 |
| deciphering | #1159 |
| countries prevalence | #1160 |
| epidemiological evidence | #1164 |
| anti ige | #1165 |
| 027 | #1165 |
| rarer | #1168 |
| preschool cohort | #1169 |
| inbred balb receptors | #1172 |
| crowding | #1173 |
| genomewide | #1176 |
| receptors ige | #1178 |
| farmers | #1179 |
| phase behaviour | #1180 |
| croup | #1183 |
| contre | #1184 |
| serum immunoglobulin | #1184 |
| food allergens | #1186 |
| asthma bronchodilator | #1189 |
| new paradigm | #1189 |
| levels measured | #1190 |
| exhaled | #1194 |
| respiratory tract | #1196 |
| censored | #1197 |
| children association | #1200 |
| management children | #1206 |
| rorc | #1207 |
| bacterial taxa | #1208 |
| fungi humans | #1211 |
| sedentary lifestyle | #1211 |
| risk childhood | #1214 |
| flg | #1215 |
| regulatory cells tregs | #1216 |
| food hypersensitivity | #1218 |
| risk children | #1218 |
| orphan | #1219 |
| bradykinin | #1220 |
| eosinophilic inflammation | #1221 |
| day life | #1223 |
| factor activity | #1225 |
| 047 | #1229 |
| male pregnancy | #1233 |
| balb ovalbumin | #1234 |
| age menarche | #1236 |
| gene variants | #1236 |
| th1 th2 | #1236 |
| adult allergens | #1240 |
| european population | #1241 |
| antitrypsin | #1243 |
| small children | #1243 |
| ulm | #1247 |
| protective factors | #1250 |
| objective aim | #1251 |
| pertussis | #1252 |
| early years | #1252 |
| food items | #1253 |
| peripheral blood leukocytes | #1253 |
| airway hyperreactivity | #1253 |
| shop | #1256 |
| questionnaires | #1256 |
| debated | #1257 |
| telephone interviews | #1260 |
| lung function | #1260 |
| mite | #1262 |
| studies gene | #1263 |
| disease case | #1264 |
| yogurt | #1267 |
| temperature humidity | #1268 |
| overweight children | #1274 |
| occupational exposures | #1277 |
| pollution indoor | #1281 |
| fev1 forced | #1281 |
| children exposure | #1282 |
| infections risk | #1284 |
| shannon | #1284 |
| immunomodulating | #1289 |
| diseases occupational | #1289 |
| pollution exposure | #1292 |
| potential risk factors | #1293 |
| 182 | #1295 |
| body sites | #1296 |
| tests risk | #1299 |
| age baseline | #1301 |
| gme | #1302 |
| explain | #1303 |
| topic polymorphism | #1303 |
| venipuncture | #1306 |
| endotypes | #1309 |
| lymphocytes regulatory | #1312 |
| factor development | #1312 |
| th1 cytokines | #1314 |
| industrially | #1314 |
| 038 | #1318 |
| sought determine | #1320 |
| harmonization | #1322 |
| cell numbers | #1322 |
| epidemiological survey | #1322 |
| objective investigate | #1327 |
| cleaning | #1329 |
| neuraminic | #1329 |
| lrti | #1330 |
| concerted | #1330 |
| zusammenfassung | #1331 |
| prevalence rural | #1331 |
| gambia | #1332 |
| respiratory allergy | #1332 |
| sponsorship | #1335 |
| induced sputum | #1335 |
| loft | #1337 |
| passive smoking | #1340 |
| 897 | #1342 |
| mass breast | #1343 |
| multiple testing | #1346 |
| puberty | #1347 |
| airway function | #1349 |
| th2 cells | #1351 |
| irf1 | #1353 |
| oxide feno | #1353 |
| expired | #1353 |
| atopic humans | #1354 |
| toxoplasma gondii | #1355 |
| 267 | #1357 |
| reduction risk | #1358 |
| 16 18 | #1358 |
| asthmatics | #1359 |
| science foundation | #1359 |
| 2 innate | #1360 |
| lung microbiota | #1363 |
| 279 | #1366 |
| france germany | #1366 |
| maternal immune | #1367 |
| asthma female | #1369 |
| innate lymphoid | #1374 |
| whey proteins | #1378 |
| preventive strategies | #1381 |
| austria | #1382 |
| common forms | #1383 |
| total ige | #1383 |
| lactococcus | #1386 |
| studies lung | #1387 |
| management asthma | #1388 |
| environmental | #1389 |
| disagreement | #1389 |
| childhood adult | #1390 |
| early intervention | #1395 |
| milk proteins | #1403 |
| severe atopic | #1404 |
| q21 | #1404 |
| risk developing | #1404 |
| fef25 | #1406 |
| airway inflammation | #1407 |
| air samples | #1410 |
| indoor | #1412 |
| dust exposure | #1415 |
| sige | #1417 |
| baseline followup | #1417 |
| bronchodilators | #1418 |
| immune mechanisms | #1418 |
| microbial | #1419 |
| hapmap | #1421 |
| il13 | #1421 |
| bronchitis | #1422 |
| longitudinal cohort | #1422 |
| male multivariate | #1427 |
| pulmonary eosinophilia | #1429 |
| pair 17 | #1429 |
| asthmatic | #1433 |
| timepoint | #1433 |
| chronic inflammatory | #1435 |
| exhaled nitric | #1440 |
| irak4 | #1442 |
| induced airway | #1443 |
| inflammatory pathways | #1444 |
| centres | #1444 |
| overweight | #1445 |
| studies europe | #1445 |
| age 5 years | #1446 |
| bronchodilator response | #1448 |
| airway responses | #1451 |
| factors prevalence | #1454 |
| agricultural workers | #1460 |
| asthma clinical | #1460 |
| infancy | #1461 |
| unique opportunity | #1461 |
| immunizations | #1463 |
| barcelona | #1464 |
| 706 | #1464 |
| a20 | #1466 |
| hand eczema | #1468 |
| association polymorphism | #1468 |
| surveys questionnaires | #1470 |
| recognition receptors | #1470 |
| asthma compared | #1472 |
| immunity | #1473 |
| leur | #1474 |
| operating characteristics | #1474 |
| adolescence | #1475 |
| nod2 signaling | #1476 |
| 362 | #1477 |
| innate immune responses | #1478 |
| 1 levels | #1478 |
| meeting | #1479 |
| dgge | #1480 |
| otitis | #1482 |
| paediatricians | #1490 |
| immunologic mechanisms | #1493 |
| peptidases | #1494 |
| strongest predictor | #1494 |
| populationbased cohort | #1504 |
| ionomycin | #1505 |
| flexural | #1505 |
| tlr2 | #1506 |
| birch pollen | #1507 |
| structured interviews | #1508 |
| tlr2 tlr4 | #1509 |
| igg1 | #1511 |
| understood | #1512 |
| sulphur dioxide | #1514 |
| bacterial composition | #1514 |
| ergosterol | #1515 |
| living environment | #1517 |
| epidemiological data | #1517 |
| moderate asthma | #1517 |
| pasteurized | #1518 |
| latent class | #1520 |
| child welfare | #1521 |
| rôle | #1524 |
| pollution levels | #1524 |
| 153 | #1527 |
| hladq | #1527 |
| respiratory tract infections | #1530 |
| differences prevalence | #1533 |
| underlying mechanisms | #1536 |
| jia | #1536 |
| dust | #1542 |
| 245 | #1551 |
| factors development | #1552 |
| wisconsin | #1555 |
| birthday | #1558 |
| previous 12 months | #1558 |
| children aged | #1564 |
| children increased | #1566 |
| antibiotic exposure | #1567 |
| austrian | #1573 |
| born children | #1578 |
| china female humans | #1579 |
| licheniformis | #1584 |
| children risk | #1584 |
| current studies | #1588 |
| treatment asthma | #1595 |
| explained | #1596 |
| trans fatty | #1596 |
| breastfed infants | #1598 |
| study populations | #1599 |
| tract diseases | #1602 |
| 775 | #1603 |
| development progression | #1603 |
| air microbiology | #1604 |
| regulatory | #1605 |
| disease process | #1607 |
| ascariasis | #1610 |
| male prospective | #1611 |
| neuropeptide | #1612 |
| erythrocyte membranes | #1612 |
| cells1 | #1613 |
| peak expiratory | #1613 |
| familial aggregation | #1617 |
| candidate gene | #1622 |
| ige antibodies | #1624 |
| cells th2 | #1624 |
| early gene | #1626 |
| precision medicine | #1627 |
| short communication | #1627 |
| tolerogenic | #1628 |
| questionnaires young | #1632 |
| studies recurrence | #1634 |
| tcell responses | #1635 |
| newborn infants | #1641 |
| gata3 | #1641 |
| th2 cytokines | #1644 |
| th2 | #1645 |
| nutritional factors | #1647 |
| population based study | #1653 |
| style male | #1653 |
| topic surveys | #1653 |
| card | #1655 |
| traffic volume | #1656 |
| microbial diversity | #1656 |
| 034 | #1656 |
| smoke exposure | #1657 |
| cells transcription | #1661 |
| northern europe | #1661 |
| expiratory volume | #1664 |
| respiratory | #1666 |
| opportunity | #1667 |
| linear discriminant analysis | #1671 |
| followup study | #1677 |
| asthmatic agents | #1678 |
| cheese | #1688 |
| epidemiologic evidence | #1688 |
| employment | #1692 |
| microbiome | #1693 |
| obesity risk | #1694 |
| early introduction | #1694 |
| innate immune | #1694 |
| gitr | #1696 |
| health‐related quality | #1697 |
| aux | #1701 |
| th2 th17 | #1702 |
| gene interaction | #1704 |
| phenotyping | #1704 |
| adulthood | #1706 |
| 476 | #1710 |
| fungal diversity | #1712 |
| provocative | #1716 |
| singlenucleotide polymorphisms | #1717 |
| mere | #1718 |
| house dust mite | #1718 |
| 029 | #1723 |
| life hrqol | #1730 |
| airflow obstruction | #1732 |
| gabon | #1733 |
| asthma control | #1733 |
| genotyping | #1734 |
| anti asthmatic | #1735 |
| innate adaptive | #1739 |
| factors breast | #1742 |
| factors children | #1746 |
| cytokine genes | #1746 |
| 5 7 | #1748 |
| inverse relationship | #1749 |
| helminth parasites | #1749 |
| preschool clinical trials | #1751 |
| inconsistencies | #1753 |
| molds | #1754 |
| male polymorphism | #1756 |
| masks | #1756 |
| fivefold | #1760 |
| gstm1 gstt1 | #1760 |
| chronic airway | #1761 |
| refugees | #1761 |
| bacterial diversity | #1764 |
| susceptibility gene | #1767 |
| street | #1768 |
| environmental tobacco smoke | #1769 |
| association body mass | #1772 |
| soot | #1778 |
| cells airway | #1778 |
| helminth infections | #1779 |
| peptidoglycan | #1782 |
| occupational exposure | #1782 |
| cd4cd25 | #1782 |
| allergic reaction | #1788 |
| exposure assessment | #1789 |
| nucleotide polymorphisms | #1799 |
| generations | #1800 |
| key feature | #1801 |
| helminths | #1801 |
| 054 | #1801 |
| rubella | #1807 |
| life factors | #1809 |
| treg cells | #1812 |
| single nucleotide receptors | #1812 |
| feno | #1817 |
| censoring | #1821 |
| protein 3 | #1821 |
| factors health | #1822 |
| dna fingerprinting | #1823 |
| breastfeeding | #1825 |
| asthma morbidity | #1828 |
| signal transducer | #1828 |
| respiratory illnesses | #1831 |
| 112 | #1831 |
| leisure time | #1834 |
| generational | #1837 |
| vocational | #1838 |
| foxp3 expression | #1841 |
| regulatory cells | #1843 |
| il4 | #1843 |
| heterogeneous disease | #1843 |
| fetal growth | #1845 |
| otus | #1845 |
| forkhead transcription | #1849 |
| sampling methods | #1854 |
| causally | #1855 |
| idiopathic arthritis | #1857 |
| 95 risk factors | #1859 |
| disease incidence | #1878 |
| hypertonic | #1879 |
| friend | #1884 |
| diseases lung | #1886 |
| unraveling | #1886 |
| interleukin33 | #1891 |
| predispose | #1892 |
| age 4 | #1893 |
| aor | #1894 |
| age 2 | #1895 |
| life | #1898 |
| microbe | #1899 |
| lung male | #1900 |
| interleukin5 | #1901 |
| population level | #1901 |
| hrqol | #1903 |
| occupational stress | #1904 |
| jedoch | #1908 |
| brought | #1909 |
| vital capacity | #1909 |
| predictive models | #1914 |
| feeding practices | #1917 |
| coeliac disease | #1918 |
| confounded | #1924 |
| weight breast | #1929 |
| basics | #1932 |
| experimental models | #1932 |
| p0012 | #1933 |
| helminthiasis | #1934 |
| pregnancy prevalence | #1936 |
| child humans | #1938 |
| barrier function | #1941 |
| european commission | #1944 |
| aetiology | #1945 |
| percentiles | #1946 |
| juvenile idiopathic | #1946 |
| cell markers | #1949 |
| galactans | #1951 |
| raised | #1959 |
| moisture | #1959 |
| asthmatic subjects | #1960 |
| immune mediated | #1960 |
| invading | #1960 |
| blood eosinophil | #1960 |
| child female | #1966 |
| lps stimulation | #1966 |
| regulatory region | #1973 |
| 658 | #1975 |
| phenomena infant | #1977 |
| dwellings | #1985 |
| children severe | #1991 |
| dollar | #1994 |
| natural environments | #1997 |
| helper type | #1998 |
| studie | #1999 |
| descriptions | #2000 |
| agriculture | #2000 |
| 041 | #2004 |
| respiratory viral | #2010 |
| infectious agents | #2011 |
| richness | #2012 |
| physical activity pa | #2014 |
| lower frequencies | #2015 |
| life risk | #2018 |
| postnatal exposure | #2019 |
| diary | #2020 |
| children data | #2020 |
| regulation genetic | #2020 |
| physician diagnosis | #2021 |
| bedding | #2024 |
| underline | #2025 |
| relate | #2026 |
| age | #2027 |
| 939 | #2030 |
| chymase | #2038 |
| bovine milk | #2038 |
| ige mediated | #2040 |
| outdoor air | #2041 |
| subsamples | #2046 |
| mass child | #2047 |
| conflicting | #2056 |
| cx3c | #2057 |
| 858 | #2059 |
| schoolage children | #2063 |
| peanuts | #2068 |
| association snps | #2070 |
| standardize | #2072 |
| asthma diagnosis | #2073 |
| early childhood | #2075 |
| bronchial epithelial cells | #2075 |
| polarizing | #2076 |
| discrepant | #2080 |
| asthma quality | #2086 |
| women association | #2087 |
| gastrointestinal microbiome | #2095 |
| confounders | #2097 |
| clinical phenotypes | #2098 |
| abstracts | #2098 |
| dusts | #2099 |
| environment interaction | #2100 |
| symptoms age | #2101 |
| male maternal | #2103 |
| 19th century | #2103 |
| disequilibrium | #2104 |
| tregs | #2109 |
| bacterial colonization | #2111 |
| reduced levels | #2111 |
| dairy products | #2114 |
| permutation | #2116 |
| prevalence children | #2118 |
| alternata | #2118 |
| children higher | #2121 |
| 5q | #2125 |
| protection | #2128 |
| child preschool | #2128 |
| glucans | #2132 |
| year | #2133 |
| th2 cell | #2134 |
| common disease | #2139 |
| mild asthma | #2141 |
| dietary interventions | #2142 |
| exhalation | #2145 |
| animals child | #2145 |
| indoors | #2149 |
| sibling | #2153 |
| offspring mothers | #2154 |
| epigenetic regulation | #2155 |
| schoolchildren | #2157 |
| immune modulation | #2157 |
| ionization time | #2158 |
| studies food | #2161 |
| interleukin4 | #2163 |
| blood samples | #2166 |
| food allergy | #2173 |
| blood sampling | #2175 |
| stat6 | #2178 |
| west | #2178 |
| consumption | #2180 |
| spirometry | #2181 |
| forced expiratory | #2184 |
| utero exposure | #2186 |
| industrialized | #2190 |
| children age | #2192 |
| subsequent risk | #2193 |
| respiratory infections | #2196 |
| topic united states | #2207 |
| occupational diseases | #2208 |
| actinomycetales | #2210 |
| acinetobacter | #2212 |
| 146 | #2213 |
| communicable | #2213 |
| indoor outdoor | #2215 |
| lung epithelial cells | #2215 |
| onset disease | #2220 |
| early development | #2220 |
| female finland | #2221 |
| lung mice | #2229 |
| guardians | #2231 |
| preschool | #2232 |
| 079 | #2234 |
| 18 months | #2236 |
| diesel exhaust | #2242 |
| 12th | #2242 |
| childhood overweight | #2245 |
| th17 cell | #2246 |
| bacteria fungi | #2247 |
| spirometric | #2247 |
| immune regulation | #2248 |
| preventive | #2249 |
| whooping | #2249 |
| bacterial load | #2251 |
| functional relevance | #2252 |
| bmi risk | #2257 |
| christianity | #2258 |
| 108 | #2259 |
| specific immunoglobulin | #2259 |
| patients responders | #2267 |
| résultats | #2268 |
| environmental influences | #2271 |
| decanoic | #2274 |
| consistently | #2277 |
| preventative | #2280 |
| cla | #2282 |
| commensals | #2282 |
| 031 | #2286 |
| objective measures | #2287 |
| association childhood | #2292 |
| foxp3 cells | #2293 |
| avenues | #2296 |
| gene interactions | #2299 |
| 11 years | #2301 |
| asthma study | #2312 |
| normal children | #2318 |
| receptor 2 | #2322 |
| box protein | #2325 |
| 0042 | #2326 |
| limulus | #2329 |
| 056 | #2334 |
| studies children | #2336 |
| methodsthe | #2338 |
| 064 | #2338 |
| variation genotype | #2341 |
| ascaris | #2349 |
| omega3 fatty acids | #2352 |
| 922 | #2353 |
| prrs | #2353 |
| spss | #2354 |
| 035 | #2358 |
| treg | #2361 |
| strongest | #2364 |
| adaptive immune response | #2366 |
| regular | #2368 |
| throat | #2371 |
| microbial composition | #2376 |
| viral respiratory | #2377 |
| populationbased cohort study | #2379 |
| diseases respiratory | #2380 |
| expiratory | #2386 |
| immunologically | #2386 |
| breath | #2395 |
| genetic variation | #2396 |
| human immune | #2397 |
| urban environments | #2401 |
| blood institute | #2402 |
| bronchodilator agents | #2405 |
| diaries | #2405 |
| models male | #2413 |
| cord | #2416 |
| adequately | #2417 |
| ripk1 | #2419 |
| 7000 | #2422 |
| finnish | #2423 |
| gstt1 | #2428 |
| pathway genes | #2430 |
| early adulthood | #2435 |
| african ancestry | #2443 |
| partly | #2445 |
| toll receptor | #2457 |
| attributable | #2459 |
| motor vehicles | #2461 |
| questionnaires sweden | #2462 |
| luciferase reporter | #2464 |
| disease review | #2468 |
| vitamin intake | #2468 |
| enhancer elements | #2474 |
| genetic ancestry | #2477 |
| crosssectional survey | #2479 |
| 095 | #2496 |
| peers | #2497 |
| case control study | #2498 |
| questionnaire | #2500 |
| children adolescent | #2508 |
| cytokines humans | #2508 |
| forkhead box | #2509 |
| tolllike receptors | #2512 |
| airway responsiveness | #2525 |
| tolllike receptor | #2525 |
| interleukin13 | #2525 |
| 239 | #2527 |
| common cold | #2528 |
| style | #2528 |
| artemisia | #2530 |
| uncontrolled | #2540 |
| forced expiratory volume | #2541 |
| young adulthood | #2552 |
| switzerland | #2553 |
| inverse | #2553 |
| modify | #2556 |
| european countries | #2564 |
| pregnancy prenatal | #2568 |
| 060 | #2569 |
| siblings | #2572 |
| th2 response | #2576 |
| suggested | #2584 |
| activator | #2584 |
| myristate | #2585 |
| disease development | #2586 |
| sectional survey | #2586 |
| human microbiome | #2588 |
| ω3 | #2590 |
| 030 | #2590 |
| air pollutant | #2602 |
| immunoglobulin levels | #2603 |
| damp | #2605 |
| large sample | #2608 |
| health children | #2616 |
| viral infections | #2623 |
| humans immunoglobulin | #2624 |
| 241 | #2625 |
| mold | #2626 |
| adverse health effects | #2628 |
| polymorphism | #2633 |
| chronic respiratory diseases | #2637 |
| illness surveys | #2638 |
| prenatal exposure | #2638 |
| translate | #2640 |
| imputation | #2641 |
| molecular patterns | #2641 |
| cb | #2643 |
| 141 | #2643 |
| early | #2646 |
| evenness | #2647 |
| life illness | #2651 |
| stockholm | #2652 |
| virus diseases | #2657 |
| exhaled nitric oxide | #2657 |
| groups children | #2665 |
| 739 | #2668 |
| urban rural | #2672 |
| il4 il5 | #2673 |
| gene expression levels | #2678 |
| confounder | #2678 |
| urgently | #2684 |
| girls boys | #2684 |
| onwards | #2687 |
| categorised | #2687 |
| positive association | #2689 |
| 0048 | #2696 |
| 061 | #2699 |
| host factors | #2699 |
| effects prenatal | #2700 |
| 793 | #2703 |
| 063 | #2712 |
| leukocytes mononuclear | #2717 |
| prenatally | #2721 |
| il23r | #2721 |
| respiratory function | #2731 |
| progression disease | #2732 |
| interaction genetic | #2738 |
| reaction polymorphism | #2739 |
| worldwide | #2739 |
| risk allele | #2739 |
| contacted | #2742 |
| 95 children | #2754 |
| preschool chromosomes | #2755 |
| complete data | #2756 |
| female fetal | #2760 |
| modern | #2764 |
| milk | #2766 |
| effects air | #2770 |
| species level | #2770 |
| potential benefits | #2771 |
| rhinovirus | #2775 |
| urban health | #2778 |
| centile | #2786 |
| messenger receptors | #2787 |
| gstm1 | #2787 |
| questionnaire study | #2796 |
| prematurely | #2800 |
| emergency department visits | #2801 |
| 893 | #2802 |
| prospective longitudinal | #2809 |
| functional variants | #2810 |
| personalized treatment | #2812 |
| 812 | #2815 |
| detailed | #2816 |
| package | #2826 |
| stat1 | #2827 |
| standardized | #2829 |
| nocturnal | #2831 |
| toll | #2843 |
| dietary factors | #2848 |
| asthma patients | #2853 |
| alternaria | #2854 |
| infant formula | #2856 |
| children mothers | #2861 |
| antibiotic treatment | #2871 |
| tobacco smoke | #2878 |
| deubiquitinating | #2878 |
| lci | #2886 |
| living | #2887 |
| respondent | #2888 |
| human bronchial | #2894 |
| persistence | #2899 |
| east | #2902 |
| complement receptors | #2906 |
| male parents | #2911 |
| intrapulmonary | #2914 |
| life span | #2915 |
| 3 mm | #2916 |
| epidemiologic methods | #2917 |
| 645 | #2919 |
| 913 | #2923 |
| transitioning | #2925 |
| male gender | #2928 |
| virtually | #2928 |
| il33 | #2940 |
| listeria | #2942 |
| matrix assisted | #2944 |
| antibiotic | #2947 |
| clinical manifestation | #2956 |
| pollen | #2957 |
| visiting | #2958 |
| reduced risk | #2961 |
| written | #2965 |
| notification | #2966 |
| 074 | #2968 |
| asthma management | #2969 |
| birth | #2974 |
| study prevalence | #2975 |
| mould | #2979 |
| 073 | #2982 |
| 8th | #2983 |
| 804 | #2985 |
| patients asthma | #2985 |
| primary prevention | #2989 |
| 2 months | #2990 |
| year age | #2996 |
| critical period | #2996 |
| forced vital | #3004 |
| 293 | #3010 |
| allergic inflammation | #3011 |
| genetic receptor | #3013 |
| tlr5 | #3022 |
| forced | #3024 |
| confounding factors | #3040 |
| methodological issues | #3047 |
| polymorphism single | #3050 |
| fungal dna | #3054 |
| frequency genetic | #3059 |
| 3 years | #3060 |
| doubt | #3065 |
| epigenetic mechanisms | #3065 |
| tlrs | #3068 |
| dna extraction | #3069 |
| findings studies | #3069 |
| snps genes | #3071 |
| vaccinations | #3079 |
| economic development | #3082 |
| adaptive immune responses | #3087 |
| preschool children | #3087 |
| rapid increase | #3089 |
| rural area | #3089 |
| viewpoints | #3090 |
| overweight obesity | #3093 |
| 066 | #3096 |
| genetic variations | #3098 |
| homes | #3099 |
| analysed | #3103 |
| malditof | #3106 |
| invited | #3110 |
| delayed effects | #3119 |
| environment | #3123 |
| 0036 | #3125 |
| inhalation exposure | #3126 |
| europe humans | #3126 |
| menarche | #3129 |
| hdm | #3131 |
| 12 months | #3141 |
| filaggrin | #3142 |
| cow | #3143 |
| preschool dna | #3154 |
| vital | #3157 |
| pha | #3159 |
| baseline follow | #3182 |
| multifaceted | #3184 |
| clarified | #3188 |
| distinct | #3192 |
| bronchodilator | #3194 |
| pleiotropy | #3196 |
| genetic receptors | #3197 |
| monitoring female | #3197 |
| aor 95 | #3198 |
| 037 | #3201 |
| development disease | #3206 |
| disease genotype | #3207 |
| volume 1 | #3208 |
| 069 | #3209 |
| suburban | #3211 |
| bronchial asthma | #3213 |
| surveys | #3214 |
| messages | #3216 |
| university students | #3218 |
| housekeeping | #3227 |
| epidemiological | #3227 |
| catarrhalis | #3235 |
| functional effects | #3245 |
| 050 | #3251 |
| agents child | #3252 |
| health surveys | #3257 |
| beds | #3257 |
| 08 | #3258 |
| 360 | #3259 |
| genetic epigenesis | #3260 |
| systemic inflammation | #3261 |
| missing data | #3261 |
| prospective cohort | #3264 |
| eventually | #3266 |
| enhanced expression | #3270 |
| spores | #3271 |
| automobiles | #3272 |
| 3rd | #3275 |
| nested case | #3280 |
| premature birth | #3283 |
| 4th | #3289 |
| appreciation | #3296 |
| 19th | #3300 |
| european ancestry | #3301 |
| 098 | #3306 |
| lab | #3308 |
| cells toll | #3314 |
| influential | #3317 |
| corynebacterium | #3318 |
| surveys humans | #3318 |
| weight children | #3327 |
| child | #3332 |
| idiotypic | #3338 |
| subtle | #3341 |
| logistic regression models | #3343 |
| th17 cells | #3349 |
| age children | #3352 |
| noncommunicable diseases | #3354 |
| acid receptor | #3354 |
| influencing | #3358 |
| 509 | #3361 |
| 086 | #3367 |
| ifn γ | #3371 |
| 166 | #3372 |
| manifests | #3374 |
| polymorphisms genes | #3377 |
| 566 | #3377 |
| genetic variants | #3379 |
| rooms | #3380 |
| gut microbiome | #3384 |
| genetic background | #3388 |
| differed | #3397 |
| 0004 | #3398 |
| genetic protein structure | #3408 |
| benzene | #3408 |
| protecting | #3409 |
| turn | #3409 |
| alternaria alternata | #3418 |
| gg | #3421 |
| tlr | #3421 |
| occupational asthma | #3423 |
| maternal health | #3433 |
| sociodemographics | #3436 |
| 092 | #3443 |
| factors smoking | #3445 |
| air pollution | #3445 |
| guangzhou | #3448 |
| epithelial barrier | #3461 |
| disease genetic | #3465 |
| trends prevalence | #3467 |
| airflow limitation | #3468 |
| 049 | #3468 |
| cytokine responses | #3469 |
| omega6 | #3470 |
| th2 cytokine | #3470 |
| rye | #3480 |
| 089 | #3484 |
| humans linkage | #3484 |
| 043 | #3484 |
| 18s | #3488 |
| ambient air pollution | #3494 |
| counselling | #3496 |
| skin patients | #3497 |
| aged children | #3500 |
| total population | #3501 |
| evidences | #3507 |
| postal | #3507 |
| raw | #3512 |
| heating | #3515 |
| onset symptoms | #3519 |
| 95th | #3523 |
| respiratory mucosa | #3525 |
| 032 | #3525 |
| analysing | #3529 |
| schoolaged children | #3540 |
| innate immune response | #3541 |
| older children | #3542 |
| microbiota | #3544 |
| 059 | #3548 |
| bronchial epithelial | #3550 |
| seasonal | #3551 |
| parent | #3557 |
| 5p | #3565 |
| molecular biomarkers | #3566 |
| microbiota composition | #3568 |
| 042 | #3570 |
| coevolution | #3578 |
| tract humans | #3594 |
| minor allele | #3596 |
| plausibility | #3603 |
| children parents | #3604 |
| birch | #3605 |
| parents children | #3606 |
| linkage disequilibrium | #3610 |
| cough | #3612 |
| association polymorphisms | #3618 |
| objectively | #3623 |
| genotype humans | #3626 |
| cats | #3627 |
| claimed | #3628 |
| relating | #3629 |
| environment female | #3630 |
| pollution | #3634 |
| risk alleles | #3638 |
| broad spectrum | #3641 |
| hej | #3643 |
| odds | #3644 |
| 0011 | #3652 |
| lung volume | #3654 |
| skewed | #3670 |
| contact | #3674 |
| publication child child | #3677 |
| resides | #3679 |
| complex diseases | #3680 |
| 251 | #3681 |
| 1995 | #3684 |
| toxoplasma | #3686 |
| disequilibrium male | #3686 |
| genetic control | #3686 |
| 046 | #3688 |
| host immune | #3691 |
| monocytogenes | #3691 |
| adult blood | #3691 |
| 655 | #3695 |
| gene frequency | #3697 |
| il17 | #3701 |
| biological agents | #3703 |
| gloves | #3704 |
| 456 | #3704 |
| study gwas | #3705 |
| cette | #3725 |
| mice models | #3726 |
| 577 | #3727 |
| allocate | #3730 |
| genetic gene | #3735 |
| desorption ionization | #3735 |
| hyper | #3748 |
| ovalbumin ova | #3753 |
| 094 | #3755 |
| glutathione transferase | #3755 |
| vehicle emissions | #3759 |
| helperinducer | #3763 |
| adaptive immunity | #3764 |
| coeliac | #3765 |
| positive bacteria | #3766 |
| regressions | #3766 |
| function decline | #3771 |
| 824 | #3786 |
| housing | #3795 |
| gm csf | #3797 |
| time trends | #3798 |
| sympathomimetics | #3802 |
| multicenter studies | #3807 |
| nutrition examination | #3820 |
| weight child | #3825 |
| tcells | #3832 |
| girls | #3834 |
| bethesda | #3837 |
| health problem | #3838 |
| relation | #3838 |
| receptors immunologic | #3843 |
| 076 | #3846 |
| models immunological | #3854 |
| exposure risk | #3861 |
| epistasis | #3865 |
| tremendous | #3867 |
| loci genetic | #3869 |
| utero | #3873 |
| immunoglobulin | #3873 |
| respiratory diseases | #3876 |
| berlin | #3876 |
| maternal smoking | #3881 |
| lymphoid cells | #3891 |
| parental | #3899 |
| positively | #3912 |
| 319 | #3920 |
| 368 | #3920 |
| colonisation | #3922 |
| volatile organic compounds | #3934 |
| confounding | #3940 |
| arthropod | #3942 |
| 051 | #3943 |
| maternal serum | #3946 |
| airway resistance | #3947 |
| maternal fetal | #3948 |
| denaturing | #3950 |
| human milk | #3950 |
| progeny | #3957 |
| asthma exacerbations | #3957 |
| faced | #3958 |
| genetic predisposition | #3958 |
| exacerbations | #3960 |
| epigenetic modifications | #3970 |
| culturing | #3971 |
| viable | #3982 |
| ecuador | #3991 |
| congresses | #3995 |
| health utilization | #3999 |
| ndvi | #4004 |
| 381 | #4005 |
| r5 | #4019 |
| newborn infant premature | #4023 |
| messenger reverse | #4026 |
| variation humans | #4026 |
| capita | #4029 |
| infant nutritional | #4032 |
| pellucida | #4033 |
| phase 2 | #4035 |
| environments | #4036 |
| ema | #4036 |
| single nucleotide | #4050 |
| occupational | #4052 |
| dipeptidyl | #4055 |
| genetic risk | #4060 |
| positive associations | #4061 |
| tlr9 | #4064 |
| humans polymorphism | #4069 |
| reverse | #4070 |
| prevotella | #4081 |
| dairy | #4093 |
| 493 | #4094 |
| 023 | #4107 |
| unbalanced | #4109 |
| clarification | #4112 |
| coding region | #4113 |
| 052 | #4118 |
| chronic disease | #4118 |
| effects exposure | #4120 |
| ethnically | #4120 |
| children 2 | #4126 |
| positional | #4136 |
| 087 | #4136 |
| salmeterol | #4139 |
| urban population | #4151 |
| luminex | #4154 |
| th17 | #4162 |
| chronic respiratory | #4163 |
| researcher | #4163 |
| 011 | #4170 |
| mrna expression | #4180 |
| husbandry | #4180 |
| sulfur dioxide | #4182 |
| th1 cells | #4183 |
| 424 | #4185 |
| rgs | #4187 |
| ruled | #4189 |
| respiratory infection | #4193 |
| protected | #4194 |
| zealand | #4204 |
| lifestyle | #4210 |
| risk loci | #4212 |
| finland | #4213 |
| preterm delivery | #4220 |
| populationbased sample | #4221 |
| growing body | #4222 |
| whey | #4236 |
| androstadienes | #4237 |
| inflammatory disease | #4243 |
| disease genotype humans | #4247 |
| body height | #4248 |
| adult onset | #4250 |
| increasing trend | #4252 |
| inhaled | #4253 |
| participated | #4256 |
| indoor environments | #4256 |
| neonatal mice | #4262 |
| children born | #4269 |
| healthy individuals | #4289 |
| metagenome | #4300 |
| ordinal | #4303 |
| influenced | #4314 |
| ephedrine | #4318 |
| cx3cl1 | #4318 |
| immunologic receptors | #4322 |
| activity pa | #4324 |
| 1 gene | #4337 |
| male mothers | #4339 |
| male obesity | #4345 |
| years life | #4346 |
| phytohemagglutinins | #4349 |
| nucleotide | #4353 |
| children study | #4356 |
| 093 | #4358 |
| diagnostics | #4359 |
| healthy children | #4370 |
| 410 | #4375 |
| urban area | #4379 |
| rationale | #4393 |
| poaceae | #4397 |
| protects | #4404 |
| age 12 | #4405 |
| fluticasone | #4405 |
| stratified | #4414 |
| lpa | #4417 |
| exposure levels | #4418 |
| cephalometry | #4418 |
| percentile | #4421 |
| hypopharynx | #4424 |
| 95ci | #4425 |
| female sex | #4428 |
| 15 years | #4429 |
| onset | #4434 |
| crohn disease | #4437 |
| participating | #4439 |
| pupils | #4442 |
| secondary prevention | #4449 |
| dr3 | #4449 |
| receptors protein | #4451 |
| rash | #4457 |
| chances | #4457 |
| goblet | #4459 |
| confers | #4461 |
| patients cystic fibrosis | #4466 |
| increased prevalence | #4468 |
| respiratory viruses | #4468 |
| 457 | #4474 |
| 0022 | #4496 |
| severe asthma | #4499 |
| prevalence risk factors | #4499 |
| culture techniques | #4499 |
| microorganisms | #4511 |
| genetic effects | #4516 |
| infant | #4517 |
| trajectories | #4530 |
| no2 | #4538 |
| inflammatory diseases | #4542 |
| statistical | #4545 |
| butter | #4551 |
| assisted laser | #4555 |
| gramnegative bacteria | #4558 |
| structural equation modeling | #4559 |
| receptor alpha | #4564 |
| control children | #4572 |
| 49 | #4573 |
| ahr | #4583 |
| population prevalence | #4583 |
| prevalence estimates | #4588 |
| 080 | #4591 |
| neutrophilic | #4598 |
| adaptor protein | #4600 |
| haplotypes humans | #4600 |
| airway | #4601 |
| knowledge gaps | #4603 |
| strikingly | #4630 |
| daily practice | #4632 |
| lactis | #4634 |
| detectability | #4660 |
| str | #4661 |
| random | #4676 |
| aiming | #4676 |
| pef | #4683 |
| 299 | #4688 |
| accumulating | #4695 |
| measles | #4697 |
| 1014 | #4699 |
| hscrp | #4700 |
| gstp1 | #4725 |
| current evidence | #4730 |
| tlc | #4741 |
| associations | #4745 |
| bacterial communities | #4747 |
| immune | #4749 |
| obstructive lung | #4753 |
| lactic acid bacteria | #4754 |
| genetic risk factors | #4755 |
| transcriptomics | #4768 |
| lifestyle factors | #4772 |
| pathophysiologic | #4775 |
| lung development | #4777 |
| unclear | #4782 |
| exposure air | #4785 |
| immune responses | #4795 |
| quantity | #4804 |
| pulmonary function | #4809 |
| filament proteins | #4812 |
| plateau | #4814 |
| helminth | #4821 |
| albuterol | #4823 |
| respects | #4823 |
| adult air | #4837 |
| 399 | #4838 |
| female food | #4841 |
| implicating | #4844 |
| pointed | #4848 |
| feeding | #4851 |
| new cases | #4858 |
| haplotype analysis | #4874 |
| ont | #4886 |
| hcs | #4889 |
| 624 | #4896 |
| occupations | #4896 |
| respiratory illness | #4897 |
| newborn male | #4902 |
| studies effects | #4919 |
| hyperventilation | #4927 |
| asthma chronic | #4928 |
| dans | #4930 |
| contributors | #4940 |
| postnatal development | #4944 |
| respective | #4955 |
| starts | #4964 |
| tolerance induction | #4965 |
| blood mononuclear | #4969 |
| natal | #4973 |
| airway disease | #4975 |
| 322 | #4975 |
| predisposition disease | #4986 |
| eosinophils | #4994 |
| potential effects | #5005 |
| explore | #5011 |
| adaptor | #5012 |
| epidemiology | #5018 |
| laser desorption | #5018 |
| serine protease | #5020 |
| functionality | #5023 |
| inbred c57bl models | #5024 |
| inhalation | #5049 |
| livestock | #5058 |
| 95 | #5062 |
| paediatric | #5065 |
| manifestation | #5069 |
| milk human | #5071 |
| inflammatory markers | #5072 |
| grass | #5072 |
| 219 | #5083 |
| genetic analyses | #5084 |
| covariates | #5089 |
| held | #5091 |
| hormonal | #5091 |
| alpha1 | #5092 |
| urgent | #5094 |
| habits | #5099 |
| unexposed | #5099 |
| genomewide significance | #5100 |
| 097 | #5100 |
| il3 | #5102 |
| highrisk | #5105 |
| lysate | #5106 |
| gwas | #5119 |
| latent | #5125 |
| smoke | #5126 |
| 103 | #5130 |
| crucial | #5133 |
| 12 years | #5134 |
| regional differences | #5144 |
| mononuclear | #5153 |
| decades | #5159 |
| traffic | #5159 |
| dysbiosis | #5183 |
| 383 | #5186 |
| lung epithelial | #5191 |
| fingerprinting | #5191 |
| reflect | #5193 |
| p40 | #5196 |
| butyrates | #5200 |
| 070 | #5204 |
| age onset | #5209 |
| airways | #5210 |
| window | #5232 |
| hallmarks | #5241 |
| taxa | #5242 |
| recruited | #5243 |
| isotype | #5247 |
| bronchopulmonary | #5247 |
| crp levels | #5256 |
| psychosocial factors | #5267 |
| quartile | #5274 |
| inflammatory disorders | #5279 |
| dietary supplementation | #5280 |
| gprotein | #5283 |
| international | #5289 |
| early phase | #5305 |
| 123 | #5306 |
| environmental variables | #5314 |
| cutoff | #5318 |
| coupled receptor | #5329 |
| excessive | #5333 |
| 136 | #5336 |
| comprehensively | #5339 |
| suppressive | #5348 |
| gene expression | #5348 |
| immunology | #5348 |
| meat | #5350 |
| disease susceptibility | #5359 |
| supernatants | #5369 |
| new strategies | #5380 |
| illumina | #5384 |
| serum proteins | #5392 |
| 233 | #5406 |
| substantial | #5412 |
| discussions | #5423 |
| smad3 | #5429 |
| vitamin supplementation | #5436 |
| sensitized | #5441 |
| certainty | #5443 |
| 337 | #5450 |
| geometric | #5456 |
| 224 | #5465 |
| marks | #5470 |
| hypothesis | #5473 |
| growing evidence | #5475 |
| challenge | #5476 |
| epidemiologic | #5476 |
| phenotype | #5481 |
| healthy control subjects | #5495 |
| cytokines disease | #5496 |
| floor | #5496 |
| 373 | #5496 |
| road | #5504 |
| aged asthma | #5537 |
| alter | #5539 |
| 556 | #5544 |
| term exposure | #5547 |
| 454 | #5550 |
| coexpression | #5570 |
| predisposition | #5574 |
| 512 | #5578 |
| 45 | #5580 |
| lose | #5584 |
| 321 | #5595 |
| methacholine | #5602 |
| figures | #5602 |
| 258 | #5610 |
| 2nd | #5610 |
| 062 | #5630 |
| ld | #5634 |
| 14 years | #5637 |
| airflow | #5642 |
| contribute | #5645 |
| aa | #5661 |
| bacterial species | #5667 |
| protein coupled | #5668 |
| 081 | #5668 |
| notable | #5679 |
| contraceptives | #5682 |
| hints | #5688 |
| cytokine expression | #5693 |
| prebiotics | #5694 |
| commission | #5700 |
| offspring | #5704 |
| 134 | #5704 |
| cows | #5713 |
| cytokine production | #5722 |
| tlr7 | #5725 |
| presentations | #5727 |
| stepwise | #5729 |
| fecal samples | #5753 |
| animal humans | #5764 |
| 021 | #5770 |
| house | #5777 |
| rna expression | #5788 |
| cold | #5790 |
| maternal | #5797 |
| predominance | #5812 |
| persists | #5817 |
| humans immunity | #5824 |
| comprehensive | #5824 |
| cholecalciferol | #5831 |
| snps | #5833 |
| hen | #5848 |
| commensal | #5856 |
| 384 | #5863 |
| mites | #5878 |
| 078 | #5881 |
| bangladesh | #5887 |
| study genotype | #5888 |
| drug development | #5891 |
| sleeping | #5898 |
| workplace | #5900 |
| immunoglobulin igg | #5902 |
| paf | #5910 |
| study associations | #5924 |
| adjust | #5930 |
| encourage | #5930 |
| helper | #5938 |
| differ | #5944 |
| western europe | #5945 |
| questionnaire survey | #5947 |
| investigate association | #5947 |
| male risk | #5953 |
| 0017 | #5958 |
| 216 | #5963 |
| eastern europe | #5978 |
| promoter polymorphism | #5989 |
| disease prevalence | #5991 |
| longitudinal data | #5995 |
| interleukin15 | #5996 |
| adaptive immune | #5999 |
| calling | #6002 |
| patients symptoms | #6008 |
| 367 | #6008 |
| panels | #6009 |
| doseresponse relationship | #6012 |
| box | #6020 |
| pathogen interactions | #6022 |
| immune tolerance | #6023 |
| tract infections | #6029 |
| adult population | #6032 |
| obese children | #6032 |
| diversity | #6047 |
| existing methods | #6054 |
| risk variants | #6060 |
| prevalent | #6063 |
| eastern | #6064 |
| gmcsf | #6064 |
| modifier | #6066 |
| persisted | #6067 |
| restricted | #6068 |
| comparability | #6070 |
| 122 | #6072 |
| implication | #6077 |
| unselected | #6082 |
| ors | #6082 |
| ovalbumin | #6086 |
| microflora | #6091 |
| interleukin17 | #6094 |
| time flight | #6103 |
| 099 | #6113 |
| recruiting | #6117 |
| conferred | #6117 |
| genetic polymorphisms | #6122 |
| causality | #6128 |
| repeated | #6132 |
| fev1 | #6134 |
| fecal | #6135 |
| ahead | #6140 |
| 24 years | #6146 |
| programme | #6152 |
| 16 years | #6157 |
| town | #6158 |
| intermediate filament | #6161 |
| avec | #6163 |
| welfare | #6164 |
| gathered | #6166 |
| keeping | #6173 |
| constituent | #6182 |
| toluene | #6192 |
| determining | #6193 |
| genomewide association study | #6196 |
| narcotic | #6202 |
| conferring | #6205 |
| gross | #6216 |
| genuine | #6233 |
| populations | #6233 |
| illnesses | #6241 |
| institute | #6243 |
| prematurity | #6246 |
| administration inhalation | #6246 |
| protease inhibitor | #6252 |
| odds ratio 95 | #6262 |
| parents | #6266 |
| indoor environment | #6270 |
| study groups | #6270 |
| proposal | #6285 |
| offers | #6287 |
| irr | #6291 |
| communicable diseases | #6301 |
| nested | #6303 |
| alpha 1 | #6304 |
| tests | #6307 |
| young age | #6316 |
| outdoor | #6321 |
| allele frequencies | #6326 |
| infrequent | #6326 |
| interferons | #6343 |
| peptidase | #6346 |
| immunity mucosal | #6349 |
| 067 | #6355 |
| lymphocytes helper | #6360 |
| studies association | #6370 |
| 090 | #6375 |
| adjustments | #6385 |
| bivariate | #6388 |
| protective factor | #6390 |
| iu | #6394 |
| levels serum | #6400 |
| decreased risk | #6401 |
| immunological | #6409 |
| selection bias | #6410 |
| cell subsets | #6411 |
| genetic determinants | #6417 |
| infant premature | #6418 |
| 119 | #6439 |
| questions | #6448 |
| hypothesized | #6466 |
| mmp9 | #6467 |
| adverse health | #6475 |
| lower respiratory | #6475 |
| 287 | #6486 |
| 274 | #6490 |
| premature | #6493 |
| omalizumab | #6501 |
| 238 | #6507 |
| sleep disturbance | #6507 |
| gst | #6507 |
| links | #6512 |
| murine model | #6515 |
| infant feeding | #6523 |
| adam | #6524 |
| repeated measurements | #6527 |
| increased expression | #6529 |
| fev1 fvc | #6530 |
| diseases risk | #6548 |
| implied | #6555 |
| centers | #6567 |
| 1012 | #6571 |
| statements | #6572 |
| completion | #6598 |
| 283 | #6602 |
| disease onset | #6602 |
| children adults | #6604 |
| pollutant | #6605 |
| hospital admissions | #6617 |
| promoter region | #6624 |
| consumed | #6647 |
| host pathogen | #6653 |
| accessible | #6653 |
| adjusted 95 | #6654 |
| intervention studies | #6660 |
| playing | #6672 |
| 138 | #6684 |
| candidate genes | #6684 |
| bacterium | #6709 |
| cell responses | #6711 |
| systematic search | #6715 |
| cytokines dendritic | #6716 |
| washout | #6720 |
| nod2 | #6730 |
| impulse | #6732 |
| haplotypes | #6732 |
| cells disease | #6734 |
| 0009 | #6734 |
| ova | #6739 |
| focuses | #6745 |
| 126 | #6750 |
| n10 | #6757 |
| cities | #6761 |
| quartiles | #6763 |
| height weight | #6765 |
| mumps | #6769 |
| plethysmography | #6771 |
| eosinophilic | #6783 |
| disease mechanisms | #6787 |
| 065 | #6794 |
| developing | #6798 |
| 330 | #6807 |
| remained | #6813 |
| chronic exposure | #6823 |
| microbiology | #6831 |
| elucidated | #6846 |
| growing | #6846 |
| mz | #6852 |
| microorganism | #6861 |
| 305 | #6868 |
| cream | #6874 |
| lower incidence | #6887 |
| functional studies | #6890 |
| beef | #6896 |
| incidences | #6900 |
| inert | #6911 |
| academia | #6924 |
| supplementary | #6934 |
| zona | #6939 |
| multivariate logistic | #6941 |
| tertiles | #6948 |
| specific effects | #6949 |
| 1 diabetes | #6962 |
| 044 | #6965 |
| pathogenic bacteria | #6972 |
| lung | #6972 |
| maturation | #6975 |
| specialists | #6986 |
| infections | #6991 |
| transducer | #6998 |
| obesity bmi | #6999 |
| attendance | #7012 |
| summarizes | #7024 |
| infectious diseases | #7025 |
| shaping | #7027 |
| ribosomal 16s | #7033 |
| organic compounds | #7037 |
| 231 | #7041 |
| 028 | #7042 |
| confirming | #7043 |
| evidence association | #7046 |
| explaining | #7053 |
| amelioration | #7060 |
| concert | #7095 |
| 313 | #7102 |
| 019 | #7109 |
| type 1 diabetes | #7111 |
| linoleic acid | #7111 |
| triggering | #7114 |
| breath tests | #7117 |
| serum total | #7117 |
| 164 | #7122 |
| increased incidence | #7128 |
| th1 | #7132 |
| homeobox | #7134 |
| male membrane | #7135 |
| health humans | #7136 |
| homozygote | #7150 |
| consenting | #7153 |
| compare | #7155 |
| daily life | #7165 |
| increased risks | #7167 |
| likewise | #7184 |
| agents anti | #7184 |
| spatial variation | #7197 |
| develop | #7209 |
| health nutrition | #7223 |
| irritable bowel syndrome | #7227 |
| helper cell | #7228 |
| discusses | #7228 |
| spore | #7229 |
| cohort | #7231 |
| grow | #7238 |
| 163 | #7243 |
| influences | #7244 |
| beta1 | #7244 |
| analyses | #7255 |
| 0015 | #7268 |
| standardised | #7277 |
| 058 | #7278 |
| 053 | #7283 |
| handling | #7288 |
| urbanization | #7299 |
| herpesviridae | #7299 |
| 022 | #7309 |
| internationality | #7310 |
| single nucleotide polymorphisms | #7317 |
| personalized | #7355 |
| attending | #7374 |
| air pollutants | #7376 |
| 199 | #7387 |
| rome | #7392 |
| university | #7411 |
| linoleic | #7424 |
| potential risk | #7443 |
| histories | #7457 |
| 9 months | #7467 |
| human body | #7474 |
| boiling | #7486 |
| stratification | #7488 |
| bronchi | #7493 |
| alps | #7515 |
| spp | #7515 |
| enrollment | #7519 |
| intestinal diseases | #7523 |
| pediatrics | #7535 |
| toxoplasmosis | #7551 |
| bowel diseases | #7561 |
| allele | #7582 |
| eosinophil | #7586 |
| oropharyngeal | #7591 |
| considerably | #7612 |
| overt | #7613 |
| diseases animals | #7613 |
| worked | #7643 |
| school | #7649 |
| 316 | #7658 |
| haemophilus | #7669 |
| health conditions | #7671 |
| peanut | #7684 |
| prenatal | #7684 |
| rna ribosomal | #7700 |
| 161 | #7725 |
| nox | #7726 |
| europe | #7728 |
| leukocytes | #7731 |
| population | #7736 |
| characterised | #7744 |
| vehicles | #7748 |
| 308 | #7763 |
| single | #7777 |
| flora | #7792 |
| clinical examination | #7797 |
| infant male | #7799 |
| attended | #7802 |
| sputum | #7804 |
| reader | #7805 |
| lymphocyte subsets | #7808 |
| 66 | #7809 |
| 171 | #7839 |
| pyrosequencing | #7845 |
| conjunction | #7848 |
| m3 | #7856 |
| pa | #7859 |
| participation | #7865 |
| 1996 | #7881 |
| investigators | #7882 |
| specific | #7895 |
| deficiencies | #7898 |
| asked | #7899 |
| specificities | #7907 |
| months age | #7912 |
| parasitic | #7915 |
| epigenesis genetic | #7919 |
| neisseria | #7922 |
| 160 | #7928 |
| protective role | #7929 |
| egg | #7933 |
| therapeutic intervention | #7939 |
| listeria monocytogenes | #7941 |
| pbmcs | #7944 |
| fall | #7947 |
| unresolved | #7949 |
| prevalence incidence | #7950 |
| lockdown | #7950 |
| immune function | #7953 |
| altering | #7959 |
| human subjects | #7966 |
| collecting | #7980 |
| explanatory | #7997 |
| fatty acid composition | #8002 |
| lacking | #8024 |
| 264 | #8040 |
| bordetella | #8049 |
| phorbol | #8077 |
| separately | #8084 |
| rising | #8086 |
| 304 | #8087 |
| helper inducer | #8091 |
| weight infant | #8101 |
| 088 | #8109 |
| determinants | #8119 |
| regarded | #8119 |
| multiple logistic | #8132 |
| career | #8149 |
| factor binding | #8160 |
| polymorphism genetic | #8162 |
| gene regulation | #8172 |
| etiologies | #8201 |
| omega3 | #8202 |
| mutually | #8209 |
| initiative | #8212 |
| sophisticated | #8214 |
| 140 | #8224 |
| community based | #8228 |
| epigenesis | #8236 |
| emerged | #8237 |
| 266 | #8255 |
| hypotheses | #8257 |
| cars | #8265 |
| examination | #8283 |
| modifiable | #8285 |
| adolescent | #8294 |
| 242 | #8295 |
| hc | #8303 |
| belonged | #8306 |
| humans immunization | #8308 |
| based cohort | #8312 |
| nights | #8331 |
| objectives | #8337 |
| critical roles | #8342 |
| 111 | #8348 |
| nasal mucosa | #8351 |
| genera | #8357 |
| nineteen | #8357 |
| pylori infection | #8359 |
| normal weight | #8367 |
| instillation | #8385 |
| interleukin10 | #8388 |
| relative abundance | #8412 |
| latest | #8415 |
| author | #8420 |
| spearman | #8422 |
| infant low | #8429 |
| covariate | #8435 |
| authorities | #8438 |
| aspergillosis | #8440 |
| reduce risk | #8441 |
| 16s | #8447 |
| 113 | #8460 |
| multifactorial | #8460 |
| syncytial | #8462 |
| anhydride | #8462 |
| contrasting | #8463 |
| minor | #8478 |
| similarities | #8478 |
| profound | #8479 |
| investigate | #8497 |
| asthmatic patients | #8506 |
| resembles | #8511 |
| mass body | #8521 |
| genetic factors | #8538 |
| relations | #8543 |
| cytokines | #8544 |
| so2 | #8558 |
| prospective cohort study | #8565 |
| extract | #8568 |
| 4 years | #8590 |
| inclusion | #8598 |
| genetic loci | #8618 |
| humidity | #8633 |
| facilitates | #8642 |
| strong evidence | #8645 |
| logistic | #8648 |
| animal | #8656 |
| dendritic cells dcs | #8665 |
| adaptive | #8676 |
| 101 | #8677 |
| oropharynx | #8681 |
| defines | #8685 |
| histamine | #8716 |
| responsiveness | #8726 |
| increased odds | #8730 |
| choosing | #8732 |
| prevention | #8737 |
| 193 | #8776 |
| exploring | #8780 |
| 30 years | #8799 |
| airborne | #8805 |
| vdr | #8811 |
| incidence infant | #8815 |
| integrates | #8824 |
| unknown | #8840 |
| alveoli | #8852 |
| antibody levels | #8861 |
| traditional | #8865 |
| 155 | #8867 |
| association analysis | #8868 |
| humans logistic | #8879 |
| cesarean | #8884 |
| ears | #8884 |
| burden disease | #8884 |
| utilization | #8888 |
| residence | #8903 |
| bdnf | #8911 |
| pools | #8916 |
| 273 | #8926 |
| processed | #8935 |
| reactive protein | #8944 |
| pattern recognition | #8957 |
| lipopolysaccharide lps | #8958 |
| olive | #8963 |
| phase | #8966 |
| 177 | #8983 |
| 194 | #8996 |
| 0007 | #8998 |
| underlying | #9006 |
| 172 | #9017 |
| preschool humans | #9028 |
| surveyed | #9029 |
| humans lung | #9031 |
| sequelae | #9032 |
| receptor 4 | #9040 |
| population surveillance | #9046 |
| transferase | #9049 |
| cytokine | #9057 |
| boys girls | #9070 |
| london | #9088 |
| lower risk | #9095 |
| median duration | #9096 |
| parturition | #9101 |
| flanking | #9109 |
| nutritional physiological | #9139 |
| determinant | #9154 |
| statistical methods | #9170 |
| differing | #9175 |
| study selection | #9180 |
| butyrate | #9182 |
| secretions | #9187 |
| food | #9198 |
| exert | #9209 |
| dogs | #9217 |
| fungi | #9222 |
| 186 | #9234 |
| accompanying | #9239 |
| pattern | #9248 |
| human skin | #9259 |
| popularity | #9269 |
| multivariate analyses | #9269 |
| 04 | #9278 |
| 275 | #9282 |
| counts | #9296 |
| quintile | #9297 |
| controversial | #9299 |
| tract | #9302 |
| 95 women | #9304 |
| allele frequency | #9306 |
| haplotype | #9306 |
| outcome measures | #9309 |
| 345 | #9313 |
| anova | #9328 |
| prospectively | #9334 |
| eosinophilia | #9338 |
| vocs | #9351 |
| logistic regression analysis | #9353 |
| funded | #9360 |
| olds | #9364 |
| responders | #9364 |
| proteinase | #9366 |
| urban | #9376 |
| tlr4 | #9383 |
| infantile | #9386 |
| numerous | #9388 |
| 232 | #9392 |
| maldi | #9404 |
| ages | #9407 |
| newborn | #9409 |
| incidence | #9412 |
| 286 | #9422 |
| 5000 | #9432 |
| streptococcus | #9438 |
| extrinsic | #9445 |
| sick | #9460 |
| countries | #9478 |
| 016 | #9481 |
| anthropometric | #9495 |
| worker | #9498 |
| fatty acids | #9509 |
| longitudinally | #9512 |
| comprise | #9517 |
| markers | #9532 |
| antigen presenting | #9554 |
| 256 | #9559 |
| body composition | #9561 |
| airway obstruction | #9573 |
| 165 | #9574 |
| pharyngeal | #9579 |
| global health | #9583 |
| social class | #9585 |
| ifn gamma | #9589 |
| actinobacteria | #9597 |
| nutritive | #9598 |
| replicated | #9599 |
| occurrence | #9605 |
| lessons | #9617 |
| increases risk | #9627 |
| substances | #9659 |
| mucous | #9666 |
| adult mice | #9669 |
| dietary supplements | #9672 |
| crude | #9672 |
| child child | #9678 |
| reference | #9687 |
| obesity | #9698 |
| common genetic | #9743 |
| diagnoses | #9743 |
| populationbased study | #9744 |
| 9 | #9746 |
| p004 | #9752 |
| mothers | #9753 |
| mononuclear cells | #9760 |
| il10 | #9761 |
| proinflammatory | #9761 |
| publications | #9772 |
| directly | #9772 |
| 1 protein | #9773 |
| obstruction | #9774 |
| body mass bmi | #9788 |
| reliable | #9790 |
| 158 | #9800 |
| electrophoretic | #9807 |
| therapeutic strategies | #9818 |
| prove | #9826 |
| 20th | #9843 |
| random allocation | #9844 |
| 102 | #9849 |
| cluster | #9849 |
| modifying | #9850 |
| rrna | #9873 |
| nps | #9884 |
| restrictive | #9899 |
| altogether | #9903 |
| reality | #9904 |
| receptors | #9909 |
| immunomodulatory | #9920 |
| tagging | #9925 |
| intranasal | #9929 |
| century | #9933 |
| 39 | #9935 |
| southern | #9938 |
| 1991 | #9964 |
| bacterial infections | #9964 |
| tnf α | #9973 |
| 0002 | #9995 |
| exclusively | #10002 |
| 152 | #10006 |
| lavage fluid | #10012 |
| presenting cells | #10012 |
| particulate matter | #10015 |
| mass bmi | #10020 |
| health outcomes | #10050 |
| reproducible | #10052 |
| 57 | #10065 |
| disappeared | #10087 |
| 87 | #10096 |
| elucidation | #10099 |
| parts | #10121 |
| superoxide dismutase | #10123 |
| immune cell | #10127 |
| 072 | #10143 |
| nasal | #10159 |
| exist | #10160 |
| bias | #10162 |
| expression genes | #10164 |
| ascertained | #10166 |
| sedentary behavior | #10168 |
| exclusions | #10169 |
| 4 months | #10169 |
| timing | #10174 |
| incidence prevalence | #10175 |
| discover | #10203 |
| western | #10210 |
| microbial communities | #10218 |
| fungal | #10222 |
| adaptor proteins | #10226 |
| alpha subunit | #10236 |
| weaker | #10259 |
| influenzae | #10264 |
| 212 | #10290 |
| study children | #10303 |
| ghana | #10324 |
| aim | #10332 |
| analyze | #10356 |
| interleukin12 | #10361 |
| factorial | #10361 |
| 142 | #10364 |
| concepts | #10386 |
| centrally | #10386 |
| methodologies | #10387 |
| ulcerative colitis | #10399 |
| respiratory disease | #10403 |
| 17 | #10408 |
| polyunsaturated | #10422 |
| parasites | #10430 |
| scientific | #10436 |
| modelled | #10448 |
| nose | #10465 |
| flow rate | #10471 |
| bronchiolitis | #10473 |
| exposed | #10477 |
| 07 | #10499 |
| realtime pcr | #10503 |
| c3h | #10522 |
| twothirds | #10527 |
| interquartile range | #10528 |
| adjusted | #10532 |
| acetates | #10561 |
| 94 | #10565 |
| new zealand | #10576 |
| 010 | #10595 |
| biodiversity | #10595 |
| societal | #10603 |
| france | #10605 |
| priming | #10614 |
| homeodomain | #10623 |
| time pcr | #10638 |
| boys | #10643 |
| indirectly | #10650 |
| bacteriological | #10653 |
| 206 | #10664 |
| 004 | #10665 |
| ribosomal | #10691 |
| vitamins | #10703 |
| bidirectional | #10706 |
| positivity | #10711 |
| possibilities | #10723 |
| 008 | #10728 |
| items | #10729 |
| newborn infant | #10763 |
| ancestry female | #10768 |
| nitrous | #10770 |
| swabs | #10771 |
| entered | #10774 |
| female gastrointestinal | #10776 |
| regulation humans | #10776 |
| responses | #10786 |
| skin | #10787 |
| transferases | #10789 |
| increased production | #10799 |
| national institute | #10805 |
| suppressing | #10825 |
| workshop | #10850 |
| physical activity | #10855 |
| postnatal | #10859 |
| prevent | #10862 |
| bronchoalveolar | #10864 |
| fvc | #10873 |
| km2 | #10911 |
| functional role | #10915 |
| standardization | #10926 |
| 2002 | #10934 |
| 036 | #10944 |
| carriers | #10949 |
| subclinical | #10957 |
| microbiological | #10968 |
| subsequent | #10971 |
| 16s rrna | #10983 |
| immunoglobulins | #10986 |
| lps | #10988 |
| 217 | #10992 |
| roc | #10992 |
| 191 | #10993 |
| constituents | #10993 |
| harm | #10994 |
| 197 | #10996 |
| aerosol | #11002 |
| swiss | #11006 |
| inconsistent | #11009 |
| chance | #11022 |
| poland | #11028 |
| antibody responses | #11043 |
| amniotic | #11054 |
| 6 12 | #11055 |
| low birth | #11092 |
| serology | #11092 |
| passive | #11120 |
| chromosomes human | #11127 |
| ulcerative | #11134 |
| disturbed | #11159 |
| 235 | #11177 |
| crohn | #11187 |
| community | #11188 |
| 144 | #11222 |
| gut | #11232 |
| il12 | #11233 |
| confined | #11247 |
| environmental pollutants | #11258 |
| fourth | #11270 |
| 157 | #11286 |
| rna messenger | #11289 |
| duration | #11314 |
| regulatory mechanisms | #11327 |
| highest risk | #11328 |
| intron | #11330 |
| studies diet | #11351 |
| persistent | #11353 |
| chronic diseases | #11376 |
| 040 | #11389 |
| birth weight | #11397 |
| juvenile | #11415 |
| nitrogen dioxide | #11427 |
| cell function | #11428 |
| modulate | #11435 |
| supplements | #11440 |
| 18 years | #11446 |
| discuss | #11455 |
| female | #11457 |
| 105 | #11459 |
| epigenetics | #11463 |
| gut microbiota | #11475 |
| quinolines | #11485 |
| genetic susceptibility | #11493 |
| 128 | #11502 |
| factor1 | #11515 |
| 86 | #11521 |
| haemophilus influenzae | #11522 |
| late onset | #11524 |
| helicobacter | #11533 |
| biomarker | #11536 |
| 012 | #11542 |
| cd28 | #11550 |
| interact | #11564 |
| 78 | #11583 |
| households | #11587 |
| proteases | #11587 |
| variant | #11588 |
| physiological phenomena | #11594 |
| healthy control | #11597 |
| 130 | #11601 |
| celiac | #11633 |
| risk disease | #11636 |
| dispersion | #11666 |
| narrative | #11668 |
| interquartile | #11709 |
| gene polymorphisms | #11736 |
| introduction | #11752 |
| trimester pregnancy | #11755 |
| confirmation | #11758 |
| harmful | #11806 |
| lipopolysaccharides | #11813 |
| 222 | #11824 |
| gram negative | #11824 |
| irrespective | #11831 |
| 075 | #11858 |
| subtypes | #11860 |
| episodes | #11867 |
| incident | #11881 |
| insight | #11899 |
| fetal | #11900 |
| 230 | #11904 |
| air | #11924 |
| started | #11931 |
| genetic | #11936 |
| ifn | #11939 |
| 1990 | #11944 |
| autoantigens | #11967 |
| natural | #11982 |
| lowest | #11990 |
| genetic association | #11992 |
| protein levels | #11997 |
| finding | #12007 |
| initially | #12014 |
| 151 | #12047 |
| solely | #12055 |
| quantifying | #12075 |
| pcr | #12106 |
| case control | #12121 |
| ultimately | #12124 |
| upregulation | #12127 |
| immunologic factors | #12176 |
| subsets | #12179 |
| estimating | #12184 |
| country | #12201 |
| young children | #12219 |
| 149 | #12221 |
| inflammatory response | #12238 |
| leukocyte count | #12248 |
| fish oil | #12249 |
| december | #12256 |
| sle | #12270 |
| shifted | #12297 |
| began | #12327 |
| relapsing | #12330 |
| antibiotics | #12339 |
| 006 | #12341 |
| gm | #12351 |
| completed | #12354 |
| european continental | #12371 |
| minority | #12421 |
| linkage | #12422 |
| reasons | #12444 |
| ifngamma | #12445 |
| relevance | #12447 |
| lung tissue | #12462 |
| colonization | #12463 |
| 170 | #12467 |
| european | #12469 |
| inflammatory cytokine | #12469 |
| lymphocyte activation | #12520 |
| saline | #12546 |
| 17 years | #12583 |
| scarce | #12583 |
| 117 | #12590 |
| defense | #12609 |
| length polymorphism | #12616 |
| predictors | #12620 |
| tobacco | #12634 |
| crohns disease | #12638 |
| discriminating | #12641 |
| 203 | #12655 |
| residence characteristics | #12657 |
| tested | #12664 |
| collect | #12680 |
| detectable | #12682 |
| 156 | #12683 |
| cd3 | #12684 |
| total | #12687 |
| child development | #12695 |
| cystic fibrosis | #12696 |
| contributing | #12697 |
| residential | #12708 |
| multicentre | #12731 |
| beta2 | #12735 |
| aspect | #12741 |
| swedish | #12751 |
| enhancer | #12752 |
| 204 | #12773 |
| clinical manifestations | #12796 |
| 184 | #12815 |
| lung diseases | #12819 |
| combinations | #12856 |
| 104 | #12860 |
| pregnancy | #12873 |
| aspects | #12899 |
| sedentary | #12908 |
| translated | #12918 |
| infants | #12943 |
| elevated levels | #12943 |
| united kingdom | #12946 |
| debate | #12955 |
| human genome | #12959 |
| inflammatory bowel | #12963 |
| coded | #12998 |
| 154 | #13016 |
| 52 | #13056 |
| annually | #13056 |
| 220 | #13057 |
| elusive | #13067 |
| extracellular vesicles | #13082 |
| future | #13086 |
| suffer | #13086 |
| glucocorticoids humans | #13096 |
| genetic rna | #13096 |
| intrauterine | #13097 |
| measurable | #13120 |
| delayed | #13147 |
| conversely | #13160 |
| schistosomiasis | #13161 |
| differential effects | #13191 |
| strong association | #13209 |
| glucocorticoid | #13217 |
| methodological | #13236 |
| great | #13255 |
| developing countries | #13257 |
| 127 | #13262 |
| consultation | #13264 |
| 276 | #13267 |
| 018 | #13274 |
| proportions | #13279 |
| stimulated | #13297 |
| weaning | #13299 |
| hallmark | #13313 |
| 017 | #13323 |
| manifestations | #13333 |
| gene | #13338 |
| odds ratios | #13351 |
| nucleotide risk | #13354 |
| pediatric | #13397 |
| crp | #13407 |
| initiate | #13419 |
| 11 | #13424 |
| burden | #13446 |
| bowel | #13447 |
| kingdom | #13448 |
| auc | #13449 |
| mechanisms underlying | #13450 |
| 210 | #13457 |
| 20th century | #13476 |
| younger | #13480 |
| secretion | #13500 |
| 129 | #13518 |
| considerable | #13527 |
| 045 | #13543 |
| relevant | #13545 |
| confirm | #13567 |
| beijing | #13578 |
| visits | #13581 |
| 188 | #13602 |
| statistically | #13612 |
| respiratory syncytial | #13621 |
| 1989 | #13652 |
| inheritance | #13663 |
| 181 | #13690 |
| argue | #13695 |
| 020 | #13702 |
| depending | #13723 |
| lavage | #13735 |
| 014 | #13736 |
| pneumonia | #13774 |
| study association | #13782 |
| neighboring | #13790 |
| impairment | #13810 |
| sweden | #13833 |
| schistosoma | #13835 |
| severe | #13852 |
| concerns | #13856 |
| cohorts | #13856 |
| establishing | #13859 |
| genomics humans | #13875 |
| human pair | #13893 |
| ranged | #13900 |
| multiplex | #13937 |
| loci | #13953 |
| membrane glycoproteins | #14048 |
| mental health | #14054 |
| additionally | #14064 |
| chromosomes | #14069 |
| fat mass | #14090 |
| restore | #14107 |
| tendency | #14138 |
| nucleotide polymorphism | #14141 |
| establish | #14142 |
| subgroups | #14166 |
| immigrants | #14182 |
| randomly selected | #14189 |
| examples | #14202 |
| fetal development | #14226 |
| expand | #14234 |
| 183 | #14237 |
| concomitant | #14257 |
| socioeconomic status | #14258 |
| multigene | #14259 |
| disease genome | #14278 |
| refined | #14314 |
| breast | #14318 |
| unsaturated | #14320 |
| addresses | #14337 |
| independently | #14350 |
| health organization | #14355 |
| tightly | #14399 |
| amniotic fluid | #14424 |
| severity | #14432 |
| 121 | #14439 |
| penicillium | #14441 |
| epidemiologic studies | #14443 |
| tuberculosis | #14444 |
| 1 month | #14454 |
| 007 | #14492 |
| studying | #14492 |
| derivation | #14517 |
| tolerance | #14521 |
| contributed | #14529 |
| conclude | #14532 |
| systematically | #14533 |
| elevated | #14573 |
| humans | #14580 |
| factors socioeconomic | #14586 |
| cystic | #14593 |
| stranded | #14599 |
| food intake | #14600 |
| horse | #14606 |
| animals antigens | #14624 |
| 6 | #14638 |
| differentially expressed | #14641 |
| effector cells | #14675 |
| 205 | #14693 |
| striking | #14700 |
| lymphocyte count | #14703 |
| lipopolysaccharide | #14704 |
| filament | #14706 |
| transcription | #14707 |
| representative | #14726 |
| tetradecanoylphorbol | #14755 |
| classify | #14766 |
| trimester | #14772 |
| operate | #14777 |
| represents | #14788 |
| glycoproteins | #14799 |
| maximal | #14801 |
| cells patients | #14821 |
| determines | #14831 |
| 2 years | #14850 |
| seropositivity | #14866 |
| genetic analysis | #14890 |
| mice mice | #14912 |
| 002 | #14917 |
| ancestry | #14925 |
| maternal age | #14929 |
| clostridium | #14981 |
| marker | #14999 |
| ctla4 | #15005 |
| 162 | #15012 |
| ethnic | #15032 |
| male | #15042 |
| receptor | #15068 |
| compared healthy | #15084 |
| modulates | #15087 |
| disparities | #15118 |
| 00001 | #15123 |
| stronger | #15140 |
| p00001 | #15177 |
| luciferase | #15184 |
| gram | #15200 |
| longitudinal studies | #15223 |
| immune cells | #15233 |
| 131 | #15264 |
| hong kong | #15269 |
| cumulative | #15330 |
| copd | #15346 |
| nfkappab | #15356 |
| environmental monitoring | #15362 |
| socioeconomic | #15368 |
| gestational age | #15392 |
| curve | #15407 |
| physician | #15419 |
| integrate | #15467 |
| induce | #15469 |
| assessing | #15476 |
| modulated | #15501 |
| cells dcs | #15509 |
| perinatal | #15516 |
| pregnancy risk | #15527 |
| gonadal | #15550 |
| marked | #15553 |
| feces | #15556 |
| dysregulation | #15556 |
| 003 | #15556 |
| 110 | #15569 |
| built | #15581 |
| archaea | #15621 |
| tgfβ | #15667 |
| cytometry | #15669 |
| controlling | #15688 |
| inflammatory agents | #15708 |
| dietary fats | #15739 |
| cell surface receptors | #15743 |
| igg | #15765 |
| genotype | #15766 |
| il1 | #15772 |
| imply | #15830 |
| pregnant | #15831 |
| exclusive | #15843 |
| developed countries | #15863 |
| 47 | #15874 |
| cells animals | #15894 |
| 116 | #15895 |
| socioeconomic factors | #15901 |
| sensitivity specificity | #15922 |
| reflected | #15966 |
| humans inflammation | #15992 |
| agreement | #16016 |
| varies | #16017 |
| diagnosed | #16043 |
| unrelated | #16046 |
| casecontrol study | #16049 |
| filled | #16050 |
| transient | #16060 |
| conditional | #16084 |
| interleukin1beta | #16103 |
| major | #16105 |
| 12 | #16129 |
| located | #16168 |
| homozygous | #16182 |
| effector | #16208 |
| inducer | #16232 |
| anti inflammatory | #16238 |
| transducing | #16239 |
| psychosocial | #16242 |
| 93 | #16314 |
| born | #16347 |
| dendritic cells | #16365 |
| define | #16372 |
| causing | #16382 |
| bacterial | #16387 |
| 7 | #16394 |
| genome wide | #16420 |
| varied | #16428 |
| squared | #16431 |
| volatile | #16432 |
| 082 | #16433 |
| bacteria | #16447 |
| represented | #16476 |
| height | #16488 |
| ibd | #16518 |
| established | #16536 |
| identifying | #16549 |
| participants | #16561 |
| thought | #16634 |
| triggered | #16636 |
| areas | #16662 |
| broad | #16671 |
| academic | #16675 |
| functionally | #16694 |
| microsatellite | #16697 |
| genetic polymorphism | #16725 |
| characterizing | #16726 |
| 0006 | #16756 |
| dendritic | #16762 |
| centre | #16765 |
| 084 | #16783 |
| distributed | #16795 |
| agricultural | #16798 |
| dead | #16800 |
| nitric oxide | #16855 |
| chromosome | #16895 |
| bowel disease | #16898 |
| personal | #16912 |
| 91 | #16918 |
| 09 | #16918 |
| investigating | #16978 |
| utilize | #16980 |
| opportunities | #17033 |
| promoter | #17034 |
| steroid | #17056 |
| anti bacterial | #17061 |
| dna bacterial | #17074 |
| 81 | #17089 |
| mother | #17091 |
| epigenetic | #17095 |
| continuing | #17105 |
| messenger | #17106 |
| progression | #17115 |
| monocytes | #17130 |
| genotypes | #17190 |
| confirms | #17201 |
| individual | #17225 |
| seasons | #17244 |
| 53 | #17287 |
| untranslated | #17292 |
| denmark | #17301 |
| 137 | #17321 |
| retinoic | #17351 |
| earlier | #17361 |
| drug therapy | #17361 |
| cross | #17377 |
| encountered | #17387 |
| taxonomic | #17423 |
| visible | #17455 |
| strong | #17549 |
| excluding | #17551 |
| tnfalpha | #17598 |
| heterozygote | #17605 |
| alleles | #17619 |
| avoidance | #17647 |
| bronchoalveolar lavage | #17656 |
| bacterial agents | #17666 |
| introduced | #17690 |
| cd4 cells | #17717 |
| dcs | #17724 |
| initiating | #17727 |
| comparing | #17740 |
| newborns | #17784 |
| quantified | #17787 |
| regression | #17798 |
| lesser | #17810 |
| geographical | #17857 |
| interviewed | #17866 |
| 84 | #17903 |
| covering | #17927 |
| prospective | #17949 |
| bmi | #17963 |
| animals | #17994 |
| 009 | #18003 |
| drawn | #18014 |
| disease chronic | #18024 |
| longitudinal | #18047 |
| particulate | #18073 |
| monthly | #18086 |
| 77 | #18100 |
| altered | #18146 |
| 085 | #18150 |
| publication administration | #18171 |
| children adolescents | #18178 |
| snp | #18187 |
| neurotrophic | #18224 |
| systemic lupus erythematosus | #18235 |
| samples | #18263 |
| restriction fragment | #18268 |
| negative | #18269 |
| dismutase | #18321 |
| susceptibility | #18324 |
| demographics | #18339 |
| recognize | #18347 |
| inflammatory responses | #18460 |
| inflammatory bowel disease | #18499 |
| chemokines | #18511 |
| served | #18518 |
| difference | #18526 |
| mast cell | #18536 |
| 148 | #18545 |
| replication | #18548 |
| exists | #18580 |
| immunization | #18589 |
| remain | #18590 |
| intervals | #18593 |
| secretory | #18604 |
| carried | #18634 |
| fold | #18655 |
| provided | #18675 |
| 83 | #18683 |
| 36 | #18709 |
| symptom | #18710 |
| differentially | #18718 |
| variation genome | #18742 |
| rise | #18757 |
| weight | #18797 |
| epithelial cells | #18798 |
| candidate | #18807 |
| sum | #18807 |
| additional | #18812 |
| immunophenotyping | #18818 |
| families | #18838 |
| basis | #18843 |
| 1997 | #18843 |
| 28 | #18854 |
| maintain | #18856 |
| variants | #18858 |
| 13 | #18882 |
| fragment length | #18919 |
| missing | #18966 |
| lower | #18985 |
| sampling | #19004 |
| receptors cell | #19024 |
| intake | #19030 |
| vitamin | #19034 |
| experiencing | #19122 |
| susceptible | #19133 |
| fats | #19173 |
| balb mice | #19208 |
| crosssectional study | #19250 |
| c57bl mice | #19256 |
| promoter regions | #19283 |
| polymerase | #19291 |
| locus | #19302 |
| clinical presentation | #19308 |
| 1992 | #19352 |
| contributes | #19382 |
| termed | #19414 |
| trait loci | #19415 |
| mouse model | #19415 |
| clear | #19476 |
| partially | #19504 |
| completely | #19506 |
| elucidate | #19510 |
| socio | #19512 |
| × 10 | #19521 |
| pollutants | #19552 |
| validated | #19554 |
| necrosis | #19582 |
| illustrate | #19602 |
| lasting | #19718 |
| time polymerase | #19720 |
| healthrelated quality | #19789 |
| polymerase chain | #19797 |
| 1998 | #19855 |
| inbred balb mice | #19855 |
| chronic obstructive | #19868 |
| 5 years | #19869 |
| selecting | #19937 |
| carrying | #19967 |
| baseline | #19977 |
| context | #19977 |
| negatively | #19998 |
| 95 confidence interval | #20023 |
| inbred balb | #20051 |
| interferon gamma | #20056 |
| easy | #20065 |
| acetaminophen | #20066 |
| shared | #20130 |
| 74 | #20150 |
| 64 | #20157 |
| health | #20163 |
| activates | #20164 |
| summary | #20181 |
| reporter | #20212 |
| serological | #20244 |
| adjusting | #20271 |
| 1 year | #20289 |
| interacting | #20295 |
| autoimmune diseases | #20301 |
| 61 | #20339 |
| stimulation | #20363 |
| 14 | #20418 |
| identifies | #20457 |
| demonstrating | #20473 |
| 2003 | #20528 |
| humans longitudinal | #20557 |
| returned | #20566 |
| ratio | #20593 |
| 26 | #20613 |
| inflammatory | #20615 |
| interactions | #20618 |
| behavior female | #20629 |
| nitric | #20636 |
| chain reaction | #20655 |
| upregulated | #20694 |
| highest | #20707 |
| genetically | #20746 |
| immunologic | #20771 |
| recurrent | #20779 |
| cells female | #20794 |
| interleukin | #20806 |
| wide | #20813 |
| clarify | #20844 |
| blood | #20864 |
| 51 | #20870 |
| cd4 cell | #20884 |
| rodents | #20894 |
| infectious | #20895 |
| causal | #20898 |
| create | #20974 |
| mucosal | #20983 |
| named | #20988 |
| obstructive | #20991 |
| interval | #21015 |
| suggesting | #21054 |
| 59 | #21130 |
| hereditary | #21187 |
| identical | #21192 |
| followup | #21199 |
| regulation | #21207 |
| epithelial cell | #21236 |
| essentially | #21325 |
| kappab | #21354 |
| variety | #21563 |
| mast | #21565 |
| celiac disease | #21617 |
| infection | #21622 |
| endpoint | #21718 |
| tumor necrosis | #21799 |
| reduced | #21829 |
| 10 years | #21837 |
| measures | #21851 |
| stress psychological | #21874 |
| alterations | #22024 |
| definitive | #22102 |
| assess | #22118 |
| continued | #22161 |
| correlate | #22201 |
| familial | #22235 |
| ensure | #22257 |
| frequency | #22288 |
| abolished | #22332 |
| continental ancestry | #22431 |
| reflecting | #22432 |
| unchanged | #22438 |
| validation | #22455 |
| score | #22546 |
| frequent | #22558 |
| tumor necrosis factor | #22615 |
| 95 confidence | #22620 |
| balb | #22645 |
| closely | #22684 |
| genes | #22753 |
| coupled | #22803 |
| continuously | #22829 |
| reactive | #22841 |
| indicating | #22843 |
| comparable | #22875 |
| murine | #22957 |
| 22 | #22977 |
| neonatal | #22988 |
| supported | #23008 |
| introduce | #23009 |
| type 1 | #23013 |
| report | #23048 |
| ifnγ | #23104 |
| necrosis factor | #23137 |
| predict | #23148 |
| lived | #23179 |
| increasingly | #23205 |
| rich | #23217 |
| count | #23292 |
| smoking | #23305 |
| modulating | #23348 |
| late | #23357 |
| mechanisms | #23394 |
| confidence | #23438 |
| 1 | #23526 |
| young | #23528 |
| adjustment | #23611 |
| exclude | #23665 |
| endopeptidases | #23709 |
| adolescents | #23720 |
| factors united | #23849 |
| defined | #23927 |
| extensive | #23929 |
| body | #24002 |
| dietary | #24027 |
| intracellular | #24110 |
| 5 | #24167 |
| 3 | #24232 |
| lymphocytes | #24242 |
| aimed | #24342 |
| increasing | #24355 |
| symptomatic | #24455 |
| depend | #24530 |
| reduces | #24548 |
| interaction | #24609 |
| collected | #24626 |
| adults | #24658 |
| remains | #24734 |
| needed | #24798 |
| responsible | #24851 |
| rsv | #24888 |
| 15 | #24969 |
| putative | #25032 |
| identification | #25068 |
| enrolled | #25223 |
| representing | #25239 |
| yielded | #25263 |
| determine | #25273 |
| extracellular | #25281 |
| analysis performed | #25297 |
| sex factors | #25359 |
| documented | #25522 |
| anti | #25535 |
| describing | #25574 |
| comprised | #25660 |
| matter | #25795 |
| transcriptase polymerase | #25871 |
| continue | #25896 |
| lymphocyte | #25994 |
| decreased | #26047 |
| enabling | #26157 |
| diminished | #26261 |
| previous | #26271 |
| healthy | #26310 |
| 16 | #26319 |
| profiling gene | #26374 |
| implicated | #26377 |
| dioxide | #26380 |
| inflammation | #26386 |
| tended | #26519 |
| applied | #26644 |
| contained | #26780 |
| describes | #26787 |
| generally | #26891 |
| multivariate | #26969 |
| capable | #27003 |
| unaffected | #27064 |
| presenting | #27110 |
| moderate | #27144 |
| 18 | #27195 |
| heterozygous | #27203 |
| acquired | #27213 |
| oligonucleotide | #27226 |
| concluded | #27331 |
| undergone | #27359 |
| topic | #27376 |
| proteins signal | #27393 |
| reached | #27432 |
| large | #27637 |
| recognized | #27654 |
| positive lymphocytes | #27691 |
| 001 | #27802 |
| linked | #27832 |
| preschool female | #27932 |
| models genetic | #27987 |
| predicted | #28046 |
| 0005 | #28071 |
| subsequently | #28087 |
| quantitative | #28099 |
| respect | #28131 |
| represent | #28157 |
| impaired | #28234 |
| reverse transcriptase | #28434 |
| continental | #28581 |
| plays | #28633 |
| positive | #28648 |
| immunoenzyme | #28655 |
| occurring | #28707 |
| screened | #28708 |
| square distribution | #28750 |
| transcriptase | #29017 |
| quantitative trait | #29137 |
| versus | #29158 |
| allowed | #29194 |
| comparison | #29267 |
| affect | #29339 |
| administered | #29469 |
| easily | #29520 |
| human | #29690 |
| weak | #29736 |
| possess | #29786 |
| physical | #29792 |
| pair | #29885 |
| correlated | #29909 |
| chain | #29911 |
| characterize | #29984 |
| gastrointestinal | #30316 |
| providing | #30537 |
| 005 | #30590 |
| aims | #30608 |
| factual | #30658 |
| 2 | #30659 |
| confirmed | #30719 |
| markedly | #30761 |
| 4 | #30907 |
| eligible | #31311 |
| fatty | #31332 |
| upper | #31437 |
| frequently | #32564 |
| mice knockout | #32696 |
| predictive tests | #32836 |
| peripheral | #32944 |
| humanized | #33092 |
| expression | #33163 |
| registered | #33261 |
| functional | #33617 |
| dominated | #33759 |
| selected | #33999 |
| mediated | #34372 |
| independent | #34407 |
| activate | #34542 |
| acids | #34703 |
| occur | #34769 |
| mediate | #35225 |
| conducted | #35568 |
| national | #35610 |
| evaluate | #35821 |
| 0001 | #35859 |
| developed | #36145 |
| characterized | #36394 |
| measurements | #36573 |
| express | #37054 |
| measured | #37778 |
| follow studies | #37967 |
| appears | #37978 |
| biological | #38141 |
| examined | #38373 |
| include | #39853 |
| adult | #39859 |
| clinically | #40140 |
| united | #42200 |
| mice inbred | #42559 |
| consistent | #42590 |
| excluded | #42832 |
| expression regulation | #43143 |
| inbred | #45657 |
Sacar un reporte | |
Prominent publications by Erika RM von Mutius
KOL-Index: 23349
BACKGROUND: Exposure to paracetamol during intrauterine life, childhood, and adult life may increase the risk of developing asthma. We studied 6-7-year-old children from Phase Three of the International Study of Asthma and Allergies in Childhood (ISAAC) programme to investigate the association between paracetamol consumption and asthma.
METHODS: As part of Phase Three of ISAAC, parents or guardians of children aged 6-7 years completed written questionnaires about symptoms of asthma, ...
| Conocido por Risk Asthma | 7 Years | Year Life | Children Aged | Rhinoconjunctivitis Eczema |
KOL-Index: 18397
BACKGROUND: Phase III of the International Study of Asthma and Allergies in Childhood measured the global prevalence of symptoms of asthma, rhinoconjunctivitis, and eczema in children.
OBJECTIVE: To investigate the associations between the use of antibiotics in the first year of life and symptoms of asthma, rhinoconjunctivitis, and eczema in children 6 and 7 years old.
METHODS: Parents or guardians of children 6 and 7 years old completed written questionnaires on current symptoms and ...
| Conocido por International Study | Rhinoconjunctivitis Eczema | Year Life | Symptoms Asthma | 95 Risk Factors |
Phenotypes of Atopic Dermatitis Depending on the Timing of Onset and Progression in Childhood
[ PUBLICATION ]
Importance: Atopic dermatitis is an inflammatory, pruritic skin disease that often occurs in early infancy with a chronic course. However, a specific description of subtypes of atopic dermatitis depending on the timing of onset and progression of the disease in childhood is lacking.
Objective: To identify different phenotypes of atopic dermatitis using a definition based on symptoms before age 6 years and to determine whether some subtypes are more at risk for developing other allergic ...
| Conocido por Atopic Dermatitis | 6 Years | Age Children | Allergic Diseases | Food Allergy |
KOL-Index: 17686
BACKGROUND: Associations between exposure to cats and dogs and respiratory and allergic outcomes in children have been reported in affluent countries, but little is known about such associations in less-affluent countries.
METHODS: The International Study of Asthma and Allergies in Childhood, phase 3 was carried out in children aged 6-7 years and adolescents aged 13-14 years across the world. Questions about cats and dogs in the home were included in an additional questionnaire. Using ...
| Conocido por Cats Dogs | Asthma Rhinoconjunctivitis | Affluent Countries | Children Adolescents | International Study |
KOL-Index: 15451
BACKGROUND: There is increasing evidence that environmental exposures determining childhood illnesses operate early in life. Prenatal exposure to a farming environment through the mother might also play an important role.
OBJECTIVE: We sought to investigate the role of maternal exposures to environments rich in microbial compounds for the development of atopic sensitization, asthma, and corresponding alterations in the innate immune system in offspring.
METHODS: In the children of the ...
| Conocido por Atopic Sensitization | Innate Immunity | Farm Exposure | Microbial Compounds | Expression Receptors |
Perennial allergen sensitisation early in life and chronic asthma in children: a birth cohort study
[ PUBLICATION ]
BACKGROUND: Reduced lung function is a feature of chronic asthma, which becomes apparent at school age. Unknown factors between birth and school age determine the progressive loss of pulmonary function in children with persistent asthma. We investigated the role of allergic sensitisation and allergen exposure early in life.
METHODS: The German Multicentre Allergy Study followed 1314 children from birth to 13 years of age. We regularly interviewed parents about their child's asthma and ...
| Conocido por Chronic Asthma | School Age | Life Children | Birth Cohort | Allergen Exposure |
Prevalence of asthma and allergic disorders among children in united Germany: a descriptive comparison.
[ PUBLICATION ]
OBJECTIVES: To compare the prevalence of asthma and allergic disorders among children in Munich, western Germany, and Leipzig, eastern Germany, where environmental exposure, particularly air concentrations of sulphur dioxide and particulate matter, and living conditions have differed over the past 45 years.
DESIGN: Prevalence surveys among school-children aged 9-11 years in Leipzig and Munich. Self completion of written questionnaire by the children's parents and lung function ...
| Conocido por Allergic Disorders | Munich Leipzig | Prevalence Asthma | Seasonal Surveys | Living Conditions |
KOL-Index: 14833
BACKGROUND: Asthma is a complex disease that has genetic and environmental causes. The genetic factors associated with susceptibility to asthma remain largely unknown.
METHODS: We carried out a genomewide association study involving children with asthma. The sample included 793 North American children of European ancestry with persistent asthma who required daily inhaled glucocorticoid therapy and 1988 matched controls (the discovery set). We also tested for genomewide association in an ...
| Conocido por European Ancestry | Association Asthma | Single Nucleotide Receptors | Tumor Necrosis Factor | Human Pair |
Early life exposure to farm animals and symptoms of asthma, rhinoconjunctivitis and eczema: an ISAAC Phase Three Study
[ PUBLICATION ]
BACKGROUND: Associations between early life exposure to farm animals and respiratory symptoms and allergy in children have been reported in developed countries, but little is known about such associations in developing countries.
OBJECTIVE: To study the association between early life exposure to farm animals and symptoms of asthma, rhinoconjunctivitis and eczema in a worldwide study.
METHODS: Phase Three of the International Study of Asthma and Allergies in Childhood (ISAAC) was carried ...
| Conocido por Farm Animals | Asthma Rhinoconjunctivitis | Isaac Phase | Early Life | Affluent Countries |
KOL-Index: 14598
The German reunification offers a unique opportunity to study the impact of environmental factors on the development of childhood respiratory and allergic disorders in ethnically similar populations. We investigated the prevalence of asthma, hay fever, atopy, and bronchial hyperresponsiveness (BHR) in 9- to 11-year old children in West Germany (n = 5,030) and East Germany (n = 2,623). A self-administered questionnaire was distributed to the parents. Children underwent cold air challenge ...
| Conocido por East Germany | Asthma Fever | Prevalence Bhr | Environmental Factors | Atopic Sensitization |
Phase II of the International Study of Asthma and Allergies in Childhood (ISAAC II): rationale and methods
[ PUBLICATION ]
International comparative studies, investigating whether disease incidence or prevalence rates differ between populations and, if so, which factors explain the observed differences, have made important contributions to the understanding of disease aetiology in many areas. In Phase I of the International Study of Asthma and Allergies in Childhood (ISAAC), the prevalence rates of symptoms of asthma, allergic rhinitis and atopic eczema in 13-14-yr-olds, assessed by standardised ...
| Conocido por International Study | Asthma Allergies | Prevalence Rates | Atopic Eczema | Childhood Isaac |
KOL-Index: 13844
BACKGROUND: Mutations in the filaggrin gene (FLG) have been shown to play a significant role in ichthyosis vulgaris and eczema, 2 common chronic skin diseases. However, their role in the development of other atopic diseases such as asthma and rhinitis has not yet been clarified in large population-based studies.
OBJECTIVES: To study the effect of FLG mutations at the population level and their effect on other atopic phenotypes.
METHODS: Association analysis of the 2 common FLG-null ...
| Conocido por Filaggrin Mutations | Atopic Eczema | Allergic Rhinitis Asthma | Role Development | Disease Genotype Humans |
Increased food diversity in the first year of life is inversely associated with allergic diseases
[ PUBLICATION ]
BACKGROUND: The role of dietary factors in the development of allergies is a topic of debate, especially the potential associations between infant feeding practices and allergic diseases. Previously, we reported that increased food diversity introduced during the first year of life reduced the risk of atopic dermatitis.
OBJECTIVE: In this study we investigated the association between the introduction of food during the first year of life and the development of asthma, allergic rhinitis, ...
| Conocido por Food Diversity | Allergic Diseases | Year Life | Development Asthma | Atopic Sensitization |
Gente clave para Atopic Dermatitis
Los KOLs mas influyentes del mundo
Seleccione una frase de búsqueda atopic dermatitis , atopic dermatitis patients , atopic dermatitis psoriasis , atopic dermatitis children , atopic dermatitis asthma
Erika RM von Mutius:Impacto experto
Conceptos para los cualesErika RM von Mutiustiene influencia directa:Atopic dermatitis, Childhood asthma, Allergic diseases, Atopic sensitization, Allergic rhinitis, International study, Farm milk, East germany.
Erika RM von Mutius:Impacto de Kol
Conceptos relacionados con el trabajo de otros autores para los cualesfor which Erika RM von Mutius tiene influencia:Atopic dermatitis, Allergic rhinitis, Childhood asthma, Food allergy, Lung function, Air pollution, Early life.
Tools
¿Es este tu perfil? Reclama tu perfil Copiar URL Incrustar el enlace a su perfil |